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First coated synthetic absorbable
Coated for smoothness
Allows adjustable knot
tension for precise knot
placement
Produces less suture drag
than uncoated synthetic
absorbables

• Low tissue reaction
• Soft—on the surgeon's
hands
• Complete absorption
before 90 days
• High in vivo tensile
strength

ETH ICO N
Innovators in wound closure
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Sofra-Hille

Tested and proven for
over 19 years...that means
quality performance.
Sofra-Tulle is a quality surgical dressing
that goes on treating the wound long after
application. Bactericidal against Gram
positive and Gram negative infections,
Sofra-Tulle remains active in the presence of
blood, pus and serum .1

Sofra-Tulle is soft and pliable with minimal
adherence, easy to cut and contour to fit
the lesion. Sofra-Tulle avoids maceration,
helps drain exudate, and provides a sterile
healing environment.

Sofra-Hille
Leadership in wound repair
from Roussel

ROUSSEL*.
1. Data on File Roussel Canada Inc.

Montreal,Quebec
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The Case for Tube Feeding
The enteral route should always be considered
first, because it is simple, economical, and
well tolerated in most patients.15'6
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‘Because it is nutritionally complete, lactose-free
and with an osmolality of only 300 mOsm/kg H Q ,
w e have been able to use this product full
strength, straight from the can, without the
►
necessity for dilution or progressive adaptation,
^
and without the induction of abdominal
cramps and diarrhea!’ 4
Isotonic, ISOCAL* is low in osmolality:
With a low osmolality (300 mOsm/kg H ,0 ),
patients adapt rapidly and absorption occurs

T
’

with few side effects.12'3’5'6
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His body has been hit hard.
A t a time like this, do you really want to subject
him to a narcotic?
W ith Marcaine, you don’t have to.
Marcaine, injected as a nerve block prior to
closure, provides up to twelve hours of pain-free
recovery tim e/1)
That’s tw o to three times longer than lidocaine/2)

It gives complete sensory block with o r without
significant motor block depending upon the con
centration used. It means you can delay using a narcotic
during that critical stabilizing post-op period.
Because Marcaine lets your patient come around
long before the pain.
Winthrop Laboratories
Division of Sterling Drug Ltd., Aurora, Ontario L4G 3H6.

Marcaine!

Delay the pain, delay the need for narcotics.

*
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Marcaine is contraindicated in persons with known sensitivity to
local anaesthetics of the amide type.
When used with epinephrine the usual caution in respect of any
vasopressor drug applies.
The use of Marcaine is contraindicated in the presence of sepsis
near the site of proposed injection, in severe shock and in heart block.

Precautions
The lowest dosage that gives effective anaesthesia should be used,
to avoid high plasma levels and serious systemic side effects.
Injection of repeated doses of Marcaine may cause a significant increase
in blood levels due to accumulation of the drug or its metabolites.
Tolerance varies with the status of the patient. Debilitated,
elderly and acutely ill patients may require reduced doses
commensurate with age and physical condition.
Safe use in pregnant women, other than in labour, has not
been established.
Foetal bradycardia may follow paracervical block with local
anaesthetics of the amide type and may be associated with foetal
acidosis. Foetal heart rate should always be monitored during
paracervical anaesthesia. Added risk appears to be present in pre
maturity, toxaemia of pregnancy and foetal distress. The physician
should weigh the possible advantages against dangers when
considering paracervical block in these conditions. When the
recommended dose is exceeded, the incidence of foetal bradycardia
increases. The incidence of foetal bradycardia, observed in clinical
trials with Marcaine in which paracervical block was used, varied
between zero and 35%.
Obstetric m s are reminded that severe persistent hypertension
may occur if oxytocic drugs are administered to patients who have
already received a vasopressor.
Solutions containing a vasopressor agent, should be used with
caution, if at all, in patients who are receiving monoamine oxidase
inhibitors or tricyclic antidepressants because severe prolonged
hypertension may result. Dose related cardiac arrhythmias may occur
if preparations containing epinephrine are employed in patients
during or immediately following the administration of chloroform,
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The decision to use a local anaesthetic containing a vasocon
strictor in areas with a limited blood supply or in patients with
peripheral vascular disease, will depend on the physician’s appraisal
of the relative advantages and risks.
Administration of Marcaine in children under 12 years is not
recommended.
Caution is advised in administration of repeat doses of Marcaine
to patients with severe liver disease.
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overdosage, inadvertent intravascular injection, or slow metabolic
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sometimes merging into unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills,
constriction of the pupils, or tinnitus. The cardiovascular manifesta
tions of excessive plasma levels may include depression of the
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Now PRE-OP sponges with
chlorhexidine
gluconate:
A popular antiseptic and a popular sponge
now com bined into ^com pletely new system.

PRE-OP* sponges with
chlorhexidine... the advantai
the complete system:
’ PRE-OP and PRE-OP II.. .choice of sponge or
sponge/brush formats.
• Excellent antiseptic.. .chlorhexidine has a
broad antibacterial spectrum, is bactericidal knd
fungicidal, has a rapid bacterial kill rate,
persistent effect, and is virtually non-irritating.
1 Maximum convenience.. .complete system
eliminates need for a separate brush.
* Economical, controlled antiseptic dose.
eliminates the frequent overuse of liquid soaps
from dispensers.
• Sterile, single-use sponges or sponge/
brushes... can’t harbor pathogenic organisms
as soap dispensers0 '2 3) and reusable
brushes can.
’ Always ready to use... no dispenser refilling, no
clogging, no mechanical problems, and no
maintenance.
• Fast, pleasant lather.. .and soecial
emollient-containing formula is easy on the
hands.
Minimal possibility of reactions.. .dilution during
use avoids high antiseptic concentration on
skin.
Superior removal of resident as well as transient
micro-organisms.. .sponge orsponge/brush
format more likely to dislodge resistant bacteria.

And, most importantly, proven
chlorhexidine effectiveness:
Improved log kill.. .the recommended scrub
time of PRE-OP and PRE-OP II sponges with
chlorhexidine provides a significantly improved
log kill when compared to that achieved with
the chlorhexidine soap recommended scrub
time (4)
Standard “Glove Juice" Antiseptic test proves
that the highly recommended 5-minute scrub
effectively utilizes the full potential of
chlorhexidine and yields a significantly greater
log kill.. .a valuable extra margin of safety.
DAViS+GECK
Cyanamid Canada Inc.

Atria North, 2255 Sheppard Ave. E., Suite E440
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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Dedication of the Archibald Amphitheatre,
Royal Victoria Hospital, Montreal, June 1981
To gather knowledge and to find out
new knowledge is the noblest occupation
of the physician. To apply that know
ledge with understanding, and with
sympathy born of understanding, to the
relief of human suffering is his loveliest
occupation; and to do both with an
unassuming faithfulness sets the seal on
the whole.
Those were the words of the great
man whose name we honour and
perpetuate today in this dedication
ceremony. He spoke them on the
occasion of the official opening of the
Montreal Neurological Institute and
he was exhorting the members of the
staff to excel — as indeed they did.
But he was really simply expressing
his own philosophy, or, better, de
scribing the personal objectives that
he had long since achieved, for he
had gathered knowledge and he had
certainly applied it with understanding
and sympathy to the relief of human
suffering. Edward Archibald was by
then both a world-renowned scientist
and a revered doctor.
As one of the most junior survivors
of those who were his students I am
indeed honoured to have been given
the opportunity to pay tribute to one
who played such a key role in the
development of surgical research, of
surgical treatment in several fields,
of the education of surgeons, of this
hospital and of his university, McGill.
My only contact with him as a
student was most impersonal; he was
the lecturer and I was one of the 120
students in a large theatre. But here
the word impersonal is misleading for
the lecturer exuded personality, and
this had its effect.
His course of lectures came at the
very beginning of our clinical careers;

we had barely recovered from the
grind of the basic sciences — we
had found anatomy particularly hard
to bear in its deadly earnestness,
where everything was so cut and
dried, so regimented and where one’s
very life seemed to hang on one's
ability to memorize. Here, to our
delight, was a new approach involving
a degree of relaxation, inquiry, spe
culation and a liberal smattering of
panache. There was a certain staging
to the relaxation; it arose from Dr.
Archibald’s lifelong conviction that
nothing should ever start on time;
that, in this case, the proper time
for the start of a 9 o’clock lecture
was 9:15 — or 9:25 on a fine day.

I)r. Edward Archibald

The first few minutes of his lecture
would be devoted to such subjects
as the importance of a leisurely break
fast, the need to vary the menu (a
principle sometimes illustrated by the
disclosure of that day’s actual fare)
together with any spicy pieces that
he had found in that day’s Montreal
Gazette or in the morning mail, both
of which he always read carefully
before he set out for the day. Having
thus attracted our attention in a way
that no other lecturer ever had, he
would then launch into his proper
subject in a fascinating way — no
dogma, just questioning, thinking out
loud. There was nothing that one
could use in answering examination
questions, to be sure, and this was
perhaps a trifle disappointing at the
time, but the method was deeply
appreciated later on when we came
to recognize the true worth of these
short sessions. And short they were.
The lecture would usually cease well
before the hour had ended — before
10 o’clock, that is — often, we sus
pect, because the professor had just
recalled that he had another ap
pointment for 9 o'clock that day and
he didn’t want to be too late.
It is not often, I think, that a man
so apparently casual and dilatory in
some respects is as effective as Edward
Archibald was. The typical absentminded professor is usually much
more absent-minded than productive.
But here we have one who, by any
standard, would be judged supremely
absent-minded, whose career was
studded with solid accomplishments.
This seeming paradox was not the
only one in his make-up for he
exhibited a host of conflicting quali-
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ties such as intuitiveness and pain
staking logic, intellectual restlessness
and a superb sense of relaxation,
earthiness and dreaminess, cautious
ness and a certain apparent rashness,
vagueness and precision.
The unopposed qualities that must
be brought to the front of the stage
at once were courage, generosity,
kindliness, wit, loyalty (to his family,
his proteges, his friends, all the insti
tutions with which he was associated,
and his country) and finally an allpervading charm to which I had the
good fortune to be exposed directly
later on when I was a junior officer
in the army and he, having responded
to his country's call for the second
time, was the chief consultant in
surgery to the National Defence
Headquarters and was reputed to be
the oldest man in a Canadian uniform
overseas during the second world war.
Clearly the resultant of this mixture
of forces or qualities (a mixture that
could only be described by a genea
logist who might determine the rela
tive proportions of Irish and Scottish
blood in his veins) was positive. In
the four professional fields in which
a man of his calling is usually judged
Dr. Archibald scored highly. Let me
examine them briefly.
To deal first with administration,
the dullest of all pursuits in a surgical
department, I can suspect that he was
the despair of the hospital and pro
bably the university’s administration.
I think it unlikely that he would
have attended meetings, filled in
forms, answered letters — in short,
that he would have done those things
that an administrator ought, strictly
speaking, to do. He had more pressing
things to attend to, but in matters of
real importance in the administrative
field he was demonstrably good. He
took over a surgical service that was
seriously dishevelled and dispirited
and moulded it into a unit effective
in every respect. He developed a train
ing program for residents; he brought
on his junior staff and trusted his
senior colleagues; he organized a sur
gical research department and he
played a vital part in the development
of the Montreal Neurological Insti
tute and the promotion of other
specialty units. In short, he did the
things that administrators really
ought to do.
I have already spoken — not ir
reverently, I assure you — about his
teaching of undergraduates. I tried
to convey the impression that he
provided a breath of fresh air that
went a long way to reviving our
spirits. If he was effective at this level
448

he was more so in his work with
graduate students (residents and re
search assistants) and with his junior
staff men, a generation of surgeons
many of whose members became
important leaders in their fields hav
ing been pushed, prodded, beguiled
and encouraged —■ in a word, edu
cated — by their chief in an era when
chiefs were inclined to defend their
own position against all comers rather
than assist those who might, indeed
would certainly, supplant them.
If one had to select a single feature
to illustrate Dr. Archibald’s contri
bution to the field of surgical educa
tion the most obvious choice would
be his influence on graduate training
in surgery. As president of the Ameri
can Surgical Association in 1935, he
outlined in his presidential address
his views on the training of a surgeon.
The immediate and most certainly
direct response was the establishment
of the American Board of Surgery
and later, when our own Royal Col
lege of Physicians and Surgeons drew
up its training requirements the
Archibald touch was clearly dis
cernible. There is no doubt that the
widespread replacement of a hapha
zard process, which had existed up
to that time, by an orderly, balanced,
carefully planned system of training
was advanced if not initiated by our
professor.
Laboratory research in a surgical
department, commonplace nowadays,
was seldom seen in the early years
of this century when Dr. Archibald
began his work. He was an avid
investigator. Soon after his graduation
in medicine in 1896 he published his
first paper, a case report, and there
followed over the next 50 years a
steady stream of publications (over
100), many of which were important.
In 10 of these he reported the results
of studies conducted in his laboratory.
The most noteworthy of these studies
had to do with his classical experi
ments in producing pancreatitis —
work that he did more than 60 years
ago which is still cited in current
articles on the subject.
While in his day he was, in the
truest sense, a general surgeon (he
was an accomplished neurosurgeon,
an expert in abdominal surgery and
an occasional urologist and ortho
pedic and plastic surgeon) he is most
widely known for his work in the
surgery of pulmonary tuberculosis in
which field he is regarded as an out
standing pioneer; he became known
as the father of thoracic surgery in
America. One cannot even begin to
describe here the extent of his con

tributions to this field; let me simply
say they were enormous. They called
for many of the qualities that I men
tioned earlier; for example, intuitively
he knew that something could be
done surgically to speed the recovery
of people afflicted with pulmonary
tuberculosis but it was painstaking
logic, based on experiments, trials
and a constant review of results that
led him to discover which patients
would benefit from one procedure or
another. Basically a cautious man he
appeared at times to be rash, just as
any pioneer appears to be rash as
he makes his first move. But if rash
ness connotes inconsiderate haste or
boldness it was certainly more ap
parent than real in this instance, for
one knows that this surgeon planned
every step with the greatest care and
only moved when he was convinced
that the chances of success warranted
the risk.
He was, in sum, a thoughtful,
courageous, versatile, brilliant man to
whom any part of the hospital might
appropriately be dedicated — a ward,
an operating theatre, a research la
boratory or an auditorium. Perhaps
the last, which is the one that has
been chosen, is the most suitable, for
it is in this hall where the results of
work in the wards, the theatres and
the laboratories will be reviewed,
where students will be taught and,
above all, where ideas will be tossed
about, dissected and recombined. It
is here where all the activities so
splendidly pursued by Edward Archi
bald are brought together and thus
where his name can only serve as an
inspiration.
H.

R ocke R o b er tso n , m d ,
FRCS(EDIN), FACS, FRCS[C]

Honorary archivist.
The Royal College of Physicians
and Surgeons of Canada,
Ottawa, Ont.
November 1981 issue
The next issue of this journal
will contain a group of three
papers on various aspects of
osteonecrosis. These papers were
presented as part of the 1980
basic science course on the sub
ject of osteonecrosis, sponsored
by the University of Ottawa.
Also appearing in the November
issue will be several papers
presented at the 1981 annual
meeting of the Canadian Asso
ciation of Clinical Surgeons,
eastern division.
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On Stopping the Heart
The heart. . .does not stop
unless forever.

In their article on page 483 of
this issue, Salerno and associates raise
an interesting question: if a surgeon
must rearrest the heart to deal with
an operative complication, would a
second cardioplegic arrest be better
tolerated than other alternatives such
as ventricular fibrillation or anoxic
arrest? The authors do not answer
this question directly, since their
control group was not subjected to
any of these alternative measures.
What they do show, both in their
clinical series and the experimental
study, is that cardioplegic rearrest is
reasonably well tolerated. In their
experiments with pigs, this mode of
rearrest did cause some deterioration
in the myocardial bioenergetic para
meters. Although ventricular function
was not significantly affected, one
cannot exclude the possibility that
such negative findings could still be
due to the insensitivity of the para
meters chosen for study as well as to
the small sample size, as surgeons are
becoming increasingly aware and
weary of the statistical fi (type II)
errors. Furthermore, their results
should not be construed as implying
that two episodes of cardioplegia with
a period of reperfusion between can

L eon ard o da V inci

Cardiac surgeons have tried despera
tely to stop the heart to obtain a
quiet, bloodless operative field. To
achieve this, hearts have been choked
(inflow occlusion), starved (anoxic
arrest), electrocuted (induced fibril
lation), force-fed (coronary perfusion)
and poisoned (chemical cardioplegia).
That the heart can withstand these
assaults is testimony to its rugged
nature, on which life iself depends.
After the rapid advances of the
last two decades, the current obsession
in cardiac surgery is how best to
protect the myocardium while the
heart is arrested during operative
procedures. The most recent and
widely employed method is potassium
cold cardioplegia, in which a high
concentration of potassium rapidly
induces cardiac arrest to conserve
energy and hypothermia drastically
reduces the metabolic processes to
minimize ischemic damage. It pro
vides a flaccid and bloodless heart,
which is optimal for delicate surgical
procedures. The safe periods achieved
generally extend beyond 2 to 3 hours,
sufficient for most cardiac operations.

be better tolerated than one single
episode of prolonged cardioplegia. In
deed, some studies1’2 indicate that the
reverse is true.
Nevertheless, Salerno and associates
are probably correct in pointing out
that under the operative circumstan
ces they describe, it is best to rein
stitute potassium cold cardioplegia.
Their study, which combined clinical,
experimental, hemodynamic and bio
chemical observations also exemplifies
the modern approach to myocardial
protection, namely, a continuing at
tempt to base the surgical techniques
on sound physiologic principles.
C.J. C h i u , m d ,
Professor of surgery,
McGill University,
Montreal. PQ
R ay

ph

d , f r c s [c

]
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SESAP III Question
Items 309-312
(A) Necrotizing fasciitis
(B) Clostridial myositis
(C) Both
(D) Neither
309. Sudden onset with overlying skin necrosis
310. Crepitation usually present
311. Often associated with diabetes
312. Wide debridement an essential of primary treatment
For each numbered phrase above select the one lettered heading that is most closely associated with it. Each
lettered heading may be selected once, more than once or not at all.
For the critique of Items 309-312 see page 531 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self-assessment Program No.
3. For enrolment in the Surgical Education and Self-assessment Program No. 3, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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nuBRin
Nalbuphine HC1 Injection

Casts new light #
on narcotic analgesia
Provides the same analgesic efficacy as
meperidine or morphine
Nubain, a new injectable analgesic, has an onset, a
peak of action, and analgesic effectiveness similar to
those of meperidine or morphine. Nubain generally
provides longer analgesia (3-6 hours) than
I meperidine (2-4 hours), helping to reduce the
1 amount of narcotic required.

With a greater margin of safety
Unlike other narcotics which can cause undesirable
respiratory depression even at moderate doses1, the
respiratory depressant effect of Nubain is limited and
does not increase appreciably beyond a peak effect
equivalent to that produced by 20 mg/70 kg of
morphine1. Therapeutic doses of nalbuphine have
been associated with hemodynamic stability, and
clinical studies of the hemodynamic effects of
Nubain in patients with coronary artery disease and
acute myocardial infarction demonstrated that
nalbuphine HC1 produced no major untoward clinical
or cardiocirculatory effects2,3.

As an adjunct, to supplement surgical
anesthesia, Nubain provides
hemodynamic stability, good
postoperative analgesia and limits
postoperative respiratory depression
A recent study showed that nalbuphine is an effective
supplement to balanced anesthesia. Post-operative
recovery time may be reduced due to limited
respiratory depression and good post-operative

Significantly fewer side effects
Nubain has a lower incidence of reported side effects
than other narcotics or pentazocine6, causing
significantly less nausea and vomiting than
meperidine or morphine7. Psychotomimetic effects
have rarely been reported1. The incidence of
constipation is less than 1%6.

£ndo Laboratories
7000 Park Avenue
Montreal, P.Q. H3N 1X1
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Subsidiary of E 1 Dupont de Nemours Co. (Inc.)
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nuBnin

NUBAIN INJECTION
(Nalbuphine Hydrochloride) Analgesic
ACTION
Nubain (nalbuphine hydrochloride) is a synthetic narcotic
agonist-antagonist analgesic for parenteral use, related
chemically to the narcotic oxymorphone and to the
narcotic antagonist naloxone. Nabulphine has an
analgesic (agonist action) potency equivalent to that of
morphine on a milligram basis, and an antagonist activity
(reversal of major effects o f opioid drugs) about
one-fourth that of nalorphine and ten times that of
pentazocine. The analgesic effect o f 10 mg of nalbuphine
is about equal to that of 10 mg of morphine sulfate. The
onset o f action begins within 2 to 3 minutes after
intravenous administration, and within 15 minutes
following subcutaneous or intramuscular injection. The
plasma half life o f nalbuphine is five hours and the
duration o f action has ranged from three to six hours.
At the usual dose of 10 mg, nalbuphine produces
respiratory depression equivalent to that of equianalgesic
doses o f morphine. At much higher doses, above 30 mg
i.v. (which produces a respiratory depressant activity
equivalent to 20 mg of morphine i.v.), the respiratory
depressant effect of nalbuphine does not appear to
increase appreciably. Nalbuphine may precipitate
abstinence, when administered to individuals taking
narcotics chronically or produce withdrawal symptoms
when discontinued abruptly after prolonged use. It is
reported to have an abuse potential comparable to that of
pentazocine. The mechanism o f action of nalbuphine has
not yet been established.
INDICATIONS AND CLINICAL USE
NUBAIN (nalbuphine hydrochloride) is indicated for the
relief of moderate to severe pain.
Clinical studies indicate that it can also be used for
preoperative analgesia, as a supplement to surgical
anesthesia, and for obstetrical analgesia during labor.
CONTRAINDICATIONS
NUBAIN (nalbuphine hydrochloride) should not be
administered to patients who are hypersensitive to the
drug or to its inactive ingredients (see section on
‘AVAILABILITY’).
WARNINGS
In patients physically dependent on opiate drugs,
NUBAIN (nalbuphine hydrochloride) should not be given
prior to detoxication since withdrawal symptoms are
likely to be produced.
Drug Dependence:
On the basis o f behavioural, substitution and direct
addiction studies in humans. NUBAIN has been shown to
have low abuse potential which approximates that of
pentazocine. Psychological and physical dependence and
tolerance may follow the abuse or misuse of nalbuphine.
Therefore, caution should be observed in prescribing it
for emotionally unstable patients or for individuals with a
history of narcotic abuse. Such patients should be closely
supervised, since increases in dosage or frequency of
administration in susceptible individuals might result in
physical dependence.
Abrupt discontinuation of NUBAIN following prolonged
use has been followed by symptoms o f narcotic
withdrawal, such as abdominal cramps, nausea and
vomiting, rhinorrhea, lacrimation, restlessness, anxiety,
elevated temperature and piloerection.
Use in Ambulatory Patients:
NUBAIN may impair the mental or physical abilities
required for the performance o f potentially dangerous
tasks such as driving a car or operating machinery.
Therefore, NUBAIN should be administered with caution
to ambulatory patients, who should be warned to avoid
such hazards until recovered from the effects o f the drug.

Interaction With Other Central Nervous System
Depressants:
Although NUBAIN possesses narcotic antagonist
activity, there is evidence that in non-dependent patients
it may not antagonize the analgesic effect of narcotic
analgesics. Patients receiving narcotic analgesic, general
anesthetics, phenothiazines or other tranquilizers,
sedatives, hypnotics, or other CNS depressants (including
alcohol) concomitantly with NUBAIN may exhibit an
additive effect. When such combined therapy is
contemplated, the dose of one or both agents should
be reduced.
Use in Children:
Because clinical experience in children under the age of
12 years is limited, the administration of NUBAIN in this
age group is not recommended.
Use in Pregnancy:
Safe use of NUBAIN in pregnancy (other than labor) has
not been established. Although animal reproductive
studies have not revealed teratogenic or embryotoxic
effects, NUBAIN should only be administered to
pregnant women when, in the judgement of the
physician, the potential benefits outweigh the possible
hazards.
Use in Labor and Delivery:
Since NUBAIN can produce respiratory depression in the
neonate, it should be administered with caution to women
delivering premature infants.
Head Injury and Increased Intracranial Pressure:
The possible respiratory depressant effects and the
potential of potent analgesics to elevate cerebrospinal
fluid pressure (resulting from vasodilation following CO 2
retention) may be markedly exaggerated in the presence
of head injury, intracranial lesions, or a pre-existing
increase in intracranial pressure. Furthermore, potent
analgesics can produce effects which may obscure the
clinical course o f patients with head injuries. Therefore
NUBAIN should be administered in these circumstances
only when essential, and with extreme caution.
PRECAUTIONS
Impaired Respiration:
Caution should be observed when administering
NUBAIN (nalbuphine hydrochloride) to patients with
impaired respiration, or who are receiving other
medications which produce respiratory depression. In the
presence of bronchial asthma, uremia, severe infection,
cyanosis, or respiratory obstruction, NUBAIN should be
administered only with great caution and in reduced
doses. Respiratory depression induced by NUBAIN can
be reversed by the administration of naloxone
hydrochloride.
Impaired Renal or Hepatic Function:
Because NUBAIN is metabolized in the liver and
excreted by the kidneys, patients with renal or liver
dysfunction may show an exaggerated response to
customary doses. Therefore, in these individuals
NUBAIN should be used with caution and administered
in reduced amounts.
Myocardial Infarction:
As with all potent analgesics, NUBAIN should be used
with caution in patients with myocardial infarction who
have nausea or vomiting. Hemodynamic studies in
patients with severe arteriosclerotic heart changes reveal
that NUBAIN has circulatory effects similar to those of
morphine, i.e., a minimal decrease in oxygen
consumption, cardiac index, left ventricular end-diastolic
pressure and cardiac work.
Management o f Narcotic Withdrawal Symptoms:
If NUBAIN is inadvertently administered to a patient
physically dependent on narcotics and unduly
troublesome narcotic withdrawal symptoms develop,
these symptoms may be controlled by the slow
intravenous administration of small increments of
morphine, until relief occurs.

ADVERSE REACTIONS
In clinical trials with NUBAIN (nalbuphine
hydrochloride) the most frequently reported side effects
were: sedation (36%) of 1066 patients treated), sweating
or clamminess (9%), nausea or vomiting (6%), dizziness
or vertigo (5%), dry mouth (4%) and headache (3%).
Other adverse reactions which may occur:
Central Nervous System: nervousness, crying,
depression, restlessness, euphoria, hostility, confusion,
faintness, floating, unusual dreams, numbness, feeling of
heaviness, and psychotomimetic effects such as
hallucinations, feeling of unreality and dysphoria.
Cardiovascular: Hypertension, hypotension,
bradycardia, tachycardia.
Gastrointestinal: Cramps, dyspepsia, bitter taste.
Respiration: Depression, dyspnea, asthma.
Dermatological: Itching, burning, urticaria.
Miscellaneous: Speech difficulty, urinary urgency,
blurred vision, flushing and warmth.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE
Symptoms:
These are expected to be similar to those of other drugs of
this class. (The administration of single I.M. doses of
72 mg of NUBAIN to eight normal subjects has been
reported to have resulted primarily in symptoms of
sleepiness and mild dysphoria.)
Treatment:
NARCAN (naloxone hydrochloride) administered
intravenously is a specific antidote for NUBAIN. Since
the duration of action of NUBAIN may exceed that of
NARCAN, the patient should be kept under continued
surveillance and repeated doses of NARCAN should be
administered as necessary. Oxygen, intravenous fluids,
vasopressors and other supportive measures should be
employed as indicated.
DOSAGE AND ADMINISTRATION
The usual recommended dose of NUBAIN (nalbuphine
hydrochloride) is 10 mg for a 70 kg individual
administered subcutaneously, intramuscularly or
intravenously. This dose may be repeated every 3 to 6
hours as required. The recommended dosage range is 10
mg to 20 mg, with a maximum single dose of 20 mg and a
maximum total daily dose of 160 mg. Dosage should be
adjusted according to the severity of the pain, physical
status of the patient, and other medications which the
patient may be receiving. (See Interaction with Other
Central Nervous System Depressants under
‘WARNINGS’.)
Patients who have been taking narcotics chronically for
pain under medical supervision may experience
withdrawal symptoms upon the administration of
NUBAIN. If NUBAIN is administered to these patients
as an analgesic, it should be introduced gradually.
NUBAIN should not be used as a substitute for other
narcotics or for withdrawal purposes in individuals
dependent on these drugs.
AVAILABILITY
NUBAIN (nalbuphine hydrochloride) is supplied in glass
ampoules of 1 ml and 2 ml, and in multiple-dose vials of
10 ml containg 10 mg of nalbuphine hydrochloride per
ml. Each ml also contains 0.1% sodium chloride, 0.94%
sodium citrate, 1.26% citric acid anhydrous, 0.1%
sodium metabisulfite and 0.2% of a 9/1 mixture of
methylparaben and propylparaben as preservatives.
STORE AT CONTROLLED ROOM TEMPERATURE
(15° TO 30°C). PROTECT FROM EXCESSIVE LIGHT.
NUBAIN (nalbuphine hydrochloride) is a Schedule G
(Controlled) drug.

Lndo Loborotories
7000 Park Avenue,
Montreal, PQ. H3N 1X1
Subsidiary of E.I. Dupont de Nemours Co. (Inc.)
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Necrotizing Anaerobic Infections
J.K. Booking, md , R.L. H olliday, md, facs, frcs[c ] and J.H. D u ff , md , frcs[c]

Severe necrotizing anaerobic infections
carry a high mortality. From a
retrospective review of 17 cases
of gas gangrene, necrotizing fasciitis
and nonclostridial myonecrosis
seen at the Victoria and University
hospitals in London, Ontario, between
Jan. 1, 1975 and Dec. 31, 1977, the
most common antecedent was found
to be minor trauma. Location of the
infection varied; the scrotum
and perineum were most commonly
involved. Local findings were most
frequently edema, skin tenderness
and induration. Mixed infections
predominated with a pure growth of
C lostridium sp. occurring in only
three cases. The overall mortality was
29%.
The mainstay of treatment after
initial administration of fluids followed
by broad-spectrum antibiotics is
early aggressive surgical debridement
of all necrotic tissue.
Les infections necrosantes graves
a germes anaerobies entrainent une
forte mortalite. Dans une etude
retrospective de 17 cas de gangrene
gazeuse, de fasciite necrosante
et de myonecrose non clostridienne vus
aux hopitaux Victoria et University
de London, Ontario, entre le
le r janvier 1975 et le 31 decembre
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1977, les antecedents les plus
frequemment retrouves ont ete ceux
d'un traumatisme benin. Le siege
de I'infection variait, le scrotum et le
perinee etant les plus souvent
impliques. Les observations locales
les plus frequentes furent I'oedeme,
une sensibilite de la peau et de
I'indurstion. Les infections mixtes ont
predomine, une culture pure de
C lostridium sp. n’etant obtenue que
dans trois cas. Le taux de mortalite
global fut de 29%.
Apres I'administration initiale de
liquides et d'antibiotiques a large
spectre, la clef du traitement repose
sur un debridement agressif immediat
de tous les tissus necrotiques.

view our experience with this condi
tion over a 3-year period.

Patients
The records of 17 patients present
ing with gas gangrene, necrotizing
fasciitis and nonclostridial myonecro
sis at Victoria Hospital and Univer
sity Hospital in London, Ontario
between Jan. 1, 1975 and Dec. 31,
1977 were reviewed with respect to
location and antecedent cause of in
fection, presentation, bacteriology,
management and outcome. While the
diagnosis was made on clinical
grounds, tissue necrosis at the time
of operation was present in all the
cases reviewed. Debridement under
general anesthesia was carried out as
soon as possible after the diagnosis
Severe necrotizing anaerobic infec was
made.
tions are relatively uncommon among
civilians, but when they do occur
they carry a high mortality. Most Findings
surgeons seldom see these infections Location and Antecedent Causes
and may have difficulty >in differen
The majority of infections in this
tiating them from more superficial series
in the perineum,
non-necrotizing infections. Adequate, scrotumoccurred
and
abdominal
Only
aggressive surgical debridement of five patients had necrotizingwall.
infections
all necrotic tissue remains the main involving the extremities (Table I).
stay of treatment. The administration Notable as an antecedent event was
of antibiotics is certainly important minor trauma (Table II). Because of
but the roles of gas gangrene anti this the patient may delay in seeking
toxin and hyperbaric oxygen remain help and the physician may delay
controversial. We recently treated
several patients with necrotizing in
fections and this prompted us to re
T a b le I I — A n te c e d e n ts to I n f e c tio n *
A n te c e d e n t

T a b le 1— L o c a tio n o f
In fe c tio n s

L o c a tio n
S cro tu m an d p e rin e u m
A b d o m in a l w a ll
L o w e r e x tr e m ity
U p p e r e x tr e m ity

No. o f
p a tie n ts
7
5
4
1

M in o r tra u m a
A p p e n d e c to m y
S ig m o id c o le c to m y
M a jo r tra u m a
R e p a ir o f in c is io n a l h e rn ia
C h ild b ir th

N o. o f
p a tie n ts
7
2
3
2
1
1

♦ In fe c tio n o c c u rre d s p o n ta n e o u s ly in 1 pat ie n t .
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treatment. Intestinal surgery was an
antecedent in five cases. In these
cases contamination of the wound
with colonic bacteria at the time of
operation probably caused the infec
tion. Episiotomy was an unusual
antecedent. We believe that Fournier's
disease (fulminating gangrene of the
scrotum) arose spontaneously in one
patient.
Presentation
Most of the 17 patients presented
with the signs of early sepsis (Table
III) such as fever, tachycardia and
tachypnea. Of importance is the fact
that only six patients had a leukocyte
count greater than 10 X 1071 and
two had leukopenia indicating over
whelming sepsis. Only two patients
presented in frank septic shock.
The wounds did not necessarily
show all the classic signs of inflam
mation, but in all there was local tis
sue swelling and exquisite skin ten
derness (Table IV). Although it was
present in only seven patients, palp
able crepitus immediately pointed to
the severity of the underlying infec
tion.
Bacteriology
The list of bacteria cultured from
these wounds is long (Table V). Three
infections were due to Clostridium
perfringens alone; all the others were
due to mixed organisms. The most
common pathogens isolated were C.
perfringens, Escherichia coli, Bacteroides sp. and anaerobic strepto
coccus.
In 14 patients, two or more organ
isms were cultured; however, we
could not tell whether they were all
pathogens.
Blood cultures were done in nine
patients. The four specimens that
grew organisms grew only one type
each.
Management
All the patients were treated as
soon as the diagnosis was made by
aggressive surgical debridement of
all necrotic tissue where possible.
Initially they were treated with fluid
infusion starting with crystalloid (our
preference); blood or albumin were
given as indicated. The majority of
these patients had central venous
pressure lines or Swan-Ganz catheters
inserted to monitor hemodynamic
parameters following initial operation.
Postoperatively they were treated in
an intensive care unit. The adult
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respiratory distress syndrome develop
ed in 12 patients who required as
sisted ventilation. The surgeon should
be aware of this complication when
managing patients with necrotizing
anaerobic infections.
Outcome
Death occurred only in patients
whose infection arose on the torso
or extended onto it. Of the 17 patients
5 (29%) died.
Discussion

The management of necrotizing
anaerobic infections must be aggres
sive. As soon as the diagnosis is
made, antibiotics should be given.
Gram-staining of a specimen from
the wound should be done. The test
is simple and is essential in guiding
the physician in his choice of anti
biotic therapy. Aerobic and anaerobic
cultures of the wound and blood are
essential. Because of the prepon
derance of mixed pathogens, peni
cillin in large doses and gentamicin
should be used initially unless the
findings on Gram-staining suggest a
strain resistant to these agents. Clin
damycin should also be used in very
ill patients and when Bacteroides sp.
is the suspected pathogen. If the
patient is allergic to penicillin, chlor
amphenicol is an excellent alternative.
Despite the value of antibiotics, it is
essential that antibiotic use alone does
not give a false sense of security.
Of paramount importance and the
key to adequate treatment is aggres
sive surgical debridement of all necro
tic tissue; repeated debridement is
often required. The surgeon should
be aware thdt apparently normal skin
may need to be sacrificed in order
to debride underlying fascia or mus
cle. Frequent inspection of the wound
is essential and further debridement
or dressing changes should be carried
out as required.
Gas gangrene antitoxin was used
in two patients who deteriorated
clinically despite surgical debridement.
Earlier the use of gas gangrene anti

toxin was recommended,1 but today
with the many antibiotics, aggressive
surgery, supportive therapy and moni
toring techniques available, the role
of antitoxin is controversial.
None of the patients in this series
received hyperbaric oxygen therapy.
Some2 believe that hyperbaric oxygen
is the treatment of choice for gas
gangrene, and others3 that it may de
crease morbidity and reduce the need
for surgical debridement. According
to Altemeier and Fullen4 hyperbaric
oxygen therapy should not replace
good surgical debridement of estab
lished gas gangrene, and, until well
controlled clinical studies have been
completed, its use should be consid
ered experimental. In our centre
hyperbaric oxygen therapy is used
for those with a proven clostridial
infection that is beyond the scope of
surgical debridement and for the pa
tient who is deteriorating clinically.
The mortality of 29% in this series
compares favourably with that of
other reviews. In a review of gas
gangrene by Duff and associates5 the
mortality was 31%, and Rea and
Wyrick6 in their review of necrotizing
fasciitis had a rate of 30%.
Conclusions

Severe necrotizing anaerobic infec
tions are rare in civilians. Aggressive
surgical debridement is the mainstay
of treatment. Broad-spectrum antibio
tics are necessary for most infections,
and hemodynamic monitoring and
ventilatory support are also often

T a b le I V - A p p e a r a n c e o f W o u n d s

W o u n d p r e s e n t a t io n
Edem a
S k in t e n d e r n e s s
In d u r a t io n
G a n g r e n e o f s k in
C r e p it a t io n
E r y th e m a

No. of
p a t ie n ts
17
17
10
7
7
5

T a b le V — O r g a n is m s Is o la t e d fr o m W o u n d s

T a b le I I I — P r e s e n t in g S ig n s a n d S y m p to m s

S ig n /s y m p t o m
Fever > 3 8°C
T a c h y c a r d ia > 1 0 0 b e a t s / m i n
T a c h y p n e a > 2 5 /m in
L e u k o c y te c o u n t > 1 0 X 1 0 9/ l
O lig u r ia < 3 0 m l/ h
S e p tic s h o c k

No. of
p a t ie n t s
14
10
14
6
4
2

O rg a n is m

C lo s tr id iu m p e r f r in g e n s
E s c h e r ic h ia c o li
B a c te r o id e s sp .
S t r e p to c o c c u s s p .
S ta p h y lo c o c c u s e p i d e r m id i s
K l e b s i e l l a sp .
S ta p h y lo c o c c u s a u r e u s
E n te r o b a c te r sp .
P se u d o m o n a s sp.

No. of
p a t ie n t s
11
11
9
9
5
3
2
2
2
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necessary. The use of gas gangrene
antitoxin and of hyperbaric oxygen
is controversial in the treatment of
these life-threatening infections.
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Common Bile Duct Exploration: Indications and Results
L.G. H a m pso n ,

G.M. F ried , m d , J. St e t s , md , O.R. A y e n i , m d , f r c s [c ] and
F. B ourdon -C onochi e , md , c m , f r c p [c ]

md , frcs [c ],

To ascertain the best diagnostic
indicators of choledocholithiasis and
to decrease the incidence of retained
stones in the common bile duct after
exploration, the authors carried out
a retrospective review of 110
consecutive patients who underwent
common bile duct exploration for
calculous biliary tract disease.
Conditions that were most often
associated with choledocholithiasis
were cholangitis and clinically
obvious jaundice. The serum bilirubin
level was helpful in identifying
patients with stones in the common bile
duct only when the value was greater
than 6 mg/dl (103 u.mol/1), and
alkaline phosphatase only when the
value was more than 250 IU (normal
110 IU). When stones are felt in the
duct at operation, the diagnosis of
choledocholithiasis is certain; positive
operative cholangiograms are highly
reliable and the coexistence of
small gallstones and a dilated cystic
duct is suggestive.
The retention of stones is best
prevented by careful exploration
followed by high-quality T-tube
cholangiography performed at
operation after the exploration is
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complete. Any missed stones found in
this way should be removed by
re-exploration at the time of the
original operation.
Stones left in the common bile
duct are best extracted nonoperatively
under radiologic control. This
technique, while effective and safe,
is associated with considerable
morbidity.

Tous les calculs residuels trouves
de cette fagon devraient etre enleves
des I'operation initiate.
La meilleure maniere d'extraire
les calculs laisse s dans le choledoque
est de fagon non operatoire, sous
surveillance radiologique. Cette
technique, tout en etant sure et
efficace, est associee a une mortality
appreciable.

Afin d'etablir quels sont les meilleurs
indicateurs diagnostiques de la
choledocholithiase et d’evaluer
comment la cholangiographie par tube
en T peut reduire la frequence des
calculs persistant dans le choledoque
apres exploration, les auteurs ont
complete une etude retrospective de
110 patients consecutifs qui ont subi
un examen exploratoire du choledoque
pour calculs biliaires. Les affections
les plus souvent reliees a une
choledocholithiase furent la cholangite
et I’ictere cliniquement declare. Les
taux de bilirubine serique n’ont
permis d'identifier les patients
porteurs de calculs du choledoque
que quand ils etaient superieurs a
6 mg/dl (103 (j.mol/1), et la mesure
de la phosphatase alcaline n’a ete utile
que quand elle depassait 250 Ul
(la normale etant de 110 Ul). Quand,
a I'operation, des calculs sont pergus
dans le choledoque, le diagnostic de
choledocholithiase est certain; le
cholangiogramme peroperatoire positif
est tres fiable et la coexistence de
petits calculs et d'un canal cystique
dilate est evocatrice.
La meilleure fagon d'eviter la reten
tion des calculs consiste a faire une
exploration minutieuse suivie d’un
cholangiographie peroperatoire
par tube en T, de bonne qualite.

Despite advances made in diagnosing
calculous biiiary tract disease, sur
geons have been slow to recognize
the need for exploration of the com
mon bile duct. To prevent unneces
sary explorations of the duct and their
resultant morbidity, techniques have
been developed to identify patients
with choledocholithiasis. Certain cli
nical, laboratory and operative find
ings suggest that exploration of the
duct is needed. Way and colleagues1
found that the only reliable indicators
of choledocholithiasis were palpable
stones in the common bile duct, the
presence of cholangitis, stones seen
by intravenous cholangiography and
a serum bilirubin level greater than
6.7 mg/dl (115 y.mol/1). In a previous
report from our institution, Hamp
son and Petrie2 addressed the problem
of retained common duct stones.
They demonstrated that most retained
stones were those overlooked at choledocholithotomy and stressed the value
of T-tube cholangiography in preven
tion.
The purpose of this study is to
evaluate clinical, laboratory and ope
rative indications for exploration of
the common bile duct and to assess
the value of T-tube cholangiography,
performed intraoperatively after ex
ploration, in preventing the retention
of common bile duct stones.
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Patients and Methods

We reviewed the records of 110
consecutive patients who underwent
cholecystectomy and exploration of
the common bile duct at the Montreal
General Hospital between Jan. 1,
1977 and Dec. 31, 1978. They con
stituted 13.8% of patients who had
cholecystectomy during the study
period. All 110 patients were operated
upon for calculous biliary tract
disease. Those with malignant tu
mours of the periampullary region
were excluded, as were those who
underwent choledochotomy in asso
ciation with surgical drainage of pan
creatic pseudocysts or for the treat
ment of pancreatitis. All operations
were carried out by attending sur
geons or by surgical residents under
their guidance. Techniques of explora
tion varied but included extraction
by stone forceps, catheter irrigation,
passage of Bakes’ dilators, use of the
Fogarty catheter and occasionally, of
the choledochoscope. Cystic duct
cholangiography was carried out be
fore exploration in selected patients
at the discretion of the operating
surgeon.
For each patient we tabulated data
on a history of pancreatitis and on
the clinical findings of jaundice and
cholangitis. Serum glutamic-oxaloa
cetic transaminase (SGOT), bilirubin

and alkaline phosphatase levels and
the results of preoperative cholangio
graphy (intravenous, transhepatic or
retrograde) were recorded. We noted
relevant operative findings including
the presence of palpable stones in
the common bile duct, the results of
operative cholangiography, the size
of the gallstones found and the dia
meters of the cystic and common bile
ducts. Cystic and common ducts with
internal diameters greater than 3 mm
and 10 mm, respectively, were con
sidered dilated. The findings of opera
tive cholangiograms and T-tube
cholangiograms were classified as
follows: positive, negative or possibly
positive for stones, or not done.
T-tube cholangiography to demon
strate any retained stones was per
formed postoperatively in all cases.
Results

Common bile duct stones were
found in 68 (61%) of patients com
pared with 48% in the previous study
of Hampson and Petrie2 (Table I).
Table II indicates the clinical,
laboratory and operative indicators
that correlated best with the findings
of common duct stones. Jaundice,
especially when associated with fever
and chills, was the most reliable
clinical indicator of choledocholithiasis. A serum bilirubin level greater

T a b le 1— C o m m o n B i le D u c t E x p lo r a t io n a t th e M o n t r e a l G e n e r a l H o s p it a l
1 9 5 5 t o 1961
C h o le c y s te c t o m y , n o .
E x p lo r a tio n o f t h e c o m m o n b ile d u c t , n o . ( % )
S to n e s r e c o v e r e d , n o . ( % )
% o f t o t a l c h o le c y s t e c t o m ie s

2090
32 7 ( 1 5 .6 )
1 5 6 ( 4 7 .8 )
7 .5

19 77 to 1978
799
110 ( 1 3 .8 )
68 ( 6 1 .0 )
8 .5

than 6 mg/dl (103 [xmol/1) or alka
line phosphatase level greater than
250 IU (normal I 10 IU) was asso
ciated with common bile duct stones
in more than 80% of patients. Serum
bilirubin levels from 1 to 6 mg/dl
(17 to 103 amol/1) were not more
often associated with choledocholithiasis (50%) than were levels in the
normal range (less than 1 mg/dl [17
amol/1]) (58%). The accuracy of the
preoperative cholangiogram that was
positive for stones was 77%.
Intraoperative findings that proved
most reliable were palpable common
duct stones and a positive cholangio
gram. Operative cholangiography was
carried out in only 39 patients (35%)
but was 95% accurate in demonstrat
ing stones. A diagnosis of “possible
stones” on cholangiography was of
dubious value with stones being
found in only 31 % of cases (Table
III).
T-tube cholangiography was car
ried out intraoperatively after comple
tion of common bile duct exploration
in 73 (66%) patients (Table IV) and
most of the stones remaining after
exploration were identified by this
technique.
This resulted in immediate re
exploration in 13 patients and re
trieval of further calculi in 4.
Ten of the 110 patients had re
tained stones following completion of
the operation; stones had been found
in 8 of them at the time of explora
tion but removal was incomplete.
Only 2 (4.8%) of the 42 patients in
whom no calculi were noted at the
time of exploration had retained
stones, whereas retained stones were

T a b le I I I — R e s u lt s o f O p e r a t iv e C h o la n g io 
g ra p h y — 39 C ases

F in d in g

T a b le I I — I n d ic a t io n s f o r E x p lo r a t io n o f C o m m o n B i le D u c t
In d ic a t io n
C lin ic a l
J a u n d ic e , f e v e r , c h ills
J a u n d ic e
P a n c r e a t it is
L a b o ra to ry
S e r u m b i li r u b in , > 6 m g /d l (1 0 3 a m o l /1 )
S e r u m a l k a li n e p h o s p h a t a s e , > 2 5 0 IU ( n o r m a l U O I U )
A b n o r m a l s e r u m g lu t a m ic o x a lo a c e t ic t r a n s a m in a s e
P o s it iv e p r e o p e r a t iv e c h o la n g io g r a m *
I n t r a o p e r a t iv e
P a lp a b le s to n e s
C y s tic d u c t c h o la n g io g r a m p o s it iv e
S m a ll s to n e s , d i la t e d c y s t ic d u c t
D ila t e d c y s tic d u c t
D ila t e d c o m m o n b ile d u c t
S m a ll s to n e s in g a llb la d d e r
‘ In tra v e n o u s , tr a n s h e p a tic o r re tr o g ra d e .
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N o . o f p a t ie n t s

% w it h s t o n e s

10
38
17

80
76
47

28
27
68
35

86
82
60
77

17
22
23
41
51
44

100
95
78
75
74
66

D e f in i t e s to n e s
P o s s ib le s to n e s
N o s to n e s

T a b le

No. of
p a t ie n ts

% w it h
s to n e s

22
16
1

95
31
0

IV -R e s u lt s
o f P o s t e x p lo r a t io n ,
I n t r a o p e r a t iv e C h o la n g io g r a p h y

F in d in g
P o s it iv e
(d e fin ite s to n e s )
N e g a t iv e ( n o r m a l )
P o s s ib ly p o s it iv e
(p o s s ib le s t o n e s )
N o t done

No. of
p a t ie n t s

% w it h
p e r s is t e n t
s to n e s

6
39

66
3

25
40

16
10
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found in 8 (11.8%) of 68 patients
in whom the exploration was produc
tive initially. There were 4 patients
with retained stones in the group of
37 who did not undergo T-tube
cholangiography and all the retained
stones were among the 24 patients
from whom bile duct stones had
already been removed.
Of the 10 patients who had re
tained calculi in the common bile
duct, attempts at nonoperative ex
traction were made in 8 using the
technique of Burhenne3 and Mazzariello.4 Seven were successful although
multiple attempts were frequently
necessary. One patient in whom peri
tonitis developed after an unsuccess
ful attempt at basket extraction re
quired reoperation. One patient with
retained calculi underwent a Jones
sphincteroplasty and another had a
side-to-side choledochoduodenostomy.
Discussion

In spite of improvement in preo
perative evaluation of the patient
with calculous biliary tract disease
selective common bile duct explora
tion resulted in retrieval of calculi
in only 62.4% of our cases. This
represents some improvement over
the yield of 47.8% reported from
this hospital in 19642 (Table I). The
possibility that the increased yield
may be achieved at the cost of not
exploring some patients with stones
cannot be excluded but the overall
percentage of patients in whom
stones have been recovered is higher
in the present group than in the
previous study2 (8.5% vs. 7.5%). The
presence of palpable stones in the
common bile duct, a total serum bili
rubin value greater than 6 mg/dl
(103 u.mol/1), alkaline phosphatase
more than 250 IU (normal 110 IU),
positive operative cholangiography
and jaundice associated with chills
and fever are absolute indications for
exploration of the common bile duct.
When there are relative indications
for exploration operative cholangio
graphy should always be done first.
The relative indications for explora
tion are: (1) the coexistence of small
calculi in the gallbladder with a cystic
duct exceeding 3 mm in internal
diameter, (2) a dilated cystic duct,
(3) a dilated common bile duct and
(4) clinical evidence of jaundice at
the time of operation. A history of
jaundice or pancreatitis and other
findings such as small stones in the
gallbladder and elevation of the SGOT
level correlated less well with the
presence of stones in the common

bile duct but should suggest the need
for operative cholangiography. These
results are not dissimilar from the
findings of Way and associates.1
The accuracy of operative cystic
duct cholangiography performed be
fore exploration was evaluated in a
biased fashion because all patients
in this study underwent exploration
of the common bile duct and only
one had a normal cholangiogram.
The examinations gave very accurate
results when stones were demonstrated
but not when the cholangiogram was
reported as “possibly positive” (stones
found in only 31%) (Table II). Films
in 25% to 30% of those reported as
“possibly positive” were of poor qual
ity and could not be considered diag
nostic. The reasons for the poor qual
ity included inadequate technique, ina
dequate duct filling or obscuring of
the duct by the spine or cannula.
Relatively small amounts of 30%
Renografin should be used but if
the duct is dilated larger amounts
of dilute dye may be necessary to
ensure adequate filling of the biliary
tree. If dye does not flow into the
duodenum despite adequate filling
the duct should be explored. Improve
ments in cholangiographic technique
and interpretation should increase the
yield of stones from exploration and
decrease the number of retained
stones.
Our data strongly support the
routine use of postexploration T-tube
cholangiography. Properly done this
examination will identify almost all
of the retained stones at the time
of initial exploration. There was only
one false-negative operative result in
39 examinations. Four of six patients
with a positive T-tube cholangiogram
had stones removed on re-exploration. Of 25 patients who had “pos
sible stones”, only 7 were re-explored
and 1 had a retained stone. There
were 3 patients with retained stones
in the 18 not re-explored. As in cystic
duct cholangiography it is important
that films be of diagnostic quality.
Frequently adequate duct emptying
is not seen in these studies following
ampullary manipulation. We have
had some recent experience with the
intravenous use of glucagon which
relaxes the ampulla. If the ducts are
particularly large, greater amounts of
dilute dye (20% Renografin) may be
effective in demonstrating stones both
intraoperatively and postoperatively.
If the 10 patients with retained
calculi in our review are analysed
more carefully one can appreciate
how this number might have been
reduced. Three did not have intra

operative T-tube cholangiography fol
lowing exploration so that retained
stones were missed. Five patients
with retained stones had inconclusive
cholangiograms. Better technique may
have allowed visualization of some
of these stones. One patient who had
a retained stone had a normal post
exploration cholangiogram. The 10%
incidence of retained stones is an
increase over the 7% rate reported
from this hospital in 1964.2 Perhaps
this reflects less diligence on the part of
the surgeons to ensure that all stones
are removed at operation because of
the possibility of nonoperative extrac
tion of retained stones. It should be
emphasized that accurate operative
T-tube cholangiography will avoid
retention of most stones and that it
is particularly important if bile duct
stones have been removed during
exploration. Operative choledocho
scopy was used infrequently in this
study but will certainly become more
important in demonstrating and re
moving bile duct stones.5
The management of retained stones
has changed greatly in 20 years and
nonoperative extraction under radiographic control must be considered
the treatment of choice today. This
procedure is not without morbidity
as one of our patients required eight
sessions to clear the duct and in
another urgent reoperation was re
quired. Two other patients required
reoperation.
Removal of stones
through the T-tube tract is also pos
sible using the flexible choledochoscope6 but we have had no experience
with this technique. Efforts are con
tinuing to find solvents for bile duct
stones but none are entirely effective.
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Pulmonary Resection in Cystic Fibrosis: a Case Report
E lliot T. G elfand ,

md , facs, frcs [ c ],

There is limited experience world wide
in the management of patients
with cystic fibrosis who undergo
thoracotomy. Because of their
shortened life-span and the diffuse
nature of pulmonary involvement,
resection is seldom performed for
uncontrolled pulmonary infections.
An 8-year-old boy with cystic fibrosis
and a chronic infection of the right
lung with abscess formation underwent
pulmonary resection after 1 week
of antibiotic therapy with tobramycin,
ticarcillin and cloxacillin, and
physiotherapy. Postoperatively, he was
kept in the intensive care unit for
48 hours. Physiotherapy was begun
immediately after operation and
continued every 2 hours for the first
day. The preoperative antibiotic
therapy was continued. The post
operative course was smooth and
the boy did well for 1 year. Over the
next 6 months his condition
deteriorated and he died 18 months
after operation.
Pulmonary resection should not be
used in patients whose pulmonary
infections can be controlled medically
but may be of value for those
with uncontrollable localized
infections.
II existe une experience mondiale
lim itee du traitement chirurgical
chez les malades souffrant de fibrose
kystique. A cause de leur courte
duree de vie et de la nature diffuse
de I'atteinte pulmonaire, on a rarement
recours a la resection lors d une
infection pulmonaire non jugulee. Un
garcon de 8 ans souffrant de fibrose
kystique et d'une infection chronique
du poumon droit avec abces a subi une
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resection pulmonaire apres 1 semaine
d'antibiotherapie a la tobramycine,
ticarcilline et cloxacilline, et de
physiotherapie. Apres I’operation ii fut
garde aux soins intensifs pendant
48 heures. La physiotherapie fut
entreprise immediatement apres
I'operation et pratiquee aux 2 heures
pendant la premiere journee.
L'antibiotherapie preoperatoire fut
maintenu. L'evolution postoperatoire
fut calme et le garconnet s'est bien
porte pendant 1 an. Durant les 6 mois
suivants, son etat s'est deteriore
et il deceda 18 mois apres I'operation.
La resection pulmonaire ne devrait
pas etre pratiquee chez les malades
dont les infections pulmonaires peuvent
etre maitrisees par des moyens
medicaux mais elle est utile chez ceux
dont I'infection localisee ne peut
etre jugulee.

Cystic fibrosis is a hereditary, systemic
disorder in which there is generalized
dysfunction of exocrine glands. Pan
creatic insufficiency and chronic pul
monary disease are the chief mani
festations. Chronic pulmonary pro
blems result from bronchial obstruc
tion due to inspissated, viscid mucus.
Overall, surgery plays a minor role
in the management of patients with
cystic fibrosis. Pulmonary resection
for severe hemoptysis in patients
with cystic fibrosis has been report
ed,1-4 as have operations for pneumo
thorax.3,5 Resection for advancing
localized pulmonary disease has also
been described.6
Because the pulmonary involve
ment is usually diffuse and afflicted
individuals have a markedly shortened
life-span, pulmonary resection has
been infrequently performed. We
describe the case of a boy in whom
a right upper lobe abscess did not
respond to antimicrobial therapy and
was a continuing cause of morbidity
and repeated hospitalization; right
upper lobectomy was performed with
a good early result.

Accepted for publication May 15, 1981

Case Report
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An 8-year-old boy was referred by
the cystic fibrosis clinic at the Uni
versity of Alberta Hospital. He had
one normal sibling and one with cystic
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fibrosis. The diagnosis of cystic fibrosis
was made when he was 4 years old,
but he functioned well among his peers
despite frequent hospitalization. He
had a chronic cough productive of
tenacious sputum and was moderately
short of breath on exercise.
During the year before operation, he
was hospitalized 11 times for a total
of 117 days. These admissions were
for acute exacerbations of his dense
right upper lobe infiltrates and fever.
The predominant organisms cultured
from the sputum specimens were Pseu
domonas aeruginosa and Staphylococcus
aureus. Despite aggressive therapy on
numerous occasions, right upper lobe
infiltrates with abscess formation had
failed to resolve.
On examination his blood pressure
was 95/60 mm Hg, pulse 90 beats/min
and regular, and his respiratory rate was
20/ min. There was moderate clubbing
of the fingers and toes. No cyanosis
was noted. His growth and develop
ment were normal. Crepitations were
present over the right apex anteriorly
and posteriorly. Bronchial breathing
was noted in the upper hemithorax on
the right side. Further physical findings
were unremarkable. The hemogram
showed slight microcytosis with a nor
mal leukocyte count. The serum bio
chemical values were normal and the
erythrocyte sedimentation rate was 45
mm/h. Examination of the sputum
showed P. aeruginosa and coliform orga
nisms, sensitive to tobramycin and
ticarcillin. When admitted to hospital,
his sputum volumes were 25 to 30 ml/d
but with antimicrobial therapy and
vigorous physiotherapy these decreased
to about 5 ml/d.
The chest roentgenogram showed
extensive diffuse changes in both lungs
with marked loss of volume of the right
upper lobe, and extensive infiltrates
with abscess formation (Fig. 1).
Bronchoscopic examination showed
that the right upper lobe bronchus was
widened and inflamed, with copious
purulent material pouring from it. Pul
monary function studies showed moder
ately severe airway obstruction asso
ciated with hyperinflation and air trap
ping (Table 1). Expiratory flow rates
and diffusion capacity were reduced.
After 1 week of vigorous physiother
apy and antibiotic therapy with tobra
mycin, ticarcillin and cloxacillin, right
upper lobectomy was performed via a
right posterolateral thoracotomy through
the fifth intercostal space. The upper
lobe was solid and markedly contracted
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and upon ventilation showed no evidence
of inflation or aeration. A few inflam
matory apical adhesions were present.
The middle and lower lobes appeared
normal. Extensive peribronchial hilar
adenopathy was noted.
The patient was kept in the intensive
care unit for the first 48 hours postoperatively. An endotracheal tube was
left in place for 24 hours for ventilation
and tracheobronchial toilet. Vigorous
physiotherapy was continued through
the postoperative period, as was his
preoperative antibiotic regimen. The
physiotherapy was instituted immediately
after the operation and for the first 24
hours was carried out every 2 hours. It
consisted of postural drainage, vibration
and percussion. Shortly after extubation,
he began to cough effectively and low
and high volume coughing were encour
aged. Vigorous arm and shoulder mo
tions were carried out. After the first 48
hours, intramuscular analgesics were no
longer required and oral nonnarcotic
analgesics were used.
The remainder of his postoperative
course was uncomplicated; he was dis
charged on the 10th postoperative day.
The resected specimen showed large
dilated air spaces filled with purulent
material (Fig. 2). The hilar lymph nodes

were soft. There appeared to be very
little functioning pulmonary parenchy
ma, which was preserved only in the
most peripheral areas. The dilated
bronchi were filled with purulent exu
date and the bronchial cartilage was
destroyed throughout (Fig. 3). Follicular
hyperplasia was present in the hilar
lymph nodes.
For about a year after operation he
did well. He went back to school and
required only three hospitalizations for
respiratory problems. In the subsequent
6 months, however, he deteriorated and
was hospitalized frequently for infection
and respiratory insufficiency.
He died 18 months after the opera
tion of severe respiratory insufficiency.
No autopsy was performed.

FIG. 1— Posteroanterior chest film
taken preoperatively showing collapsed,
infiltrated upper lobe of right lung and
diffuse changes of cystic fibrosis.

Discussion
When there is localized pulm onary
involvement in patients with cystic
fibrosis the right lung tends to be
most commonly involved as in our
patient.* Despite vigorous antibiotic
treatment of the lung abscess, there
was no response and purulent secre
tions from the right upper lobe
caused multiple bouts of pneumonia.
It is well known that lobar atelec
tasis persisting for several m onths
may herald the onset of an acute ful
minating pulmonary infection2 in this
disease; in our patient, abscess form a
tion followed.
Close attention to detail is im pera
tive in these patients. G ood antibiotic
coverage taking into account organism
sensitivities is paramount. Vigorous
physiotherapy is also of utm ost im
portance. In early articles on this
subject, it was suggested that trache
ostomy should be done prophylactically at the time of pulm onary re 
section. Today with current techni
ques in intensive care of the patient
with pulmonary dysfunction, prophy
lactic tracheostomy is not indicated.
One-lung anesthesia is advanta
geous to prevent purulent spill intraoperatively. In this small child, how 
ever, it was not feasible.
In cystic fibrosis, the bronchi are
shortened so bronchial division must
be done with utmost care. Stapling
devices now available make bronchial
closure simple and expeditious.
Other pulm onary com plications of

FIG. 2—Resected right upper lobe
with dilated air spaces filled with pus.

T a b le 1— P u lm o n a r y F u n c t io n T e s ts

Test

6 mo
p re o p

T o t a l lu n g c a p a c ity ( h e l iu m ) , 1
V i t a l c a p a c ity , 1
F o r c e d v i t a l c a p a c ity , 1
F o r c e d in s p ir a t o r y f lo w , l / s
F o r c e d e x p ir a t o r y v o lu m e in 1 s , 1
E n d - t id a l fo rc e d e x p ir a t o r y v o lu m e in 1 s ( 7 5 % ) ,
F o r c e d e x p ir a t o r y f lo w ( 2 5 % — 7 5 % ) , l / s
F lo w /v o lu m e lo o p , V 5 0 % , l / s
F lo w /v o lu m e lo o p , V 7 5 % , l / s
M a x im u m v o lu n t a r y v e n t i la t i o n , l / m i n
D if f u s io n c a p a c ity , %

2 .6 7
1 .8 9
1 .5 0
1 .7 1
1 .2 7
0 .2 5
0 .8 7
1
0 .3 0
4 5 .3
66

Im m e d ia t e ly
p re o p
2 .6 1
1 .4 9
1 .3 0
1 .5 7
0 .8 7
0 .0 7
0 .3 8
0 .6 4
0 .2 3
2 8 .1
53

Im m e d ia t e ly 2 m o
p o s to p
p o s to p
2 .5 2
1 .4 7
1 .1 9
1 .5 7
0 .8 7
—
0 .4 5
0 .4 5
0 .2 2
2 3 .3
65

2 .1 7
1 .4 1
1 .0 8
1 .6 3
0 .7 4
0 .1 1
0 .3 1
0 .4 1
0 .1 5
33 .3
58

FIG. 3— Bronchi filled with exudate,
parenchyma and bronchial wall destroyed
(hematoxylin and eosin, reduced by 32%
from X 30).
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cystic fibrosis have been treated by
thoracotomy. These include exsan
guinating hemoptysis,1"4 and pneumo
thorax.3,5 In profuse hemoptysis,
prompt resection may be life-saving.
Stowe and associates5 have shown
that open thoracotomy can reduce
morbidity and hospital stay in patients
with pneumothorax.
Results of pulmonary function stu
dies (Table I) indicated the presence
of features generally associated with
cystic fibrosis: severe airway obstruc
tion with air-trapping and hyper
inflation and reduced diffusion capa
city. These did not change postoperatively.
The largest report on patients
operated upon for localized advancing
infections in cystic fibrosis is that of
Mearns and colleagues.6 In their 23
patients the benefits of resection for
localized intrapulmonary infections,
even in those with diffuse pulmonary I
involvement, were apparent as shown |
by a decreased frequency of hospi
talization and return to a more
normal life-style.
Our patient derived short-term
benefit from the operation. We did
not anticipate that resection would
affect the progression of the pul
monary disease and in fact it did
not. We thought that the consequences
of continued sepsis both on the lung
and on the patient as a whole would
be lessened by removing the source
and this aim was achieved in the first
year after resection.
For patients with pulmonary infec
tions that can be controlled without
operation, resection is not recom
mended. It is only of value for those
with localized infective complications
of pulmonary cystic fibrosis.
We thank Dr. Frances Harley for her
help in management of this patient and
for her review of the manuscript.
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Death and Complications after Total Colectomy
for Inflammatory Bowel Disease
G il l e s B ea u c h a m p , m d , frcs [c ],* D en is B eliv ea u , m d * and A n d r e A r c h a m b a u l t , md , F R cp [c]f

Deaths and complications related to
proctocolectomy in inflammatory
bowel disease remain a serious
problem for the general surgeon.
Review of experience at a general
hospital over a 25-year period
disclosed that although there was
substantial morbidity and 12.5%
mortality there was a notable
improvement over the last 10 years
of the study. This was due mainly
to a more aggressive surgical approach,
meticulous preparation of the bowel
for elective procedures, more
physiologic monitoring peroperatively,
careful replacement of fluid losses
and intensive care postoperatively.
Many patients with septic and
nonseptic complications required
reoperation. Intestinal occlusion by
adhesions and ileostomy dysfunction
are the most common nonseptic
complications. One-stage proctocolec
tomy is a good choice for elective
surgery but should be used with
caution in emergency situations.
Dans les maladies inflammatoires
de I'intestin, la mortalite et les
complications associees a la
procto-colectomie demeurent un
serieux probleme pour le chirurgien
general. L'etude de I'experience
accumulee dans un hopital general
au cours d'une periods de 25 ans
a revele que bien qu’il y ait eu une
morbidity considerable et une
mortalite de 12.5%, on a enregistre
une amelioration marquee au cours
des 10 dernieres annees de cette
etude. Ceci est attribuable principalement a une approche chirurgicale
plus agressive, a une preparation
meticuleuse de I’intestin lors des
interventions non urgentes, a une
surveillance physiologique plus grande

From the departments of *surgery and
t medicine, Hopital MaisonneuveRosemont, Universite de Montreal.
Montreal PQ
Presented at the 85th annual meeting
of the Canadian Association of
Clinical Surgeons, eastern division,
Montreal, PQ, May 1 and 2, 1981
Accepted for publication May 15, 1981
Reprint requests to: Dr. Gilles
Beauchamp, Hopital MaisonneuveRosemont, 5415, bold, de I’Assomption,
Montreal. PQ H IT 2M4

dans la periode peroperatoire, a la
correction soigneuse des pertes
liquidiennes et aux soins intensifs
en postoperatoire.
Plusieurs patients qui ont eu des
complications infectieuses ou non
infectieuses ont necessity une
reintervention. L'occlusion intestinale
causee par des adherences et le
dysfonctionnement de I’ileostomie
sont les complications non infectieuses
les plus frequentes. La proctocolectomie en un temps represente
un bon choix lors des interventions
non urgentes mais elle devrait etre
utilisee avec precaution lors des
situations d'urgence.

Granulomatous disease of the colon
and chronic ulcerative colitis, two
nonspecific inflammatory bowel di
seases, still present a challenge for
the general surgeon. Every year, about
10% of patients with inflammatory
bowel disease require total procto
colectomy or subtotal colectomy with
preservation of the rectum. Operation
may improve the outcome of the dis
ease but can be associated with high
morbidity and appreciable mortality.
Although a number of reports on the
overall surgical management have
emanated from centres with exten
sive experience,1'8 there are very few
reports on surgical morbidity and
mortality9,10 and only a few of these
come from a general hospital.
The purpose of this study is to
review the surgical treatment of in
flammatory bowel diseases at a gen
eral hospital. Over the past 25 years
our management of patients with
chronic ulcerative colitis and granu
lomatous colitis has improved sub
stantially and consequently morbidity
and mortality have been reduced.
Patients and Methods

All patients in this study were
managed by a group of 12 surgeons
between Jan. 1, 1954 and Dec. 31,
1979. During this period, 552 patients
with inflammatory bowel disease were
treated at the Hopital MaisonneuveRosemont in Montreal. Of these, 219
had chronic ulcerative colitis and 333
granulomatous disease of the large
and small bowel.

Seventy-two patients (45 women,
27 men) underwent proctocolectomy
or total colectomy with preservation
of the rectum. They ranged in age
from 15 to 69 years (mean 31 years).
We reviewed the surgical indications
and studied the incidence of early
complications and death between
1954 and 1970 and between 1971
and 1979.
Clinical Features

Most patients were first managed
medically. A complete work-up car
ried out on all patients included
history-taking, physical, radiologic
and endoscopic examinations and
rectal biopsy. The resulting findings
allowed for a preoperative diagnosis
of chronic ulcerative colitis or gra
nulomatous colitis in most patients.
Roentgenography after barium enema
was not performed when perforation
or toxic megacolon were suspected.
Analysis of the surgical specimen was
used to provide the final diagnosis
by which we classified the patients,
according to the criteria of LockhartMummery and Morson.11
By these criteria 58 patients were
classified as having chronic ulcerative
colitis and 1 1 as having granulo
matous colitis. It was impossible to
determine the specific type of in
flammatory bowel disease in only
three patients.
Operation

The incidence of operation for in
flammatory bowel disease in our
hospital increased from 10% between
1954 and 1970 to 15% between 1971
and 1979 (Table I). One-stage proc
tocolectomy was performed in 69
patients and total colectomy with
rectal preservation in 3. Including all
our patients during that 25-year
period, 26.5% with chronic ulcerative
colitis and 3.3% with granulomatous
colitis had a one-stage proctocolec
tomy.
Indications

Indications for operation were
either acute complications or intrac
tability (Table II).
Acute complications .— In the first
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group of 25 patients who had acute
complications, the indication for
operation was toxic megacolon in 10,
perforation in 8 and severe colonic
hemorrhage in 7. The mean duration
of disease before operation was per
formed was 2.7 years for those with
toxic megacolon and perforation and
5 years for those with hemorrhagic
colitis. All had received medical treat
ment within 24 hours to 2 weeks
before emergency operation. Protocol
ectomy was performed in 23 and sub
total colectomy in 2. Patients were
operated on as soon as possible after
the life-threatening complication had
been diagnosed.
Intractability.—The other group
of 47 patients with intractable disease
(chronic ulcerative colitis 37, gra
nulomatous colitis 10) were operated
on because of failure of long-term me
dical treatment. None presented with
neoplasia. The mean duration of
disease before operation was 5 years.
Except for one patient who had a
total colectomy with rectal anasto
mosis, all underwent proctocolectomy
and ileostomy.
Eleven patients had had chronic
ulcerative colitis for more than 10
years. Four of them required an
emergency operation and seven under
went elective operation for intractable
disease. Only 1 of these 11 patients
was operated on because of pyoderma
gangrenosum and arthritis. Patients
received support from a psychiatrist
before operation. Antibiotics were
used prophylactically in the bowel
preparation in all patients treated
electively after 1975. Total parenteral
nutrition was used in 20 patients after
1970. The time spent in hospital be
fore operation was 11 days.
Medical treatment used in this
group was varied during the 25-year
period. Treatment for symptoms con
sisted of normalizing bowel habit and
controlling pain. Since 1960, adreno
corticotropic hormone (ACTH) and
steroids have been used intravenously
for severe attacks of chronic ulcera
tive colitis and sulfasalazine, steroid
enemas and oral steroids were used
in the treatment and maintenance of
these patients. Intravenous or oral
steroids were used in patients with
granulomatous colitis. Only two pa
tients received azathioprine (Imuran)
before operation. When in hospital
all patients had nasogastric tube and
intravenous feedings in order to rest
the bowel. Some received antibiotics
intravenously.
Operative Technique
A two-team approach was routine
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tients had at least one major com
plication; 13 patients had two or
more complications. For the purpose
of analysis, complications are divided
into septic and nonseptic (Table III).

for proctocolectomy. A left parame
dian incision was used. Minimal and
gentle manipulation of the colon was
the rule. Liberal saline irrigation of the
peritoneal cavity was used in cases
of perforated colitis. A Brooke type
ileostomy was constructed in all of
our patients. Proctectomy was always
performed close to the rectal wall.
Intra-abdominal drains were rarely
used and primary closure of the
abdominal wall was performed with
silk, Prolene or Dexon sutures. Every
patient had primary perineal closure
and perineal drainage was by Penrose
drains.

Septic Complications
Nineteen septic complications de
veloped in 17 (23.6%) patients (Table
IV). They included severe abdominal
and perineal wound infection, intra
abdominal abscess, peritonitis and
septicemia. Reopening of the wound
under local anesthesia was necessary
in 13 patients because of abdominal
wall or perineal wound infection. Five
patients needed reoperation for drain
age of an intra-abdominal abscess or
localized peritonitis. One patient with
septicemia responded well when anti-

Complications of Operation
During the 25-year period, 50 pa

T a b le 1— D is t r ib u t i o n o f D e a th s a n d C o m p lic a tio n s in t h e T w o P e r io d s

P e r io d
1954 1970, n =
1971 - 1979, n =

No. of
d e a th s

N o . o f s e p tic
c o m p lic a tio n s

N o . o f n o n s e p t ic
c o m p lic a t io n s

7
2

9
10

17
20

9
(1 2 .5 % )

19
(1 7 p a t ie n t s , 2 3 .6 % )

37
(3 3 p a t ie n t s , 4 5 .8 % )

23
49

T a b le

I I — T y p e o f O p e r a t io n P e r fo r m e d a n d In d ic a t io n

H e m o rrh a g e

R e s is t a n t to
m e d ic a l
tr e a tm e n t

P r o c to c o le c to m y
T o t a l c o le c to m y

6
2

9
1

7
0

47
0

T o ta l

8

10

7

47

T y p e o f o p e r a t io n

P e r f o r a t io n

T a b le

T o x ic m e g a c o lo n

I I I — P o s t o p e r a t iv e C o m p lic a tio n s
No. of
p a t ie n t s

N o . o f s e p tic
c o m p lic a t io n s

N o . o f n o n s e p tic
c o m p lic a t io n s

P e r f o r a t io n
T o x ic m e g a c o lo n
H e m o rrh a g e
R e s is t a n t t o m e d ic a l t r e a t m e n t

8
10
7
47

5
2
0
12

3
1
2
31

T o ta l

72

19

37

In d ic a t io n s f o r o p e r a t io n

T a b le IV - S e p t i c C o m p lic a tio n s (1 7 P a t i e n t s )

C o m p lic a tio n
W o u n d in f e c t io n
In t r a - a b d o m in a l a b s c e s s
P e r in e a l in f e c t io n
S e p tic e m ia
P e r it o n it is
T o ta l

No.

N o . o f p a tie n ts
r e q u ir in g r e o p e r a t io n

7
4
6
1
1

0
4
0
0
1

19

5
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T a b le V

N o n s e p tic M a j o r C o m p lic a tio n s (3 3 P a t i e n t s )

C o m p lic a tio n

No.

N o . o f p a t ie n t s
r e q u i r i n g r e o p e r a t io n

I n t e s t i n a l o c c lu s io n
Ile o s to m y d y s fu n c tio n
R e c u r r e n c e a t ile o s to m y s it e
P e r in e a l w o u n d
P e r in e a l h e m o r r h a g e
U r i n a r y f i s t u la
P a n c r e a t it is
P u lm o n a r y e m b o lis m
C o n v u ls io n , c o m a
C a t h e t e r e m b o lis m

10
8
5
6
1
2
1
2
1
1

10
8
5
0
1
1
0
0
0
1

37

26

T o ta l

biotics were given. In the patients who
underwent elective surgery for intract
able disease, the rate of septic com
plications was 25.5% compared with
62.5% for infectious complications
in patients with perforation. From
1954 to 1970, 9 (39%) of the 23
patients operated upon had a major
septic complication. In the subsequent
period (1971 to 1979), 10 (20.4%)
of the 49 patients had one major sep
tic complication. In each group, five
needed reoperation.
Nonseptic Complications

Major nonseptic complications were
more frequent than septic complica

T a b le V I — O p e r a t iv e M o r t a l it y R e la t e d to
P r o c to c o le c t o m y
In d ic a t io n f o r
o p e r a t io n

N o. of
p a t ie n t s

No. of
d e a th s

P e r f o r a t io n
T o x ic m e g a c o lo n
H e m o rrh a g e
R e s is t a n t to m e d ic a l
tr e a tm e n t

8
10
7

1
2
3

47

3

T o ta l

72

9

tions. Thirty-three patients sustained
37 major nonseptic complications.
Treatment was surgical in 26 (Table
V). During the last 10 years, among
49 patients, we reduced our major
nonseptic complications to 20. The
most frequent complication was intes
tinal occlusion which occurred in 10
patients. Only one patient required
bowel resection; the other nine were
managed by lysis of adhesions.
Ileostomy dysfunction, necessitating
reoperation, occurred in eight pa
tients. Recurrent disease at the ileo
stomy site developed in three patients
with granulomatous colitis and two
patients with chronic ulcerative coli
tis. Six patients had perineal wound
dehiscence or a fistula, but did not
require reoperation. Perineal hemor
rhage, immediately after proctocolec
tomy, occurred in one woman. Bleed
ing was controlled by tight perineal
packing. Major urinary fistulas, in
two men, were secondary to a peroperative accident. Both injuries, one
to the membranous urethra and the
other to the bladder, were managed
by a urethral catheter left in place
for 3 weeks in one and by suprapubic
cystostomy in the other.

T a b le V I I — D e t a ils o f N in e P a t i e n t s W h o D ie d

P e r io d (n o . o f
d e a th s )
1975
(0 )
1971
(2 )

19 79

1960
(3 )

1970

1954
(4 )

1974

1959

In d ic a t io n fo r
o p e r a t io n
—

T o x ic m e g a c o lo n
(p a c e m a k e r )
T o x ic m e g a c o lo n
H e m o rrh a g e
R e s is t a n t to
m e d ic a l t r e a t m e n t
P e r f o r a t io n
H e m o rrh a g e
H e m o rrh a g e
R e s is t a n t to
m e d ic a l t r e a t m e n t
R e s is t a n t to
m e d ic a l t r e a t m e n t

A ge,
yr
—

D u r a t io n o f
d is e a s e , y r

C a u s e o f d e a th
—

?

30
23

10
3

20

4

50
23
40
43

1 mo
3
2
4

34

1

Deaths

Nine patients died within 30 days
of operation, giving an operative
mortality of 12.5%. Five of the
deaths followed emergency surgery
and four elective surgery for intrac
table disease (Table IV). Five patients
aged 30 to 59 years died (Table VII).
When the duration of illness is
considered, there was only one death
in the 11 patients who had had
chronic ulcerative colitis for 10
years or longer. There were no deaths
in our patients with granulomatous
colitis. Although steroids were given
to 46 patients, only 3 of these died
of surgical complications. Six patients
died of sepsis; almost all had septic
shock. During the 1950s two patients
died of hypovolemic shock and one
of aspiration pneumonia. Seven deaths
occurred before 1971 and only two
between 1971 and 1974 (Table VII).
Of our last 35 patients (almost half
of our patients) none died.
Discussion

—
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Two patients had a pulmonary
embolism, one patient preoperatively
and the second 3 weeks after procto
colectomy. The first patient had
hemorrhagic colitis while receiving
heparin and required emergency proc
tocolectomy with plication of her
inferior vena cava. In the second
patient the pulmonary embolism was
not associated with thrombophlebitis.
The patient was treated for 4 months
by anticoagulants taken orally.
Convulsions in the immediate post
operative period occurred in a 21year-old woman. She was taking
steroids before operation for chronic
ulcerative colitis of 3 years' duration.
She required an emergency procto
colectomy and the convulsions started
the following day. Uncontrollable
seizures for 1 week led to an irre
parable neurologic deficit. Extensive
investigation could not identify the
cause of her convulsions.

P e r ito n itis
S e p tic s h o c k
S e p tic s h o c k s e c o n d a ry
to p e r i t o n i t i s
S e p tic s h o c k
A s p ir a t io n p n e u m o n ia
S h o c k, re n a l in s u ffic ie n c y
S h o c k , p e r in e a l h e m o r r h a g e
P e r it o n i t i s
S e p tic s h o c k

Surgery for inflammatory bowel
disease has been associated with con
siderable mortality and morbidity,
although there has been marked im
provement during the last 20 years.
Until recently reported mortality of
20% was not rare, but improved
care has reduced mortality to 5% to
6% even in those requiring emergency
operation.12
The reason for this impressive
improvement is the more aggressive
surgical approach recommended by
Goligher and colleagues.13'15 They
cut their mortality of 11.3% in
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the period 1951 to 1963 to 4% in
the period 1964 to 1969 by reducing
the duration of medical treatment be
fore operation. We have followed
this recommendation since the early
1970s.
Our improved results over the past
10 years are also explained by factors
such as more meticulous attention
to: the preoperative preparation with
respect to hydration, electrolyte
levels, nutrition and the presence of
sepsis; a more physiologic monitoring
during surgery and careful replace
ment of all fluid losses. Postoperative
intensive care, use of total parenteral
nutrition, control of sepsis and im
proved nursing care as well as the
addition of a stomotherapist are also
important factors.
There is no consensus on the choice
of emergency intervention. Binder
and associates16 found no statistical
difference in mortality in two groups,
one of 37 patients who underwent
proctocolectomy and another of 43
patients who had subtotal colectomy.
Mortality was 9.1% in the first group
and 7.5% in the second. Our mor
tality since 1970 compares favourably
with this; only 2 of the last 49 pa
tients died and there has been no
death in our last 35 patients treated
by proctocolectomy.
Few reports relating to surgical
treatment of inflammatory bowel
disease separate their septic from
their nonseptic complications. Binder
and colleagues'" reported a 29.4%
incidence of septic complications in
emergency proctocolectomy and 35%
in subtotal colectomy. Steinberg and
associates17 also reported a 35% in
cidence of sepsis postoperatively.
Perineal wound sepsis was the major
cause (6%) for reoperation after
colectomy in their series.
Our rate of septic complications is
certainly high but has improved con
siderably in the last 10 years because
of better bowel preparation, the libe
ral prophylactic use of antibiotics preoperatively as well as the administra
tion of more appropriate antibiotics
in therapy. In the 1950s, chloram
phenicol and penicillin were occa
sionally used. Today, the more fre
quently used antibiotics are genta
micin or tobramycin and clindamycin.
Steroids, or ACTH, were given to
almost all our last 49 patients, but
we could not reach any conclusion
on their effectiveness. Jalan and asso
ciates,18 Allsop and Lee19 and Knudsen and colleagues,90 did not find that
steroids had any influence on surgical
mortality and morbidity.
Nonseptic complications appear to
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be at least as frequent as septic com
plications in some series.16,17 Intestinal
occlusion is the most frequent of
these complications.21 Reoperation for
intestinal occlusion was performed in
10 of our patients, an incidence of
7.2%. In only one was bowel re
section necessary. Because patients
were operated on very soon after
diagnosis, there were no deaths.
Eight of our patients had intestinal
occlusion secondary to stenosis of
their ileostomy. All needed resection
and reconstruction of the ileostomy
which resulted in a major complica
tion or death. Although the incidence
appears high, it is similar to that
reported by Ritchie.22
Because of the well known changes
in coagulation associated with in
flammatory bowel disease, pulmonary
embolism should be found more fre
quently. Block,23 in an editorial,
emphasized that pulmonary embolism
is a major cause of death in these
conditions and recommended that
caval interruption be performed in
any high-risk patient who must under
go proctocolectomy. On the basis of
our experience and the review of
literature, we cannot agree with
Block. We carried out caval interrup
tion in one of our patients with
chronic ulcerative colitis only because
she had pulmonary embolism and
hemorrhagic colitis necessitating an
emergency proctocolectomy.
Convulsions in patients who under
go surgery for inflammatory bowel
disease have occasionally been re
ported.24,25 One of our young patients
had convulsions postoperatively with
no evident cause. This is a catas
trophic complication because of the
neurologic consequences. We must
be aware of this complication, but
we have no way of telling who is at
risk.
Conclusions

Surgery for inflammatory bowel
disease, particularly emergency pro
cedures, is associated with consider
able mortality and morbidity although
notable progress has been made.
Earlier operation and better prepara
tion of patients were among the
factors responsible for our improved
results.
Septic complications usually can
be controlled with adequate antibiotic
therapy. Death is often secondary to
septic shock. The most frequent non
septic complication is intestinal oc
clusion secondary to adhesions or
ileostomy dysfunction. The majority
of patients require operation for such

complications. Little morbidity ensues.
There is still considerable debate
as to the best emergency operative
procedure. Proctocolectomy has been
our choice in the majority of cases,
but we cannot tell if the results
would have been better with total
colectomy and second-stage proctec
tomy.
One-stage
proctocolectomy
seems to be a safe procedure for
elective surgery, but we would not
recommend it for the severely de
bilitated patient, and the inexperienc
ed surgeon should not attempt it.
Moreover, with the availability of
Kock’s pouch, Park’s pouch and ileorectostomy it seems reasonable to
preserve the rectum so that these
types of reconstruction may be car
ried out later where applicable.
We thank Mrs. M. Turbide for secre
tarial assistance and Mr. R. Seguin. We
also thank all the general surgeons of
the Hopital Maisonneuve-Rosemont and
Drs. Florent Thibert and Roger Mousseau for permitting us to include their
patients in this study.
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Eiase' O intm ent & Solution"
Simple, low-cost therapy
for decubitus ulcers:

“Decubitus ulcers present a great problem in prolonged bed
occupancy and expensive and protracted nursing care.”14'

• Helps speed healing through enzymatic debridement"'
• Has a highly selective lytic function12'
• Total elimination of odour and necrotic tissue"
• As high as 95.9% show improvement or healing"
References: 1. Lee, M. et al: The decubitus ulcer patient: Statement of the problem. Contemporary Surgery/Vol. 14, 3/79. 2. Landi. G.: Local enzymatic
treatment in dermatology: First results with fibrinolysin and desoxyribonuclease. Clin. Ter. 25:47-57. 1963. 3. Coon, W. W„ et al: Enzymatic debridement with
bovine fibrinolysin. Am. J. Surg. 98: 4-8, 1959.4. Vasile, J., Chaitin, H.: Prognostic factors in decubitus ulcers of the aged. Geriatrics 27: 126-129. 1972.
THERAPEUTIC CLASSIFICATION
Fibrinolysin—Desoxyribonuclease Enzymatic Debriding Agent.
INDICATIONS
Elase is indicated for topical use as a debriding apent in a variety ol
inflammatory and infected lesions. These include: (1) general surgical
wounds (2 ulcerative lesions -tro p h ic decubitus, stasis, arteriosclero
tic (3) second-and third-degree burns; |4) circumcision and episiotomy.
Elase is used intravaginally in: (1) cervicitis-benign, postpartum, and
postconization and (2) vaginitis. Elase is used as an irrigating agent in
the following conditions: (1) infected wounds-abscesses, fistulae, and
sinus tracts (2) otorhinolaryngologic wounds; (3) superficial hematomas
(except when the hematoma is adjacent to or within adipose tissue).
If in the judgement of the physician both a debriding agent and a topical
antibiotic are indicated, Elase-Chloromycetin* Ointment provides both
types of therapeutic action. Establishment in the laboratory of bacterial
sensitivities will guide the physician in selecting the proper antibiotic.
Elase-Chloromycetin may be useful in the topical treatment of infected
burns ulcers, wounds, cervicitis and vaginitis when the organisms are
susceptible to chloramphenicol and utilize a process of fibrin deposition
as a protection device.

PRECAUTIONS
The usual precautions against allergic reactions should be obseived.
particularly in persons sensitive to materials of bovine origin, anti
biotics or thimerosal If Elase-Chloromycetin Ointment is used, it should
be borne in mind that following topical use ot chloramphenicol the
patient may become sensitized to the drug.
Elase-Chloromycetin should be used only for serious infections caused
by organisms which are susceptible to the anti-bacterial action of
chloramphenicol.
WARNINGS
Elase should not be used parenterally.
Elase-Chloromycetin should not be used as a prophylactic agent.
Chloramphenicol when absorbed systemically from topical application
may have toxic effects on the hemopoietic system. Prolonged use may
lead to an overgrowth of non-susceptible organisms including fungi.
ADVERSE REACTIONS
Although deleterious side effects from Elase have not been a problem at
the dose and for the indications recommended herein, local hyperemia
has been observed with higher concentrations. If Elase-Chloromycetin

Ointment is used, allergy to the chloramphenicol portion of the preparation
may show itself as angioneurotic edema or vesicular and maculopapular
types of dermatitis.
DOSAGE AND ADMINISTRATION
General Topical Use:
The Elase form used and the duration of treatment must be largely at the
discretion of the physician. For specific use and for details on individual
dosage forms, please refer to the CPS and package inserts.
Full prescribing information available on request.
•R e g . T .M . Parke, Davis & C om pany,
Parke-Davis C anada Inc., auth. user.

*‘Reconstituted Powder
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Parke-Davis Canada Inc., Scarborough, Ontario
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Acute Suppurative Cholangitis Secondary to
Malignant Obstruction
I ssie S. W eissglas,

Acute suppurative cholangitis due
to malignant obstruction of the distal
biliary tract is uncommon. Only
16 cases have been documented in the
English literature (excluding patients
with previous surgery for their
malignant tumours). The authors add
five new cases and discuss the clinical
characteristics of the process. The
possible relation of endoscopic
retrograde cholangiography to the
pathogenesis of acute suppurative
cholangitis in these patients is
presented and prophylactic antibiotic
therapy is advised once obstruction
is demonstrated. Immediate operative
decompression of the obstructed
common bile duct as a life-saving
procedure is of prime importance, in
preparation for a later palliative
or curative surgical procedure.
L'angiocholite suppurative aigue due
a une obstruction maligne de la partie
distale des voies biliaires est une
affection rare. Seulement 16 cas ont
ete decrits dans la litterature de
langue anglaise (en excluant les
patients qui avaient ete operes au
prealable pour une tumeur maligne).
Les auteurs ajoutent cinq nouveaux
cas et discutent les caracteristiques
cliniques de cette maladie. On
indique le role possible de la cholangiographie endoscopique retrograde
dans la pathogene de l'angiocholite
suppurative aigue chez ces patients,
et on recommande I'emploi prophylactique d’antibiotiques une fois
qu'une obstruction est demontree.
Comme mesure vitale dans ('obstruc
tion du choledoque, il est de toute
premiere importance de proceder
a une decompression chirurgicale
immediate en preparation pour
une intervention chirurgicale palliative
ou curative subsequente.
From the department o f surgery, the
M ontreal General Hospital and M cGill
University, Montreal, PQ
Presented at the 85th annual meeting of
the Canadian Association o f Clinical
Surgeons, eastern division, Montreal,
PQ, M ay 1 and 2, 1981
A ccepted for publication May 15, 1981
Reprint requests to: Dr. R.A. Brown,
Rm. 1522, The Montreal General
Hospital, 1650 Cedar Ave., Montreal,
PQ H 3G 1A4
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In 1877, Charcot1 described the
clinical syndrome of suppurative
cholangitis. He astutely noted that
this might not occur exclusively with
biliary lithiasis; indeed, it could occur
"in any case of persistent obstruction
of the choledochal canal whatever the
cause, by fibrous stricture, by cancer
of the head of the pancreas or other”.
Since then, relatively few cases have
been documented of acute suppurative
cholangitis secondary to malignant
ductal obstruction in patients who
have not previously undergone a sur
gical procedure for their malignant
tumour. The reasons for the uncom
mon occurrence of this entity are
unclear and many believe that acute
suppurative cholangitis is seldom, if
ever, seen in the presence of an
obstructing neoplasm unless there are
associated common duct stones, stric
tures or some sort of operative mani
pulation of the biliary tree.2-6
The diagnosis of acute suppurative
cholangitis should, by definition, de
pend on the following: (a) biliary
tract obstruction due to stones, stric
ture or tumour; (b) an acute clinical
syndrome characterized by right upper
abdominal pain, jaundice and fever
and chills (Charcot’s triad) and (c)
the presence of purulent bile in/the
distal biliary tract. In this report we
refer specifically to patients .with this
clinical presentation and to those who
also display hypotension and mental
depression (Reynolds' pentad).7 Al
though these rigid criteria have de
fined the condition called acute
obstructive suppurative cholangitis® in
the past, we think this terminology
is redundant; acute suppurative chol
angitis seems to be a more appropriate
term, separating those patients who
are acutely ill with septic shock from
others with acute cholangitis.
Using this definition, we have
encountered five such cases secondary
to malignant obstruction of the com
mon bile duct in the 2-year period
1978 and 1979 (Table I). Patients
who had had previous biliary tract
operation were excluded.
Clinical Data
Tables I and II outline the signs,
symptoms, laboratory data and other

pertinent information about our pa
tients. All displayed a depressed
mental state, ranging from restless
ness to frank coma. Finally, the rapid
onset of acute suppurative cholangitis
in every patient was extraordinary
and unexpected.
Discussion
Since Charcot’s description of the
classic triad noted in acute cholan
gitis, we could find only 16 docu
mented cases of acute suppurative
cholangitis secondary to malignant
obstruction of the extrahepatic biliary
tree (Table III). Although Rogers®
found a case reported in 1889 this
was a finding at autopsy; no clinical
details were given. The first well docu
mented case, described by Ostermiller
and associates10 in 1965, was due to
an adenocarcinoma of the common
bile duct in a series of patients with
acute obstructive cholangitis. In 1961
Glenn and Moody" acknowledged the
possibility of, but did not encounter
any, cases of acute suppurative chol
angitis due to malignant obstruction.
Furey12 described a patient suffering
from the condition who had obstruc
tion of the common bile duct by a
carcinoma of the papilla of Vater. In
1969, three more cases were reported
by Hinchey and Couper" (carcinoma
of the head of the pancreas) and
Dow and Lindenauer8 (unspecified
neoplasms). Bismuth and associates14
later documented a case in their series
of patients who had cholangitis with
renal failure. In 1976 Thurnherr and
associates15 described a patient with
carcinoma of the bile duct in whom
fatal acute suppurative cholangitis
developed shortly after endoscopic
retrograde cholangiography (ERC).
The authors inferred that ERC was
the precipitating factor in this case
and warned that the procedure should
only be performed when operation is
planned within 24 hours, and the pa
tient should be treated prophylactically with antibiotics as soon as the diag
nosis of biliary obstruction is made.
Welch and Donaldson16 presented
one patient who had simultaneously
carcinoma of the head of the pancreas
and stones in the common bile duct.

VOLUME 24, NO. 5, SEPTEMBER 1981 / T H E C A N A D IA N JO U R N A L O F SURGERY

cholangitis due to malignant obstruc
tion of biliary outflow, who fulfil,
at least in part, our criteria, but spe
cific clinical details were not given.
From the 21 cases of acute sup
purative cholangitis due to malignant
obstruction collected in our series and
from the literature, several conclu
sions may be drawn and some im
portant questions may be asked. Of
the nine identified obstructing malig
nant tumours, four were carcinomas
of the head of the pancreas, three
were carcinomas of the ampulla of

not include this case in our review
because of the possibility that in this
case the pathogenesis might have
been distinctly different. They also
referred to a single case due to ex
trinsic compression of the common
bile duct caused by “enlarged or
metastatic lymph nodes” or “a pan
creatic mass”. We cannot know, from
the data presented, whether this case
involved a malignant lesion and thus
have excluded it from consideration
also. Finally, O’Connor and asso
ciates19 reported on six patients with

Because the stones were probably
the cause of this patient’s cholangitis,
we have not included the case here.
It illustrates that these obstructing
lesions may possibly coexist. Saharia
and Cameron17 reported 12 patients
who had malignant growths causing
obstruction in 78 cases of acute
cholangitis. Since the authors did not
state how many of these patients met
our criteria of acute suppurative
cholangitis, none of them can be
included in this survey. Boey and
Way18 reported an impressive series
of 99 consecutive cases of acute
cholangitis. They believed that chol
angitis due to malignant stricture is
now being encountered more fre
quently and they stressed that the
term “suppurative cholangitis” is an
unsatisfactory synonym for severe
cholangitis. They presented three
patients who (by our definition) had
acute suppurative cholangitis second
ary to primary pancreatic or common
bile duct neoplasms. They also in
cluded one case of acute suppurative
cholangitis in a patient with a Klatskin tumour whose external drainage
tube had become blocked. We did

T a b le I I I — R e p o r ts o f A c u t e S u p p u r a t iv e C h o l a n g i t i s d u e to M a l i g n a n t O b s t r u c t io n

A u th o rs

Year

N o . o f p a tie n ts

O b s t r u c t in g le s io n

O s t e r m i l l e r a n d a s s o c ia t e s 10
F u r e y 12
H in c h e y a n d C o u p e r 13
D o w a n d L in d e n a u e r8
B is m u t h a n d a s s o c ia t e s 14
T h u r n h e r r a n d a s s o c ia t e s 15
B o e y a n d W a y 18

19 65
19 66
1969
19 69
1975
19 76
19 80

1
1
1
2
1
1
3

O 'C o n n o r a n d a s s o c ia t e s 19
W e is s g la s a n d B ro w n

1981
1981

6
5

A d e n o c a r c in o m a o f c o m m o n b i l e d u c t
C a r c in o m a o f p a p i l l a o f V a t e r
C a r c in o m a o f h e a d o f p a n c r e a s
N e o p la s m ( u n s p e c if ie d )
N e o p la s m ( u n s p e c if ie d )
C a r c in o m a o f c o m m o n b ile d u c t
P a n c r e a t ic o r c o m m o n b i le d u c t
n e o p la s m ( u n s p e c if ie d )
N e o p la s m ( u n s p e c if ie d )
C a r c in o m a o f h e a d o f p a n c r e a s , 3
C a r c in o m a o f a m p u lla o f V a t e r , 2

T a b le 1— S u m m a r y o f C a s e s

A n te c e d e n t
b ilia r y d is e a s e

P a tie n t
no.

Age, yr

S ex

i

81

F

C a r c in o m a o f
h e a d o f p a n c re a s

2

69

M

3

45

4

5

E R C (tim e in te r v a l, h )

P o s t o p e r a t iv e s t a t u s

None

Y es (2 4 )

C a r c in o m a o f
a m p u lla o f V a t e r

None

Y es (2 4 )

F

C a r c in o m a o f
a m p u lla o f V a t e r

H e p a t it is (3 2 y r
b e fo re )

No

55

M

C a r c in o m a o f
h e a d o f p a n c re a s

A lc o h o lic liv e i d is e a s e

Y es (9 6 )

67

F

C a r c in o m a o f
h e a d o f p a n c re a s

C h o le lit h ia s is
(c h o le c y s te c to m y
10 y r b e f o r e )

Y es (4 8 )

P a llia tiv e b y p a s s 16 d la te r .
D ie d 1 m o f o l l o w i n g l a s t
o p e r a t io n
W h ip p le o p e r a t io n 8 d l a t e r .
D i e d 9 w k f o l l o w i n g la s t
o p e r a t io n
W h ip p le o p e r a t io n 2 w k l a t e r .
A l iv e l y r f o l l o w i n g la s t
o p e r a t io n
P a l l i a t i v e b y p a s s 14 d l a t e r .
A l iv e 1 5 m o f o ll o w i n g
la s t
o p e r a t io n
S im u lt a n e o u s ( p a l l i a t i v e ) b y p a s s
s u r g e r y . P r o g re s s iv e ly
d e t e r io r a t e d o v e r 3 m o
u n t il d e a th

D ia g n o s is

E R C = e n d o s c o p ic r e t r o g r a d e c h o la n g io g r a p h y .

T a b le I I - S ig n s , S y m p to m s a n d L a b o r a t o r y V a l u e s *

P a t ie n t
F e v e r C h ills
no .
1

+

2
3
4
5

+
+
+
+

J a u n d ic e

R ig h t
upper
a b d o m in a l
p a in

S eru m
a lk a lin e
p h o s p h a ta s e ,
U /l

SGO T,
U /l

H y p o te n s io n

M e n ta l
d e p re s s io n

L e u k o c y te s ,
X 10*71

T o ta l
s eru m
b il ir u b in ,
m g /d l

9 .7

1 4 .1

655

100

K lebsiella s p .

18.5
15.8
25.9
25.7

9 .9
1 5 .0
15.7
11.1

309
4 35
254
3 07

124
27
120
117

P seudom onas

+

+

+

+■

+

+
+
+
+

-F
- j-

-f-

+
+
+

+
+
+
+

+
+

+
+
+

• N o r m a l v a lu e s f o r le u k o c y te s = 5 to 10 X 1 0 *7 1 , t o ta l s e r u m b il ir u b in =
( S G O T ) ■= < 4 0 U / l
- f = p r e s e n c e , — = a b s e n c e , E. c o l i - E scherichia coli.

B ile
c u lt u r e

B lo o d
c u lt u r e

E. coli
E n te ro c o c c i

< 1 .0 m g /d l, a lk a lin e p h o s p h a ta s e =

E. coli
E. coli

sp .

P seu d o m o n a s
E. coli
E. coli
E. coli
P seudom o n as

sp.

sp.

< 1 05 U / l , s e ru m g lu ta m ic o x a lo a c e t ic t r a n s a m in a s e
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Vater and two were carcinomas of
the common bile duct. The outcome
in 15 of the 21 patients is known; 13
survived following emergency opera
tive decompression.
It is noteworthy that in 50% of the
patients reported to have undergone
ERC, acute suppurative cholangitis
developed within 24 hours of the
procedure. Thus, there may have
been an iatrogenic component in some
of these cases. It is known that 15%
of patients with any extrahepatic
biliary obstruction will have some
type of cholangitis following ERC 20,21
and, considering the generally poor
condition of patients with these neo
plasms (depressed immunologic and
nutritional status), they should be
prime candidates for seeding of or
ganisms beyond the obstructing le
sions and for development of acute
suppurative cholangitis after ERC.
We strongly agree with Thurnherr
and associates15 in their belief that
these patients must be treated with
appropriate antibiotics as soon as the
diagnosis of biliary obstruction is
made by ERC and operation should
follow shortly thereafter. Chloram
phenicol or clindamycin and gentami
cin seem to be suitable for prophy
laxis .2224
These cases raise the question of
etiology and pathogenesis of acute
suppurative cholangitis. A common
belief exists that enteric organisms
responsible for the condition are
brought to the extrahepatic ducts via
the portal venous system .25' 27 If this
is the case, why is acute suppurative
cholangitis due to obstruction by a
malignant lesion so uncommon? Pos
sible explanations include: (a) some
cases are not reported; (b) patients do
not survive long enough for the con
dition to develop; c) bile duct con
tamination results from an infected
gallbladder,28-29 which these patients
rarely have; (d) some unknown prop
erty of the obstructing tumour pre
vents the occurrence of acute suppu
rative cholangitis in most cases and
(e) a complete neoplastic obstruction
prevents an ascending infection by in
testinal flora30 from reaching the bile
duct. We believe that the pathogenesis
of acute suppurative cholangitis is re
lated to the reflux of enteric organisms
through the sphincter of Oddi and
complete malignant obstruction would
prevent this in most cases. However,
once bacteria are introduced beyond
the obstructing lesion, as by ERC,
the setting for suppurative cholangitis
is established. Furthermore, if organ
isms reached an obstructed common
bile duct through the portal venous
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system, we would expect acute sup
purative cholangitis in the presence
of malignant obstruction to be much
more common clinically.
The management of any patient
with this condition, with or without
malignant obstruction, is quite straight
forward. Since the condition is acute
and lethal if untreated, the patient’s
survival depends on early recognition
of the syndrome, immediate and ade
quate drainage of the biliary tract
and intensive medical therapy.31 To
achieve adequate biliary decompres
sion a relatively easy and rapid
method should be used; a T-tube
choledochostomy is preferred. Cholecystostomy alone may be inade
quate.32 Recently, percutaneous transhepatic drainage of the biliary tract
33,34 j,as t>ecome an accepted pro
cedure and has been used in patients
with malignant obstruction of the
common bile duct.35' 38 Adequate bili
ary drainage in the face of acute
suppurative cholangitis will be achiev
ed by this method; however, we have
little experience with it.
Most patients with acute suppura
tive cholangitis secondary to malig
nant obstruction will recover with
aggressive management and may then
undergo a curative or palliative oper
ative procedure later. An understand
ing of its pathogenesis, awareness of
its clinical presentation and prompt
surgical therapy are the keystones in
dealing with acute suppurative chol
angitis due to malignant obstruction.
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Palliative Surgery in Tetralogy of Fallot
P aul H. Stanley, md,* C laude Chartrand, md, frcs[c ],* A ndre D avignon, md, FRCP[c],f
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Because much controversy surrounds
the palliative surgical treatment of
young children with tetralogy of Fallot
the authors review their experience
over 13 years with two procedures
— the Blalock-Taussig operation
and the Waterston shunt.
Blalock shunts were performed
195 times in 172 patients; 147 had a
single Blalock anastomosis which
carried them through the critical period
and allowed for later correction
of the tetralogy. Thrombosis of the
Blalock anastomosis occurred in
two patients in the early postoperative
period. In 23 patients a second shunt
was necessary after the first Blalock
shunt became inadequate in spite
of being patent. The age of the children
ranged from 2 weeks to 9 years,
7 4 % being operated upon under the
age of 2 years. There were four
early deaths (2 % ) and five late deaths
(2.5%) in this group. Of the last
91 consecutive patients operated upon
between Sept. 1, 1972 and June 30, 1980
none have died.
Between September 1968 and
June 1980, 14 patients with tetralogy
of Fallot underwent a Waterston shunt.
Their ages ranged from 2 days
to 4 years. Six patients were younger
than 35 days at the time of operation.
There were two operative deaths in
this group.
The Waterston shunt carries a high
risk and is reserved for the occasional
patient who needs palliation during
the first weeks of life and in whom
the anatomy of the subclavian artery
does not favour a good Blalock-Taussig
shunt. The Blalock-Taussig operation
is preferred because it is safe and
gives good sustained clinical
results. The mortality was much lower
than previously reported. The growth
of the pulmonary arteries was good in
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most patients. The Blalock shunt
did not increase the pulmonary
resistance and it did not influence
the operative mortality.

L'anastom ose de Blalock n’est pas
augmente la resistance pulmonaire
et n'a pas influence la mortalite
operatoire.

En raison de I’importante controverse
qui entoure le traitement palliatif
chirurgical de la tetralogie de Fallot
chez le jeune enfant, les auteurs
passent en revue leur experience
de 13 ans avec deux modes operatoires,
I'operation de Blalock-Taussig et le
shunt de Waterston.
Des shunts de Blalock ont ete
pratiques 195 fois chez 172 patients;
147 ont eu une anastomose simple
de Blalock qui leur a permis de passer
a travers la periode critique en
attendant une correction subsequente
de la tetralogie. Chez deux patients
une thrombose de I'anastomose
de Blalock est survenue dans la periode
postoperatoire immediate. Chez
23 patients un deuxieme shunt a ete
necessaire lorsque la premiere
anastomose de Blalock, bien que
fonctionnelle, est devenue insuffisante.
L'age des enfants allait de 2 semaines
a 9 ans, 7 4 % etant operes alors
qu'ils avaient moins de 2 ans. On a
enregistre quatre mortalites precoces
( 2 % ) et cinq deces tardifs (2.5%)
dans ce groupe. Des 91 derniers
patients consecutifs operes entre
le 1er septembre 1972 et le 30 juin
1980, aucun n'est decede.
Entre septembre 1968 et juin 1980,
14 patients souffrant de tetralogie
de Fallot ont subi un shunt de
Waterston. Leur age variait de 2 jours
a 4 ans. Six patients avaient moins
de 35 jours au moment de I’operation.
On compte deux morts operatoires
dans ce groupe.
Le shunt de Waterston presente
un risque eleve et est reserve pour le
malade occasionnel qui necessite
un traitement palliatif durant les
premieres semaines de la vie et chez
qui I'anatomie de I'artere sous-claviere
ne favorise pas une bonne anastomose
de Blalock-Taussig. L'operation de
Blalock-Taussig est preferable parce
qu'elle est sure et qu'elle donne
des resultats cliniques bons et
prolonges. La mortalite enregistree
a ete beaucoup plus faible qu'il
a ete prealablement signale. La
croissance des arteres pulmonaires
a ete bonne dans la plupart des cas.

The use of palliative procedures in
treating young children with tetralogy
of Fallot is highly controversial.1’6 The
controversy relates mainly to the
morbidity and to the early and late
mortality of the shunt procedures.
Our impression based on our own
experience and that of others7'9 is that
the risk of corrective surgery in
patients with severe tetralogy of Fallot
is lower in the older child. Our policy
has been to perform palliative pro
cedures in patients under the age of
4 years and to delay elective correc
tion until the age of 4 or 5, unless
the physical development of the child
and the anatomy of the heart and
pulmonary arteries were judged fa
vourable for earlier open-heart cor
rection.
In this paper we review our entire
experience with palliation in patients
with tetralogy of Fallot from Jan. 1,
1960 to June 30, 1980 including
surgical indications and the technical
details and causes of early and late
death. We shall also analyse the
short- and long-term results in two
groups of children, 172 who had a
Blalock-Taussig operation and 14
who had a Waterston shunt.
Indications for Palliative Operation

Our indications for surgical treat
ment have been based on symptoms:
severe cyanosis (with a high hemo
globin level [19 mg/dl] and hema
tocrit [60% ]), anoxic spells occurr
ing even in the absence of severe
cyanosis and other symptoms such as
apathy, dyspnea and feeding diffi
culties.
Our indications for doing a shunt
have been liberal in the young child.
However, the newborn infant who is
cyanotic can usually be tided over
the first weeks of life so that only
the exceptional patient will require
operation during this critical period.
Shunts are also performed in older
patients with hypoplastic pulmonary
arteries in whom correction has been
judged inadvisable.
We shall consider two groups of
patients — those who have had a
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Blalock-Taussig operation and those
who have had a Waterston shunt.
Blalock-Taussig Operation

Patients
The Blalock-Taussig operation was
performed 195 times in 172 patients
with tetralogy of Fallot. The children
ranged in age from 2 weeks to 9 years
and 74% of them were operated
upon under the age of 2 years (Table
I). Only three patients were younger
than 1 month. In 147 children a
single shunt carried them through the
critical period and allowed for later
elective correction. Thrombosis of the
anastomosis occurred in two children
in the early postoperative period and
a further emergency operation had
to be performed; in the first child a
second Blalock-Taussig anastomosis
also thrombosed and was followed by
a Waterston shunt that gave satisfac
tory results; in the other child a
Waterston shunt was carried out as
the second procedure. Twenty-three
patients required a second shunt
several months later because the first
provided insufficient blood flow; 22
underwent a second Blalock-Taussig
operation and 1 a Waterston shunt.
Surgical Technique
Preoperatively, the aortic arch and
the origin of the subclavian arteries
are identified on chest roentgeno
grams. We now prefer to perform the
anastomosis through a right thoracot
omy. For reasons we shall explain
later we avoid doing a Blalock-Taus
sig operation when an aberrant sub
clavian artery is present.
The fourth rib is resected. The
subclavian artery is dissected free and
cut above the first rib. The collateral
branches are ligated as far distally
as possible. By longitudinal incision
of the distal subclavian artery and
its collateral branches, and with some
tailoring, the distal end of the artery
is transformed into a flange that
allows for an anastomosis wider than
the artery itself (Fig. 1). The pulmo
nary artery is freed, encircled with
a loop of heavy silk, drawn upwards
and completely occluded with an angulated Pott’s ductus clamp. The ar
tery is then incised longitudinally on
its upper edge. Both the pulmonary
and the subclavian arteries are irrig
ated with heparin solution (500 units/
500 ml saline). The anastomosis is
then carried out with a simple overand-over continuous suture of 6-0
monofilament polypropylene.
When the subclavian artery arises
from the aorta the kink often present
476

at its proximal end is corrected by
placing a few oblique aorto-aortic
stitches under the origin of the sub
clavian in order to roll the aorta over
a little at this point (Fig. 2). This
brings the subclavian artery anterior
and downwards and suppresses the
angulation. The efficacy of the ana
stomosis is assessed by the intensity
of the continuous thrill in the pul
monary artery.
Postoperative Care and Follow-up
Postoperative care of these children
is kept as simple as possible. Only
rarely is the endotracheal tube left
in place postoperatively. Arterial
pressure is monitored with a dual
high-frequency Doppler system (Parks
Electronics Laboratory, Beaverton,
Ore.) and blood analyses are done on
capillary blood by micromethods.
All patients are digitalized during
the 24 hours following operation.
Digitalis is continued until total sur
gical correction is carried out. Anti
biotics are administered routinely.
All patients have been followed up
closely.
Results
There were four deaths (2%)
within 1 week of operation and five
late deaths (2.5%), 1 to 12 months
(average 8 months) after operation,
for a total mortality of 4.5%. All
deaths occurred before Sept. 1, 1972.
From then until June 30, 1980, 91
consecutive Blalock-Taussig opera
tions have been done without a single
death. There were no deaths follow
ing a second or third shunt.
The four early deaths were related
to the surgical procedure. One 8month-old infant died after emer
gency reoperation for postoperative
hemorrhage; two infants, 2 and 3
months of age respectively, died of
hypoxia and one 4-year-old girl with

severe ischemia of the arm necessi
tating two reinterventions died during
the third procedure — her shunt had
been done on the same side as the
tracheal artery that had been used
for heart catheterization the day
before.
The five late deaths occurred as
follows: a 6-month-old infant treated
for supraventricular arrhythmia died
suddenly at home 3 months after
operation; two children died of in
fection — one had meningitis before
the anastomosis, done at 3 months
of age, and died of a cerebral abscess
12 months later and the other died
of an acute infectious syndrome in
the emergency clinic at the age of 13
months, 1 year after operation; a 1year-old child died 2 weeks after
operation from respiratory problems
for which a tracheotomy had been
performed and a boy who had his
shunt performed at 3 months of age
died at home 4 months later of un
known cause. The shunt had been
patent in all these children at their
last visit. The patency was confirmed
in the two autopsies that were carried
out.
Morbidity
The postoperative course is now
uncomplicated in most patients. How
ever, ligation of the subclavian artery
and its collateral branches causes
moderate ischemia of the arm in most
patients, although it was of con
sequence in two only.

T a b le 1 - B la lo c k T a u s s ig O p e r a t io n : A g e
a t O p e r a t io n a n d D e a th s

FIG . I — Preparation
artery for anastomosis.

N o . o f d e a th s
Age
6 - 9 yr
4 yr
3 yr
2 yr
ly r
6 - 12 m o
3 - 6 mo
2 - 3 mo
1 2 mo
0 - 1 mo

No. of
s h u n ts
4
6
15
28
48
30
37
17
7
3
195

E a r ly
—

of

subclavian

L a te
—

1

—

—

—

—

—

1

—

1
1
1
—

—

3
1
—

~

—

4 (2 % )

5 (2 .5 % )

FIG . 2— Correction of kink at em er
gence of subclavian artery from aorta.
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One child had necrosis of the skin
on the dorsal aspect of the hand
following infiltration of an intra
venous infusion. The hand needed
skin grafting. To avoid such pro
blems, no intravenous needle is
placed on the side of the shunt and
the hand is protected with a cotton
mitten to avoid all blood sampling
from the ischemic limb. Also the
shunt should not be done on the side
on which the circulation is not
normal.
Horner’s syndrome is present in
most patients after operation but the
condition improves during the fol
lowing months.
Retarded growth of the limb has
been noted but it is mild and has not
been a handicap.
One patient had a chylothorax fol
lowing the shunt and was operated
upon for ligation of the oozing
lymphatic.
Efficacy of the Blalock—Taussig
Operation
The Blalock anastomosis is efficient
if it decreases cyanosis, protects
against anoxic spells and allows for
near-normal activity and a hemo
globin value ranging from 15 to 18
g/dl and a hematocrit of 50% to
55%. At 4 or 5 years of age correc
tion can be carried out electively.
In 84% of patients the first BlalockTaussig operation met these criteria
and in 14% in whom the shunt, al
though patent, became inefficient, the
second Blalock-Taussig operation suc
ceeded. A Waterston shunt was car
ried out as a second or third proce
dure in three children (1.7%). None
of these patients has required emer
gency corrective surgery.
A measure of efficacy of these
shunts is the number of months from
the palliative operation to the elective
correction. In the group of 78 patients
who underwent a single BlalockTaussig operation in our institution,
this period was 45.5 months. In 29
children the operation had been per
formed before the age of 1 year and
the period of efficacy was 47.5
months; in 17 the operation had been
performed before the age of 6 months
and the average period of efficacy
was 5 1 months.
Failure of the Blalock-Taussig
Operation
Obstruction or late insufficiency of
the flow resulting from patient growth
can cause the Blalock-Taussig shunt
to fail.

Early obstruction occurred in four
patients. It was the cause of death
in two and in two others it led to
reintervention because of the severity
of the cyanosis. These four patients
were mentioned earlier.
The insufficiency of flow through
the shunt can be diagnosed by recur
rence of the symptoms (cyanosis,
asthenia) with a persistent and con
tinuous shunt murmur. Either pallia
tive or curative surgical treatment is
required according to the age of the
patient and the severity of the cardiac
malformation.
The anatomy of the subclavian
artery is an important element in
the efficacy of the shunt. If the col
laterals of the subclavian artery arise
proximally along its trunk they cannot
be used to widen the distal end and
the anastomosis to the pulmonary
artery will be of small diameter.
When there was an aberrant sub
clavian artery the efficacy of the
anastomosis was short-lived. This oc
curred in three patients. A second
intervention was required within 1
year. The length of the aberrant
subclavian artery and its emergence
from the posterior wall of the aorta
were most likely responsible. More
over, anastomosis of an aberrant sub
clavian artery to the ipsilateral pul
monary artery creates a vascular ring
that may eventually lead to com
pression of the esophagus.
The diameter of the pulmonary
artery does not seem to be an im
portant factor in the failure of the
Blalock-Taussig operation. In 16
patients with an insufficient first
shunt, the pulmonary artery measured
an average of 10 mm (range from
5 to 15 mm) at operation as com
pared with the average of 9 mm
(range from 2 to 20 mm) in a group
of 39 patients in whom a single shunt
functioned satisfactorily.
Subclavian Artery Origin and
Efficacy of the Blalock-Taussig
Operation
In the first 9 years of our expe
rience we preferred to do the opera
tion through a left thoracotomy. As
we came to realize that the right
sided anastomosis was easier to per
form than the left we have since
done Blalock shunts through a right
thoracotomy in most patients. In 78
patients with a single shunt, 34 had
an anastomosis done with a subclavian
artery arising directly from the aorta
and 44 had the shunt performed with
the subclavian arising from the bra
chiocephalic trunk. In the first group,

the average duration of efficacy of
the shunt was 47 months and in the
second 44.5 months.
In the 22 patients with two Blalock
shunts, exclusive of the 3 whose first
anastomosis was done with an aber
rant subclavian artery, the origin of
the artery could not be linked to
failure of the first operation. In nine
patients, the first anastomosis was
done with a subclavian artery that
arose from the aorta; the average
duration of efficacy of the shunt was
24 months. In the 1 1 in whom the
subclavian originated from the bra
chiocephalic trunk the average effi
cacy was 25 months.
In our experience the origin of
the subclavian artery either from the
aorta or the brachiocephalic trunk
has no effect on the efficacy of a
Blalock shunt.
Pulmonary Hypertension
At cardiac catheterization before
corrective operation, the pulmonary
artery pressure was measured in 51
patients who had one or two func
tional Blalock shunts; the systolic
pressure ranged from 8 to 30 mm Hg
(average 18 mm Hg). Although the
pulmonary capillary resistance was
not measured it is most unlikely that
it can be elevated at this pressure.
Pulmonary Artery Stenosis
Proximal and distal stenoses of the
pulmonary arteries so common in
tetralogy of Fallot have often been
noted in these patients. However,
stenosis of the pulmonary artery at
the level of the anastomosis was not
found.
Corrective Operation
Upon admission for corrective
operation a patient with severe tetra
logy of Fallot who has a well func
tioning Blalock-Taussig shunt is more
active, less cyanotic and better nou
rished than a patient without a shunt.
Before heparinization at the time
of total correction, the subclavian
artery leading to the shunt anasto
mosis is encircled with 2-0 silk and
ligated upon instituting extracorporeal
circulation. The right subclavian
artery is approached by extrapericardial dissection along the inner aspect
of the superior vena cava and is
readily identified just behind this
vessel. The left subclavian artery,
although more distal, is also ap
proached by extrapericardial dissec
tion along the anterior aspect of the
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aortic arch to be ligated at its
emergence from the aorta.
Of the group of 109 patients with
one or two Blalock shunts who under
went total correction there was only
one problem (laceration of the sub
clavian artery, which was quickly
repaired) at the time of ligation
of the subclavian artery. A review
of our 232 patients with and without
palliative shunts who have undergone
total correction has shown that the
presence of a shunt has little influence
on the mortality (unpublished data).
Waterston Shunt
Patients

Fourteen patients with severe tetra
logy of Fallot had a Waterston shunt
during the period between September
1968 and June 1980 (Table II). They
ranged in age from 2 days to 4 years.
Six patients were less than 35 days
old at the time of the operation.
Three patients (previously noted) had
already had a Blalock-Taussig shunt
(Table III).
Indications

The indications for operation were
the same as those for the BlalockTaussig operation. The operation is
more risky than a Blalock-Taussig
procedure but we do perform it in
the newborn infant who cannot be
maintained with medical care and
in whom the anatomy of the sub
clavian artery does not permit a good
Blalock anastomosis. We have also
performed Waterston procedures in
older children with severe pulmonary
hypoplasia in the hope of stimulating
growth with a larger and more direct
shunt.

the aorta around the anastomosis to
lower the pressure in the pulmonary
artery to an acceptable level.
Results

There have been two operative
deaths in this group, in 1968 and
1973 respectively, one from hypoxia
because of an inadequate shunt and
the other from pulmonary edema be
cause of excessive shunting. Of the
survivors, one patient had pulmonary
edema and needed emergency inter
vention to reduce the shunt with a
purse-string suture as described above.
The others have done well. Three
patients have now undergone suc
cessful correction of their malforma
tion.
Discussion
Our early experience with ascend
ing aorta to right pulmonary artery
anastomosis (Waterston shunt) for
tetralogy of Fallot and for other ano
xia-producing malformations soon led
us to recognize the problems inherent
in this operation reported by others.10'12
Technically it carries more risk than
the Blalock-Taussig operation. When
the ascending aorta is clamped the
left coronary artery close to the
anastomostic site may be kinked. The
size of the anastomosis is difficult
to assess when the aorta is clamped,
so that the shunt may be too large or
too small. We have seen pulmonary
edema in the early postoperative
phase in two patients as a result of
an excessive shunt. Kinking of the
pulmonary arteries is difficult to avoid
entirely. It can lead to a preferential
shunt and early or late stenosis of the
pulmonary arteries. As it is a direct

T a b le II

Surgical Technique

The vessels are approached through
a right thoracotomy. In the small
infant where the type of shunt de
pends on its anatomy, the subclavian
artery is dissected to assess its use
fulness in creating an adequate
Blalock-Taussig shunt. If the artery
is not long enough or if its collaterals
are scattered along it a Waterston
shunt is done. We find it difficult
to make a fistula of appropriate size.
Therefore, we endeavour to evaluate
the shunt by measuring the pressure
gradient from the aorta to the pul
monary arteries by needle puncture.
If the systolic pulmonary artery
pressure is more than 35% of the
aortic pressure, we narrow the orifice
with a purse-string suture placed on
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P e r io d o f
o p e r a t io n

W a te r s t o n S h u n t

No. of
p a t ie n t s

1968 - 1973
1974 - 1980

No. of
d e a th s

8
6

2 (2 5 % )
0

14

2 (1 4 % )

T a b le I I I — W a te r s t o n S h u n t : A g e a t
O p e r a t io n a n d D e a t h s
Age
2 -3 d
14
30 d
1 - 5 mo
1 - 4 yr
T o ta l

N o . o f p a t ie n t s
2
4
5
3
14

N o . o f d e a th s
0
1 (1 6 d )
1 (3 m o )
0
2

aortopulmonary shunt, elevation of
the pulmonary resistance can develop
as it has following the Pott’s anasto
mosis.
For these reasons we reserve the
Waterston operation for the occa
sional patient who needs palliation
during the first weeks of life and in
whom the anatomy of the subclavian
artery does not favour a good Bla
lock-Taussig anastomosis. This was
the case in only six of the nine new
born infants who needed an early
shunt. Like others1'0,12 we prefer the
subclavian-to-pulmonary artery ana
stomosis, a safe and relatively simple
operation that gives good clinical
results. Its mortality is much lower1,6
than had previously been reported.2
Between 1960 and 1972 it was 4.5%
in our series and there were no deaths
in the last 91 consecutive cases.
The reasons for the improvement
since 1972 are a better understanding
of anesthesia in these hypoxic chil
dren, improved early and late post
operative care and a change of atti
tude in that we reoperate if the shunt
does not appear to be functional in
the immediate postoperative period.
In 84% of the patients a single
Blalock-Taussig anastomosis gave
sustained good results while 16%
of our patients needed a second shunt.
The growth of the pulmonary arteries
following a Blalock procedure, studied
in depth by Gale and associates,13
has been good in most of our patients
and there was no pulmonary artery
stenosis at the level of the anasto
mosis. Corrective operation would not
be precluded if pulmonary artery
stenosis occurs.12 The Blalock-Taussig
shunt does not elevate the pulmonary
resistance. It does not hinder cor
rective surgery and it has not influ
enced the operative mortality (un
published data). This has also been
noted by others.614,15
Contrary to earlier reports16 we
had good results with the BlalockTaussig operation whether the sub
clavian artery arose from the brachio
cephalic trunk or from the aorta.
Hypoplasia of the pulmonary arte
ries remains an important problem in
tetralogy of Fallot. In most patients
the arteries will dilate following the
increase of flow through a shunt and
develop satisfactorily while in others
the tiny arteries do not seem to de
velop in spite of a functional shunt.
One patient operated upon at 2 weeks
of age had a 2-mm right pulmonary
artery directly anastomosed to the
aorta. Catheterization 1 year later
showed no increase in the size of that
artery in spite of good patency of
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the anastomosis. It may be that in
certain patients hypoplasia reflects a
disease of the arterial wall that
prevents its growth while in others
the normal arterial structure will
permit dilatation and normal growth
following an increase in flow. The
results of palliative outflow tract
patching are encouraging and should
shed light on this problem.517
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reactions. Eleven patie nts developed superficial thro m b o p h le b itis and one patient developed both superficial and deep thro m bo phleb itis
The m ajority o f these cases developed in conjunction w ith the use o f in dw elling IV catheters and it is d iffic u lt to know how m uch the drug
c o n trib u te d to the irrita tio n . Two patie nts developed lo calized erythem a, swelling and pain at the site of the infusion.
S ystem ic Side E ffects: Twenty-eight patients of 596 treated w ith c lindam ycin phosphate by either the intram uscular or intravenous routes
developed system ic side e ffe c ts as follow s:
Num ber o f Patients
R a s h .............................................................................................................7
U rtic a ria ..................................................................................................... 1
P ru ritis ....................................................................................................... 1
Fever, L e u c o c y to s is ............................................................................... 1
Nausea, w ith or w ith o u t v o m itin g .......................................................... 1
Diarrhoea (See also under "W a rn in g s” ) ...............................................4

N um ber o f Patients
H yp ote nsion...............................................................................................1
H yp e rte n s io n .............................................................................................-j
Shortness of B reath............................................................................... 1
S u pe rin fe ctio n *.........................................................................................4
Cardiac a r re s t* * ....................................................................................... 1
Bad or bitter taste in m o u th ....................................................................5

S uperinfection is a co m plication of a n tib io tic therapy in general and is not necessarily a true side effect of clindam ycin phosphate.
* Due to underlying m yocarditis in th is patient.
C linical and Laboratory Findings: Patients treated during c lin ic a l tria ls o f clindam ycin phosphate were follow ed w ith clin ic a l laboratory
tests, including com ple te haematology, urinalysis and liver and kidney function tests. Some of these tests were abnorm al in itia lly and
returned to norm al durin g therapy w ith clindam ycin phosphate, w h ile others were normal in itia lly and became abnorm al during therapy.
O verall evaluation of c lin ic a l laboratory values in these patients does not indicate that clindam ycin phosphate therapy has a to x ic effect on
the haem atopoietic, hepatic or renal systems. Transient elevations o f serum transaminases have occurred in some patients, but other liver
function te s ts (alkaline phosphatase, serum b ilirubin) have not show n any tendency to increase and there have been no c lin ic a l siqns of
drug-induced hepatic toxicity.
S ym ptom s and Treatment of Overdosage: No cases o f overdosage have been reported. No specific antidote is known. Doses as high as
1200 mg every six hours (4800 mg/day) by infusion fo r five days have been given w ithout adverse effect.
DOSAGE AND ADMINISTRATION
Adults
Intram uscular In je c tio n : 600 m g/d ay in tw o equal doses.
M oderately severe in fe c tio n s : 600 to 1200 m g/day in tw o or three equal doses.
Severe in fe c tio n s : 1200 to 2400 m g/d ay in two, three or four equal doses. Intram uscular in jection s of more than 600 mq into a sinqle site
are not recom mended.
Intravenous A d m in is tra tio n : Dalacin C Phosphate m ust be d ilu te d prior to IV adm inistration to a d ilu tio n o f 300 mg in 50 ml o f diluent
(6 m g /m l) or more, and infused in not less than 10 m inutes. A d m in istra tio n of more than 1200 mg in a single one-hour in fusion is not recom 
mended. Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
M oderately severe in fe c tio n s : 900 to 1800 m g/day by contin u o u s drip or in tw o or three equal doses, each infused over 20 m inutes or longer.
Severe in fe c tio n s : 1800 to 2700 m g/d ay by contin uous drip or in three or four equal doses, each infused over 20 m inutes or longer. In lifethreatening in fe ctio n s, doses of 2700 to 4800 m g/d ay by contin u o u s drip or in three or four equal doses each infused over 20 m inutes or
longer may be given.
C hildren: (Over one m onth of age)
Intram uscular In je c tio n : 10 to 15 m g /k g /d a y in two. three or fo u r equal doses.
M oderately severe in fe ctio n s: 15 to 20 m g /k g /d a y in three or fo u r equal doses.
Severe in fe c tio n s : 20 to 30 m g /k g /d a y in three or four equal doses.
Intravenous A d m inistra tion:
M oderately severe in fe c tio n s : 15 to 25 m g /k g /d a y by contin u o u s drip or in three or four equal doses, each infused over 20 m inutes or
longer. In severe in fectio ns, it is recommended that children be given not less than 300 m g/d ay regardless of body w eight. (Dilute Dalacin C
Phosphate S terile Solution in the same manner as for adults.)
AVAILABILITY:
Dalacin C Phosphate Sterile S o lution - Each ml contains c lindam ycin phosphate equivalent to clindam ycin base 150 mg in 2 ml ampoules.
Product M onograph available upon request.
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Is Cardioplegic Rearrest Safe?
T omas A. Salerno, md, facs, frcs [c],* E dward J.P. C harrette,
Miguel A. C hiong, md, ph d, FRCP[c]t
In cardiac bypass procedures the
use of anoxic arrest or ventricular
fibrillation is known to cause severe
myocardial damage. The authors have
investigated the safety of using
cardioplegic rearrest when surgical
difficulties are encountered at the
end of a cardiac bypass procedure after
cardioplegic arrest and reperfusion
of the myocardium. From their clinical
experience with 12 patients and
laboratory experience with 13 pigs
the authors conclude that although
cardioplegic rearrest is not ideal it can
be used safely in this situation.
Durant une operation de pontage
coronarien, le recours a un arret
anoxique ou a la fibrillation ventriculaire
est reconnu pour causer des
dommages myocardiques graves.
Les auteurs ont etudie la securite
d'utiliser un second arret cardioplegique
a la fin d’une operation de pontage
apres qu'il y ait eu arret cardioplegique
et reperfusion du myocarde. De leur
experience clinique chez 12 malades
et d’etudes de laboratoire chez
13 cochons, les auteurs concluent
que bien qu'un deuxieme arret
cardioplegique ne soit pas ideal, son
emploi est sur dans la situation
decrite precedemment.

Because it is not always feasible to
perform cardiac surgery on a beating
heart, a safe method of arresting the
heart during cardiopulmonary bypass
operation has been sought. Unfor
tunately, methods such as ventricular
fibrillation or anoxic arrest, or both,
which were commonly used in the
past, are now known to cause severe
myocardial damage.1'3 The addition of
From the departments o f *surgery and
medicine (cardiology), Queen’s
University, Kingston, Ont.

t

hypothermia minimizes but does not
eliminate the damage.4 Ventricular
fibrillation, in particular, was exten
sively used in the 1970s since it
allowed for a quiet perfused heart
during operation. It was soon recog
nized, however, that maldistribution
of blood flow in the myocardium put
the subendocardial layers in jeopardy2,5,6 and led to concentric hemor
rhagic necrosis of the left ventricle.7’8
Therefore ventricular fibrillation is
now seldom used. Direct coronary
artery perfusion has also been tried
especially during aortic valve replace
ment in a beating heart. Even with
this approach, serious problems occur
including unbalanced coronary arterial
flow,9 dislodgement of the cannulas
and early or late damage to the coro
nary ostia.
Recently, cardioplegia has allowed
total arrest of the heart, a dry opera
tive field and decreased myocardial
metabolism with reasonable preserv
ation of the cellular structures. With
cardioplegia, periods of 60 to 120
minutes of arrest are well tolerated,10,11
although some cellular damage occurs
during early reoxygenation, the socalled “reperfusion injury”.1213 Repe
titive periods of ischemic arrest have
an adverse effect upon the myocar
dium1417 and reperfusion of the is
chemic heart can increase, rather than
prevent, this ischemic damage.1719
What should the surgeon do at the
end of cardioplegic arrest and reper
fusion, if surgical difficulties are
encountered, such as a “sticking”
valve prosthesis or profuse hemor
rhage from a saphenous vein-coronary
artery anastomosis? Fear of inducing
a second period of cardioplegic arrest
may lead the surgeon simply to reclamp
the aorta without cardioplegia (anoxic
arrest) or to induce ventricular fibril
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lation. These methods could worsen
the “reperfusion injury” already pre
sent, leading to serious damage to
the heart during the recovery phase.
Clinical Experience
with Cardioplegic Rearrest

When faced with a patient with
severe hemorrhage at the coronary
artery-vein anastomosis or malfunc
tion of a valve prosthesis after cardio
plegic arrest and reperfusion, we
have simply reclamped the aorta and
proceeded with a second period of
cardioplegic arrest.20 All hearts re
covered immediately from the re
arrest. All were weaned from cardio
pulmonary bypass without the use of
vasopressors. As determined by left
atrial pressure immediately postoperatively and 24 hours after operation,
the postoperative hemodynamic status
of all patients compared favourably
with that preoperatively. Unfortuna
tely left ventricular biopsies were not
performed and no patient has been
recatheterized. Clinically, all are well
after 12 months of follow-up.
Laboratory Data in
Cardioplegic Rearrest

To define the hemodynamic and
metabolic changes occurring with
cardioplegic rearrest, we thought it
important to confirm our clinical
observations with animal studies.
Beating hearts of pigs that under
went 3 hours of normothermic cardio
pulmonary bypass (group 1) were
compared with those of another group
of pigs subjected to 1 hour of cardio
plegic arrest, then 20 minutes of re
perfusion, followed by another 1-hour
period of cardioplegic arrest and 40
minutes of reperfusion (group 2).

Table 1—Hemodynamic Studies Performed in 13 Pigs*
Cl

SI

LVEDP

dp/dt

LVSWI

81 ± 15
80 ± 23

87 ± 47
81 ± 29

- 0 . 6 ± 3.6
4.1 ± 4.6

134 ± 36
94 ± 32

87 ± 45
82 ± 52

‘ Results are expressed as a percentage of values obtained at the end of the control period.
Percentages are mean ± standard deviation.
Cl = cardiac index, SI = stroke index, LVEDP = left ventricular end-diastolic pressure, dp/dt
= first derivative of pressure/time, LVSWI = left ventricular stroke work index.
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DEATH A N D COMPLICATIONS
Table II— Myocardial Glycogen and Energy Stores in 13 Pigs*

(continued from pane 466)

Group

Glycogen

Creatine
phosphate

ATP

TAN

EC

1 (n = 5)
2 (n = 8)
P v a lu e )

104 ± 7
74 ± 15
0.005

84 ± 15
198 ± 14
0.001

84 ± 4
54 ± 7
0.001

82 ± 7
55 ± 7
0.001

101 ± 3
97 ± 6
NS

•R esults are expressed as a percentage of values obtained at the end of the control period.
Percentages are mean ± standard deviation.
fS tatistical analysis was by the t-test.
A TP = adenosine triphosphate, TAN = total adenine nucleotides, EC = energy charge. NS =
not significant.

Hemodynamic values were measur
ed and myocardial biopsy specimens
were obtained before cardiopulmo
nary bypass (control period) and at
the end of the second reperfusion.
Data were presented as percentages
of values obtained at the end of the
control period. Table I shows no
significant differences in hemodyna
mic values between groups 1 and 2.
Myocardial energy stores (Table II)
were lower in both groups at the end
of the study than during the control
period. When proper corrections were
made, the energy stores in group 2
were found to be 30% less than in
group 1 at the end of the experiment.
These changes, however, did not pre
vent recovery of the group 2 hearts
to an almost normal hemodynamic
status.

Conclusions
Cardioplegic rearrest appears to be
a safe alternative to anoxic arrest or
ventricular fibrillation when surgical
difficulties are encountered at the end
of the first period of cardioplegic
arrest and reperfusion. Long-term
follow-up studies on hearts that have
been subjected to cardiac rearrest are
necessary to delineate precisely the
morphologic changes and long-term
abnormalities that may be associated
with this method of myocardial pro
tection.
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Wagner Resurfacing Total Hip Arthroplasty:
Early Results
R.A. L app ,

This preliminary report deals with
the early results obtained from
a new conservative hip arthroplasty —
the Wagner resurfacing total hip
arthroplasty in which the acetabulum
is replaced with a high-density
polyethylene cup and the femoral
head resurfaced with a metallic cup.
Between February 1977 and
September 1978, 51 patients, ranging
in age from 12 to 70 years, underwent
this operation. They had a variety
of hip diseases. All patients were
assessed prospectively by the
Harris hip rating method. The results
of operation were excellent. All
patients but one had complete or
marked relief of pain. To date there
have only been two failures.
With this procedure the considerable
problem associated with the
conventional hip arthroplasty, that
of stem loosening, is avoided. It is
possible to salvage a failed Wagner
resurfacing operation by hip
arthrodesis or by conventional total
hip arthroplasty. While it is still
too early to advocate its universal
acceptance, the Wagner resurfacing
total hip arthroplasty is expected
to be widely adopted and used with
success.

From the division of orthopedic surgery,
the Wellesley Hospital, Toronto, Ont.
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Ce rapport preliminaire s'interesse
aux premiers resultats obtenus avec
une nouvelle methode conservatrice
d'arthroplastie de la hanche, I'arthropiastie total de la hanche de Wagner
par restauration des surfaces, alors que
I'acetabulum est remplace par une
cupule de polyethylene a haute
densite, et que la surface de la tete
du femur est recouverte d’une
cupule metallique.
Entre fevrier 1977 et septembre 1978,
51 patients ages de 12 a 70 ans
ont subi cette operation. Ms
presentaient une variete de maladies
de la hanche. Tous les patients
ont ete evalues de maniere
prospective selon la methode
devaluation de la hanche de Harris.
Les resultats chirurgicaux furent
excellents. Tous les patients, sauf un,
eurent un soulagement net ou
complet de la douleur et, jusqu'a
maintenant, on n'a enregistre que
deux echecs.
Grace a cette intervention, on evite
le serieux probleme relie a
I'arthroplastie classique de la
hanche que constitue le decollement
de la tige de la prothese. II est
possible de corriger I’echec d'une
restauration des surfaces de Wagner
soit par une arthrodese de la hanche,
soit une arthroplastie totale classique
de la hanche. Bien qu’il soit trop
tot pour promouvoir son usage
universel, on s'attend a ce que
I'arthroplastie totale de la hanche
de Wagner par restauration des
surfaces soit largement adoptee et
qu'elle soit utilisee avec succes.

Although total hip joint replacement
by the conventional method is effec
tive in treating severe hip disability,
it has inherent shortcomings. A major

problem is loosening of the femoral
component within the femoral canal.1
Also the femoral head and neck are
sacrificed so that if the operation fails
no completely satisfactory alternative
exists.
To avoid these major problems, the
Wagner system2 and others of similar
design,3’8 known as double cup arthro
plasty or resurfacing hip arthroplasty,
have been developed. The Wagner

F IG . 1— Polyethylene acetab u lar cup.
m etallic fem oral cup. retained fem oral
head and neck.

F IG . 2— M etallic fem oral com ponent.
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system consists of a high-density poly
ethylene acetabular cup (4 mm thick)
(Fig. 1), available in three sizes, and
a matched stainless steel femoral
component 3 mm thick (Fig. 2). The
femoral component is similar in design
to the old Smith-Petersen cup.7 The
procedure is carried out through a
modified anterior Smith-Petersen ap
proach preserving the posterior joint
capsule and retinacular vessels. The
acetabular cup is cemented at an
angle of 45° to the sagittal plane and
in 10° of anteversion. The femoral
component is cemented in valgus and
anteversion.
Several theoretical advantages of
surface replacement are evident. The
weight-bearing characteristics of the
proximal femur are maintained. If
the procedure fails because of loosen
ing, another surface replacement, an
arthrodesis or a conventional total
hip replacement can be carried out.
The quantity of implant material used
is small and the dead space is minimal.
There are a number of disad
vantages unique to the surface re
placement technique. With the ante
rior approach, which gives an unob
structed exposure of the femoral
head and acetabulum for correct
orientation of the components, care
ful reattachment of the hip abductors
and rectus femoris are required fol
lowed by specific rehabilitation. Since
anterior dislocation of the femoral
head is necessary, avascular necrosis
is possible. Great care should there
fore be taken to preserve the retina
cular vessels. To demonstrate ade
quacy of these vessels intraoperatively
a gauze sponge may be tied around
the femoral neck momentarily to
observe a diminution of blood flow
from the reamed femoral head. Post
operative assessment of femoral head
vascularity by radiologic or radio
isotope studies is difficult. Avascular
necrosis and notching of the superior
neck of the femur while reaming
could lead to fracture of the femoral
neck.
Contraindications to this procedure
include deficiency of the femoral
neck and sepsis.
In this paper we report our pre
liminary experience with the Wagner
resurfacing total hip arthroplasty
carried out between Feb. 1, 1977 and
Sept. 30, 1978 at the Wellesley Hos
pital in Toronto.

ranged from 12 to 70 years (mean
50 years) (Fig. 3). Twenty patients
were younger than 50 years while
those in the sixth decade constituted
the largest group.
The procedure was used for a
variety of hip diseases (Table I). One
25-year-old patient with ankylosing
spondylitis had many peripheral joints
involved. In one of the two patients
with a slipped capital femoral epi
physis, chondrolysis developed and
the resurfacing procedure was carried
out when the patient was 12 years old.
Another patient had what was pre
sumed to have been a slipped epi
physis at the age of 12 years and
underwent resurfacing at the age of
55 years. One 30-year-old patient
with hip dysplasia had previously
had an arthrodesis. A 12-year-old
child with Marfan’s syndrome had an
incapacitating protrusio acetabuli. Of
the four patients considered to have
avascular necrosis, the first was a
boy who at the age of 12 years had
Perthes’ disease of late onset which
was treated by two trochanteric
osteotomies before the resurfacing
procedure which was performed when
he was aged 14. Extensive myositis
ossificans developed. This resulted in
a painless but ankylosed hip. A 28year-old woman with systemic lupus
erythematosus had bilateral avascular
necrosis presumably from high-dose
steroid therapy. Forage procedures
were carried out bilaterally before the
right hip was resurfaced.
All 51 patients were prospectively
assessed according to the Harris hip
scale;8 hip values were calculated
preoperatively and then at regular
intervals postoperatively. The Harris
method assigns a value of 100 to an
ideal hip. It emphasizes pain and
function; a maximum of only 5 points
are allowed for a full range of hip
motion, whereas pain is assigned 44,
function 47 and absence of deformity
4 points.
Seven patients were operated on
in the last 2 months of the study and
four either failed to return or lived
too far away to return for regular

review. Forty-one hips were available
for complete assessment.
Results

In the group as a whole there was
substantial improvement in the Harris
rating postoperatively (Fig. 4). There
were two failures: a 14-year-old boy
had extensive myositis ossificans and
a 48-year-old woman suffered deep
sepsis. Despite these problems they
both made gains on the Harris scale,
from 33 to 87 points and from 29
to 44 points, respectively. No patient
lost rating points as a result of the
operation.
The average rating preoperatively
was 44. An average gain of 44 points
was made to a level of 88 at the
most recent review. These patients
showed a characteristic pattern of im
provement that continued slowly; for
example, at 3 months the average
rating was 75 and at 6 months 88.
All patients have had full or marked
relief of their preoperative pain
except for the woman with deep

T a b le 1— H ip D is e a s e s T r e a t e d
D is e a s e
P r im a r y o s t e o a r t h r it is
P o s t - t r a u m a t ic o s t e o a r t h r i t i s
R h e u m a to id a r t h r it i s
A n k y lo s in g s p o n d y lit is
S lip p e d c a p it a l e p ip h y s is
A c e t a b u la r d y s p la s ia
P r o t r u s io a c e ta b u li
( M a r f a n 's s y n d r o m e )
M o r q u io ’ s s y n d ro m e
A v a s c u la r n e c r o s is :
P e r t h e s ’ d is e a s e
S y s te m ic lu p u s e r y t h e m a t o s u s
A lc o h o lic
O th e r

N o . o f h ip s
35
4
2
1
2
2
1
1
1
1
1
1

Patients and Methods

During the study period we oper
ated on 52 hips in 51 patients (33
females and 18 males). Their ages
486

F IG . 4— Fre- and postoperative H arris
hip scale ratings.
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sepsis. To date we have not seen any
femoral neck fractures or loosening
of the femoral component.
Complications are summarized in
Table II. Only one patient showed
sufficient myositis ossificans to inter
fere with function. About 25% have
shown minor degrees of heterotopic
bone formation of no functional im
portance. It appears more frequently
than in the conventional total hip
arthroplasty and is probably related
to the exposure.
The patient with deep wound in
fection diagnosed 1 year postoperatively had several early postoperative
dislocations. At 1 year, her loose
acetabular component was removed
but her femoral component was firmly
anchored. A biopsy specimen of the
femoral head showed viable bone
without signs of loosening at the
bone-cement interface. Two instances
of superficial infection caused no
late problems.
Two patients had persistent weak
ness of the abductor muscles due to
avulsion of the abductor muscle ori
gin but both improved. One of these,
a patient with ankylosing spondylitis,
also had one of the superficial in
fections.
One patient dislocated her hip in
the first postoperative week. She did
well following a single closed reduc
tion. One patient died of an acute
myocardial infarction within 1 week
of operation.

The major problem of conventional
total hip arthroplasty — loosening of
the femoral component — has been
avoided in this series so far. Preserva
tion of the weight-bearing part of the
proximal femur must help to prevent
loosening of the femoral component.
The components are not loaded in
shear or bending but only in com
pression. Where impingement of com
ponents does occur, there should be
little torque loading.

Table I I —Complications of
O peration*

Extensive myositis ossificans
Wound infection
Deep
Superficial
Abductor muscle avulsion
Postoperative dislocation
Myocardial infarction
*7 patients.

®Sofra-Ttille®
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VOLUNTARY CONTRIBUTIONS

Peritoneoscopy in General Surgery
M.M. C o h e n ,

Peritoneoscopy is a simple and
effective means of diagnosing or
excluding intra-abdominal disease. It
is currently underutilized and merits
increased recognition particularly
by general surgeons.
The first 77 peritoneoscopic examina
tions performed by a general surgeon
in a large hospital associated with
a cancer agency are reviewed. An
exact diagnosis was made in 78% of
58 patients in whom the primary
diagnosis was in doubt and in 93%
of that group management was
influenced. Surgical exploration of
the abdomen was avoided in 29
patients. The major indications for
using the method were: to search
for metastases, to evaluate the acute
abdomen and to stage lymphoma. Local
anesthesia and nitrous oxide insuf
flation were used almost exclusively.
Biopsy was performed in 36 patients
and there was one death directly
attributable to liver biopsy. In two
patients peritoneoscopy was unsuc
cessful.
La peritoneoscopie est un moyen
simple mais efficace de diagnostiquer
ou d'exclure une maladie intraabdominale. Presentement, elle est
sous-utilisee et elle merite une
meilleure reconnaissance, particulierement de la part du chirurgien
general.
On a etudie les 77 premiers examens
au peritoneoscope pratiques par un
chirurgien general dans un gros hopital
rattache a une agence de lutte
contre le cancer. Un diagnostic precis
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a ete pose dans 78% des 58 malades
chez qui le diagnostic primaire etait
incertain et, chez 93% de ce groupe,
le traitement a ete influence.
L'exploration chirurgicale de I'abdomen
fut evitee chez 29 patients. Les
principales indications pour I'empioi
de cette methode ont ete: la
recherche de metastases, 1'evaluation
d’un abdomen aigu et la classification
par stade d'un lymphome. Une
anesthesie locale et I’insufflation
d’oxyde nitreux furent presque
exclusivement utilisees. Une biopsie
fut pratiquee chez 36 patients et
un deces est directement attribuable
a la biopsie hepatique. Chez deux
patients, la peritoneoscopie fut
un echec.

Peritoneoscopy is well established. It
affords a simple, safe and effective
method of examining the abdominal
cavity and obtaining tissue for diag
nosis. It can be performed equally
well with local or general anesthesia.
Recovery is rapid and peritoneoscopy
done as a day-stay procedure is safe
if biopsy is not performed. Despite
these adantages general surgeons in
Canada have been slow to adopt this
procedure. In recent years there has
been a sharp increase in interest in
laparoscopy among North American
gastroenterologists prompted by the
impressive reports of its value from
Germany.1,2 Because driving a largebore trocar and cannula through the
abdominal wall implies that this is
a surgical procedure, it is unlikely
that peritoneoscopy will find support
in Canada unless it is approved by
general surgeons. This paper reports
on my initial experience with perito
neoscopy in 77 patients.
Peritoneoscopy and laparoscopy are
used interchangeably in this paper.
Patients and Methods

Peritoneoscopy was performed on

38 men and 39 women between Jan.
1, 1978 and June 30, 1980. The men
ranged in age from 18 to 82 years
(mean 47 years) and the women from
17 to 80 years (mean 43 years). All
procedures were performed in the
operating room under strict aseptic
control. In 67 cases (87%) local anes
thesia (1% lidocaine. 10 to 20 ml)
was used. This was supplemented,
with a few exceptions, by a variety
of intravenous medications such as
diazepam, meperidine hydrochloride,
fentanyl citrate, Nisentil or Innovar
according to the individual preference
of the anesthetist. In the other 10
patients peritoneoscopy was per
formed with general anesthesia usual
ly because the patient insisted. Carbon
dioxide was used to insufflate the
peritoneal cavity of the first 11 pa
tients but thereafter nitrous oxide was
used exclusively. Nitrous oxide has
been championed as an insufflating
gas by the German gastroenterologists
because it does not induce peritoneal
pain and is almost as rapidly absorbed
as carbon dioxide. My initial expe
rience with carbon dioxide convinced
me that it did cause pain and was
suitable only when general anesthesia
was used. I believe that nitrous oxide
may even provide some local anal
gesia. Unlike carbon dioxide, nitrous
oxide supports combustion, and in
the extremely rare event that the
colon is punctured, methane is re
leased, and if cautery is used there
is a theoretical risk of explosion.
Monopolar electrocautery was avail
able in every case but was used in
only four patients. Bipolar cautery is
safer and is suitable for tubal ligation,
but is not appropriate for cauterizing
the liver, which was the indication
for use in our four cases. The only
contraindication to peritoneoscopy
was a major abnormality of blood
coagulation. Advanced age, the pre
sence of cardiorespiratory disease and
severe debility were not contraindica-
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tions. No patient was turned down
because of previous abdominal sur
gery. In only 7 of 26 patients with
abdominal scars was assessment of
the abdominal cavity limited by the
presence of adhesions. In one patient
with extensive Crohn’s disease, peri
toneoscopy was completely unsuccess
ful because of adhesions although he
had not had abdominal surgery.
Technique

The technique of peritoneoscopy
was essentially that described in the
literature.3 With few exceptions the
puncture site was cephalad and to
the left of the umbilicus although in
some patients the site used was
influenced by the indication for the
peritoneoscopy and the position of
abdominal scars. In every instance
the trocar and cannula were inserted
at the point chosen for insertion of
the Verres cannula. We always
checked that the tip of the Verres
cannula lay within the peritoneal
cavity by inserting by syringe and
attempting to aspirate 20 ml of saline.
In most patients approximately 4
litres of gas was insufflated but in
some as little as 2 litres proved suf
ficient and in no case was more than
6 litres used. Intra-abdominal pres
sure was monitored during insufflation
by careful observation of the gauge
on the insufflator. Pressure was never
allowed to rise above 30 mm Hg and
usually remained below 20 mm Hg.
Intraperitoneal insufflation was as
sured by observing a free flow of gas
and a respiratory excursion on the
intra-abdominal pressure gauge. The
main telescope used was the Storz
7-mm “diagnostic” (Karl Storz, GmbH
& Co., Tuttlingen, West Germany).
With a special dilator the more
conventional 11-mm cannula could
be placed, allowing the insertion of
either a larger telescope for photo
graphy or a biopsy channel in con
junction with the 7-mm telescope.
It was usually found more convenient,
however, to take a biopsy specimen
using a separately inserted Tru-cut
needle as described below. By mani
pulating the operating table into
extreme Trendelenburg and reverse
Trendelenburg positions and by lateral
rotation a complete examination, par
ticularly of the liver and spleen, was
much easier. Fogging of the lapa
roscopy lens was not a problem and
a prewarmer was not required. In
many patients a photographic record
was obtained. The insufflating gas
was released at the end of the pro
cedure and the small incision either

sutured or approximated with Steristrips. The average time for the pro
cedure was 20 minutes.
The patients were usually observed
in the recovery room for about 1
hour and then allowed to return to
their ward to resume preoperative diet
and activities. Patients in whom liver
biopsy was performed were kept in
hospital overnight but many others
were discharged on the day of the
procedure.
Liver biopsy was performed in 33
patients; in 4 the indication for the
guided biopsy was an unsatisfactory
blind liver biopsy. In most cases a
core of liver was obtained with the
Tru-cut needle although in a few
patients with liver metastases the
biopsy was taken with punch biopsy
forceps inserted through a separate
3-mm cannula. Three patients with
cancer had biopsy specimens taken
from other sites, namely stomach,
omentum and peritoneum.
Indications and Results

The commonest indication for peri
toneoscopy (Table I) was the inves
tigation and assessment of the patient
known to have malignant disease. The
next largest group comprised the
patients with acute abdominal pain
or abdominal trauma. In general sur
gical practice peritoneoscopy was
not commonly done for assessment
of liver disease. Occasionally it was
used as a last resort instead of sur
gical exploration in patients with
unexplained abdominal pain.
Search for Metastases4
Twenty-three patients had perito
neoscopy performed to identify or
exclude the presence of metastases.
In 15 patients metastatic disease was
suspected on the basis of altered liver
function, radionuclide scanning, ultra
sonography or computerized tomo
graphy. The primary tumour in these
cases had been identified as being in
the breast (four patients), colorectum
(three), stomach (one) and as a mela
noma (one); in six patients no primary
malignant tumour had been found. In
10 of these 15 patients peritoneo
scopy and guided biopsy confirmed
the presence of liver or other meta
stases and appropriate chemotherapy
was initiated. In several patients the
metastases were small and would
probably have been missed by blind
biopsy and in one patient there was
a solitary metastasis less than 1 cm
in diameter.
In five patients with suspected liver

metastases no tumour was found. In
three of these, other liver diseases
were found in biopsy specimens to
explain the clinical suspicion of
metastases. In another patient the
tentative decision not to proceed with
gastrectomy was changed as a result
of the negative laparoscopy and a
“curative” gastrectomy was per
formed.
In eight cases peritoneoscopy was
performed to exclude liver metastases
before embarking on radical surgery
for cure. In three patients liver meta
stases were demonstrated; in another
patient a gastric carcinoma was shown
to be inoperable because of local
spread (confirmed at autopsy 1 month
later); a fifth patient was shown to
have severe cardiac cirrhosis but no
metastases. In all five cases plans for
surgical extirpation of the primary
tumour were abandoned. In the re
maining three cases no liver or other
metastases were found and the pro
posed treatment was carried out. At
surgical exploration in these patients
the laparoscopic findings were con
firmed.
Staging Procedures5
Thirteen patients underwent peri
toneoscopy as a staging procedure for
Hodgkin’s disease (10 patients) or
non-Hodgkin’s lymphoma (3 patients)
to determine the presence or absence
of liver involvement. In every case
a liver specimen was obtained with
the Tru-cut biopsy needle. The liver
of 11 patients appeared normal and
the biopsy specimen showed no evi
dence of lymphoma. One of these
patients subsequently had a staging
laparotomy at which the liver was
confirmed to be normal. In a 28-yearold man with clinical stage IIB (Ann
Arbor classification0) Hodgkin’s dise
ase the liver appeared normal grossly,
but the biopsy specimen showed
the presence of disease. In the re
maining 40-year-old woman with
clinical stage IIA Hodgkin’s disease
but with hepatomegaly and abnormal

Table 1— Indications for Peritoneoscopy
Indication

No. of patients

Search for metastases
Staging procedure
Acute abdomen
Abdominal traum a
Undiagnosed chronic
abdominal pain
Assessment of liver disease

23
13
20
6

Total

77
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liver enzymes, peritoneoscopy showed
an obviously cirrhotic liver and this
was confirmed by biopsy.

patients the findings at laparoscopy
were either normal (2 patients) or
showed the presence of nonsurgical
disease (9 patients). All were treated
medically and all recovered.

Acute Abdom en’

Peritoneoscopy was performed in
20 patients with an acute abdomen.
All had symptoms and signs indicating
the need for urgent surgical explora
tion but there was sufficient doubt
about the diagnosis that the surgeon
would have entered the abdomen
through a midline incision. The diag
noses made at peritoneoscopy in these
20 patients are set forth in Table II.
In the six patients for whom a
positive diagnosis was made at peri
toneoscopy and the abdomen was
subsequently explored, the diagnosis
was confirmed histologically. In one
patient, peritoneoscopy was unsuc
cessful because of drug-induced hys
teria and as a result an unnecessary
laparotomy was performed. Such a
patient would now be investigated by
peritoneoscopy under general anes
thesia. The only patient in the entire
series in whom peritoneoscopy was
misleading was a 78-year-old woman
taking steroids in whom acute ap
pendicitis was suspected. Peritoneosscopy showed definite retrocecal in
flammation but despite all attempts
it proved impossible to visualize the
appendix. Laparotomy revealed that
the inflammation was secondary to a
large right perinephric abscess. In 11

Abdominal Trauma8

In six patients peritoneoscopy was
performed for either blunt (three) or
penetrating (three) abdominal trauma.
The first peritoneoscopy performed
in this series was in a 20-year-old
man who received a karate blow to
his left lower quadrant and 24 hours
later presented with severe left-sided
abdominal pain but no abnormal phy
sical signs and a normal blood pres
sure and hemoglobin level. Perito
neoscopy under local anesthesia
showed a ruptured spleen, which at
laparotomy was found to have a
laceration 12-cm long.
An acute abdomen developed in
a 22-year-old man 10 days after re
section of the thoracic aorta ruptured
in a motor vehicle accident. The diag
noses entertained were delayed rup
ture of the spleen, subcapsular hema
toma of the liver and pancreatitis.
Peritoneoscopy, performed under lo
cal anesthesia without additional
medication, demonstrated extensive
pancreatitis. He was managed con
servatively and made a complete re
covery. Peritoneoscopy may be of
great value in investigating patients
on respirators in whom it is difficult

Table II— Diagnosis and Effect of Peritoneoscopy on Treatm ent
of 20 Patients w ith Acute Abdomen
Diagnosis

No. of patients

Treatm ent

A cute cholecystitis
Ruptured ovarian cyst
Pelvic inflam m atory disease
A cute appendicitis
G angrene of omentum

1
2
7
4
1

R etrocecal inflammation
Adhesions

1
1

No disease

2

Cholecystectomy
Analgesics
Antibiotics
Appendectomy
Excision of omentum for primary
torsion
Laparotomy (perinephric abscess)
Laparotomy (perforated ileum due to
Crohn’s disease)
E s c h e r ic h ia c o li found in u r in e antibiotics given (1)
Conservative (1)
Laparotomy (ruptured ovarian cyst)

None made

1

Table I I I — Peritoneoscopic Findings and Treatm ent in Eight
Patients w ith Undiagnosed Pain
Diagnosis

No. of patients

Treatm ent

No disease

2

Laparotomy: biopsy of metastatic
nodes of celiac axis (1)
Conservative (1)
Laparotomy (chronic pancreatitis)
Cholecystectomy (cholesterolosis)
Laparotomy and lysis of adhesion
Conservative

Pancreatic mass
Chronic cholecystitis
S olitary band adhesion
M u ltip le adhesions
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to assess the abdomen by clinical
methods.
Two patients with abdominal stab
wounds and no clinical evidence that
the abdominal cavity had been pen
etrated (including a negative “stabogram”) had peritoneoscopy; in both
free blood was found in the peritoneal
cavity. Laparotomies were performed.
One had a major laceration of the
small bowel mesentery repaired;
although several hundred millilitres
of blood was present in the other
patient, the only injury identified was
a hematoma of the splenic flexure.
The third penetrating injury in this
group was in a 33-year-old woman
with a self-inflicted gunshot wound
of the left upper quadrant of the
abdomen and an exit wound in the
left loin. Peritoneoscopy under local
anesthesia showed conclusively that
the bullet had not entered the peri
toneal cavity and therefore a laparo
tomy was not performed. She made
a smooth recovery.
Peritoneal lavage has been used
with increasing frequency and ac
curacy to diagnose severe bleeding
in blunt abdominal trauma. It is
unlikely that many patients with a
negative lavage would be considered
suitable for further investigation by
peritoneoscopy. It is not uncommon,
however, for a positive lavage to be
followed by a laparotomy at which
some blood but no active bleeding
is found. If the patient’s condition is
quite stable and laparotomy is not
urgently indicated on clinical grounds,
peritoneoscopy may be a satisfactory
method of examination.
The role of peritoneoscopy in
penetrating injuries will be limited to
the small number of patients in whom
all clinical evidence suggests that the
peritoneal cavity has not been entered.
In this country where our experience
with penetrating injuries is relatively
small, we are still, correctly, reluctant
to manage these patients expectantly.
Undiagnosed Chronic
Abdominal Pain9

Intractable undiagnosed abdominal
pain was the indication for peritone
oscopy in eight patients. All had been
extensively investigated and a diag
nostic laparotomy was being consi
dered. The findings at peritoneoscopy
and the subsequent management of
these patients are shown in Table
III.
The three patients who were oper
ated upon for solitary adhesions were
relieved of their pain. They have been
followed up for 9 to 18 months and
remain asymptomatic.
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Assessment of Liver Disease10
Peritoneoscopy was performed in
seven patients with suspected liver
disease to obtain a guided liver biopsy
specimen and assess the appearance
of the liver.
In one patient the liver was not
visualized because of adhesions. In
the other six patients biopsy speci
mens were obtained with the Tru-cut
biopsy needle. The diagnoses made
were cirrhosis (two patients), hepa
titis (two), leukemia (one) and hepa
tocellular carcinoma (one).
Morbidity and Mortality

There were no major complications
of peritoneoscopy itself. Early in the
series insufflation of the rectus sheath
caused transient discomfort in one
patient and the procedure was un
successful. Laparoscopy was unsuc
cessful in only one other patient be
cause of extreme agitation induced
by the administration of diazepam.
There were no deaths within 1 week
of the procedure. A 69-year-old
woman with known bone metastases
from a primary carcinoma of the
breast was admitted to another hos
pital, 10 days after guided liver
biopsy, complaining of right upper
quadrant pain. The liver biopsy spe
cimen had shown severe cirrhosis but
no evidence of metastases. She died
several days later and at autopsy was
found to have a large intrahepatic
hematoma attributable to the biopsy
procedure. There were no other com
plications or deaths that could in
any way be attributed to either peri
toneoscopy or the biopsy procedure.

In this paper I have reported my
experience learning the technique and
role of peritoneoscopy. No case has
been excluded. In the first 77 patients
investigated over a 2'/i-year period
there were two failures and seven
cases in which the examination was
limited by adhesions. Twenty-six
patients had had previous nongynecologic abdominal surgery. The pro
cedure proved to be of considerable
diagnostic value (Table IV). Although
a precise diagnosis was established
in only 78% of 58 patients in whom
peritoneoscopy was performed for
this purpose, useful information
(e.g., a normal examination) was
obtained in nine other patients result
ing in an alteration in management.
Thus, in those 58 patients, peritone
oscopy determined the management
in 54 (93%).
In 29 cases, surgical exploration
of the abdomen was avoided (Table
V). In all patients the next step in
management would have been lapa
rotomy but the information obtained
at peritoneoscopy indicated that this
would serve no useful purpose.
Patients with an acute abdomen were
shown not to have a surgical cause
of their pain and tenderness and in
10 patients unsuspected metastases
were found in the liver, omentum or
peritoneum. Eight patients with mis
cellaneous problems had exploratory
peritoneoscopy rather than explora
tory laparotomy and in none was a
laparotomy subsequently performed
or indicated.

I thank the physicians and surgeons
who referred their cases for further in
vestigation, particularly the oncologists
at the Cancer Control Agency of British
Columbia for their enthusiasm and sup
port, and Ms. Diane Steel and Mrs.
Bertha Kruska for secretarial assistance.
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No. of patients

Diagnosis established
visually
Diagnosis established
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No definite diagnosis
established
Unsuccessful
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58-

Total

7.

Table V— Patients in Whom
Laparotomy Was Avoided by
Peritoneoscopy

8.

Nonsurgical acute abdomen
Inoperable malignant disease
Nonsurgical jaundice
Abdominal trauma
Chronic abdominal pain
Others

11
10
2
2
2
2

Total

29
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Table IV— Value of Peritoneoscopy
in Diagnosis

Discussion

The two primary advantages of
peritoneoscopy are: it allows guided
biopsy of the liver and it provides
information that could otherwise be
obtained only by surgical exploration
of the abdomen. The first advantage
is recognized by most gastroentero
logists but in this country they have
been slow to adopt the procedure.
The second advantage should be ap
parent to general surgeons, but its
acceptance by them has been even
slower. Most general surgeons believe
that with modern general anesthesia
more reliable information is obtained
by a rapid exploratory laparotomy
and with almost equal safety. But
laparotomy in elderly and debilitated
patients carries a high mortality and
morbidity" and even a negative ex
ploration for suspected abdominal
trauma is associated with a 1.6%
mortality.12

The accuracy of peritoneoscopy
will clearly be related to the expe
rience of the operator. It is likely
that familiarity with the appearance
and anatomy of normal and abnormal
abdominal viscera will prove to be
more important than familiarity with
the equipment, which although essen
tial is rapidly gained. Gastrointestinal
laparoscopy should not therefore be
relegated to the gynecologist or
gastroenterologist-endoscopist. There
will be situations in which the desired
information can be obtained much
more readily by surgical exploration.
These cases will be easily recognized
by the general surgeon and the more
appropriate procedure performed.
In this series, there was one death
directly related to a liver biopsy. In
this patient the outcome would have
been the same if the biopsy had been
performed by the conventional blind
technique. There were no other deaths
attributable to either peritoneoscopy
or biopsy and there were only two
minor complications, both of which
were associated with unsuccessful
peritoneoscopy.

9.
10.
11.
12.
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Enteral nutrition begins in the
recovery room ...

Vivonex Jejunostomy Kit
All you need to perform a
needle-catheter jejunostomy in one
complete, economical kit.
Each kit contains:
- hinged easy access tray
- 90 cm (36”) 5 Fr radiopaque polyurethane catheter
- 100 cm ‘soft tip, stainless steel, flexible guidewire
- No. 14 gauge, thin-wall, non-coring needles (2)
- No. 20 gauge, needle cannula with female adapter hub
- catheter/adapter sleeve for nonshearing, leak- and
kink-proof connection
- specially designed anchoring catheter retainer to
prevent accidental dislodgement
- instruction sheet
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And continues on the ward
New Formula

Vivonex HN
- New formulation containing molybdenum,
selenium, and chromium; less sodium and
chloride; added potassium
- Unique amino acid formula is absorbed with
minimal digestion
- Less than half the cost of TPN
- Virtually eliminates the risk of sepsis associated
with parenteral feedings
- Safe and effective

“Nutritional benefits are realized early when the
needs are greatest. Although the present study did
not com pare intrajejunal feeding with total paren
teral nutrition, the nutritional benefits appear to
be equal or better, and alm ost all the hazards o f
total parenteral nutrition are avoided
-

_a s

Hoover. HC Jr., Ryan, JA, Anderson, E J, and Fischer, JE: Nutritional
benefits of immediate postoperative jejunal feeding of an elemental diet.
Am J Surg 139:153 (Jan) 1980.
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Rectus Femoris Myocutaneous Flaps
for Trochanteric Ulcers
M.S.G. B e l l ,
The local skin flaps traditionally
used to repair trochanteric ulcers in
paraplegics are usually thin, have poor
padding qualities and often break
down. The rectus femoris myocutaneous
flap was used to repair trochanteric
ulcers in eight paraplegic patients.
Three flaps healed primarily. In three
there was some necrosis at the distal
corner of the flap but this healed
spontaneously. The cutaneous portion
of two flaps necrosed and had to be
excised but the muscle remained viable.
All eight flaps remain healed with no
evidence of breakdown.
The repetitive shear forces over the
prominent mobile hip joint cause
particular problems in providing a
stable flap repair, but the rectus
femoris myocutaneous flap has
demonstrated, in this series, its
stability and durability.
Les lambeaux cutanes regionals utilises
traditionnellement pour reparer
les ulceres trochanteriens chez les
paraplegiques sont habituellement
minces, offrent peu de coussin de
protection et se dechirent souvent.
Un lambeau myocutane du muscle droit
anterieur de la cuisse a ete utilise
pour reparer des ulceres trochanteriens
chez huit patients paraplegiques.
Trois lambeaux ont cicatrise par
premiere intention. Chez trois autres
il y eut une certaine necrose du
coin distal du lambeau qui guerit
neanmoins spontanement. La partie
cutanee de deux lambeaux s'est
necrosee et elle dut etre excisee,
mais le muscle demeura viable. Les
huit lambeaux demeurent sains
sans signe de lachage.
Les forces repetees de cisaillement
exercees sur I'articulation saillante
mobile de la hanche causent des
problemes particuliers a la recherche
d'une reparation stable par lambeau
cutane; toutefois, dans cette serie, le
lambeau myocutane provenant
du muscle droit anterieur de la cuisse
s'est avere a la fois, stable et durable.

From the department of surgery,
University of Ottawa, Ottawa Civic
Hospital, Ottawa, Ont.
Accepted for publication Mar. 24, 1981
Reprint requests to: Dr. M.S.G. Bell,
Department of surgery, Ottawa Civic
Hospital, 1053 Carling Ave.,
Ottawa, Ont. K IY 4E9
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Myocutaneous flaps consist of a pad
dle-shaped portion of skin attached to
the underlying muscle. This is trans
ferred with its vascular pedicle to
close tissue defects. Perforating ves
sels from the underlying muscle sup
ply the skin.
Many clinically useful myocutan
eous areas have been defined1,2 for
application to specific tissue defects.
Trochanteric ulcers have been suc
cessfully treated by the tensor fascia
lata myocutaneous flap and the rectus
femoris and vastus lateralis myo
cutaneous flaps.3 We present a 2-year
follow-up of the rectus femoris myo
cutaneous flap used to repair trochan
teric ulcers in eight patients. There
have been no recurrent sores.
Anatomic Considerations of
Trochanteric Pressure Sores

The ulcer is located over the bony
prominence of the greater trochanter,
surrounded by thin skin and bordered
by attenuated muscle fibres from the
insertions of gluteus maximus and
tensor fascia lata. Trochanteric ulcers
may be large and osteomyelitis of the
trochanter is a commonly associated
problem. Surgical management may
be complicated by pre-existing sur

md

gical scars. Traditionally, local skin
flaps have provided coverage after
excision of the ulcer and part of the
bony prominence, but a serious prob
lem with this technique is recurrent
breakdown of the flap. Factors con
tributing to this breakdown in para
plegics include thin, poorly padded
skin and repetitive shear forces on this
skin which covers the prominent tro
chanter in the presence of a mobile
hip joint.
Anatomy of the Rectus
Femoris Muscle

This muscle arises from two ten
dinous origins-—a straight origin from
the anterior inferior iliac spine and a
reflected origin from the groove above
the rim of the acetabulum and from
the capsule of the hip joint. The
muscle ends in a broad thick aponeu
rosis, which becomes narrow and
flattened as it enters its point of in
sertion in the patella (Fig. 1).
The main blood supply is a branch
of the lateral circumflex femoral ar
tery which arises from the deep
femoral artery. The neurovascular
bundle enters the posterior surface
of the muscle approximately 7 cm
distal to the inguinal ligament.
The boundaries of the myocuta
neous flap have been well described.1,2
Sensibility is good when the interme
diate cutaneous nerve of the thigh
is retained. This would be useful in
patients who are not paraplegic. Per
forating vessels vascularize the skin.
In three of our patients a smaller vas
cular pedicle entering the distal one
third of the muscle belly was also de
tected. Ligation of this had no effect
on the viability of the flap.
The Operation

FIG . 1— R ectus fem oris m uscle with
skin flap it will c arry late ra lly to cover
tro ch an teric ulcer. R o tatio n is a t site of
n e urovascular bundle.

The patient is placed supine on
the operating table to prevent the
thigh muscles from rotating with
gravity and the skin is marked (Fig.
2). The patient is then rotated to allow
elevation of the affected side for bet
ter access to the region of the tro
chanter. After excision of the ulcer
the myocutaneous flap is raised. Start
ing distally, the skin and deep fascia
are incised. The rectus femoris ten
don is isolated and divided. The mus
cle is separated from its bed by blunt
dissection. As dissection proceeds
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FIG. 2—Trochanteric ulcer. Line of incision is marked
on skin.

proximally, the skin margins are serial
ly sutured to the underlying muscle,
thus preventing a plane of dissection
from developing between the two
which would compromise the vascular
supply to the skin. The neurovascular
bundle is then isolated and preserved.
The flap may now be swung laterally
to the site of the ulcer and sutured
into place. The vastus lateralis muscle
may be incised to allow a better fit.
The tensor fascia lata may also be
divided distally and rotated to cover
the bone, providing a second muscular
layer.
Two chest tubes are inserted, one
under the flap, and the other in the
donor site anteriorly. The anterior
thigh defect can be closed without
undue tension.
Patients

Between Jan. 17, 1978 and Dec. 1,
1978, eight trochanteric ulcers in
seven patients were closed using rec
tus femoris myocutaneous flaps. Five
of the patients were quadriplegic or
paraplegic, one was diabetic and one
was senile and bedridden. Three pa
tients had undergone previous surgical
procedures, including skin grafting
and the use of local flaps to repair
the ulcers.
The ulcers in these patients had
been present for an average of 5 to
6 months; the largest had been
present for more than 1 year. All ex
tended to the trochanter and aver
aged 11.4 cm in diameter. The largest
was 15 cm in diameter. The size of
the skin portion of the flap ranged
from 10 X 7 cm to 20 X 10 cm
\ (average 1 5 x 8 cm). Initially, oper
ation lasted an average of 90 minutes,
although the later operations were
completed in less than 1 hour. Blood
loss averaged less than one unit. No
patient required transfusion.

FIG. 3__One year after placement of myocutaneous flap.
Area has healed well and flap is viable.

Results

Three of the eight flaps healed
primarily. Another three showed some
delay in healing, usually with a small
area of skin necrosis at the distal
corner of the flap. Spontaneous heal
ing occurred in these necrotic areas.
The cutaneous components of two
flaps necrosed, were subsequently ex
cised and the area left was success
fully covered with split skin graft. The
muscle remained viable in every case
(Fig. 3). At follow-up, 2 years after
the first operation, all the flaps re
mained healed. One elderly diabetic
with chronic obstructive lung disease
died from bronchopneumonia 21 days
after operation.

loss of skin at the distal corner of the
flap all wounds eventually healed and
in-patient care was not necessary.
In our experience a cutaneous com
ponent 15 X 10 cm can be expected
to survive. Even if a portion of skin
is lost, the muscle can be covered by
split skin graft.
Conclusions

The rectus femoris myocutaneous
flap is useful for repairing trochan
teric ulcers. The results of the oper
ation have been encouraging and the
flap appears to be durable.
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NOW IN STROKE
The Advantages of ENTROPHEN*
To reduce the risk
of stroke

with reduced risk
of stomach upset

Now, ENTROPHEN* is
indicated for reducing the risk
of recurrent transient ischemic
attacks or stroke in men who
have had transient ischemia
of the brain due to fibrin
platelet emboli. At present
there is no evidence that
ASA is effective in reducing
transient ischemic attacks
in women, or is of
benefit in the treatment
of completed strokes
in men or women.
Inhibition of platelet
M
cyclooxygenase activity
by a single dose of
-ENTROPHEN*-10
was comparable to
that of plain ASA,
./ aM !
although the effect was FlW |
delayed, reflecting the
delayed appearance of
ASA in the plasma.1

When you prescribe
ASA for long-term use,
it is important not to create
additional problems for
your patients.
While they may benefit
from the therapeutic
effect of ASA, there is
still a potential for
gastric irritation and
upset, particularly
when the regimen calls
for continuous daily
dosage.
Clinical experience
has shown that
ENTROPHEN*, coated
with POLYMER 37*
reduces gastric distress
in long-term treatment
with high doses of ASA.
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salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.

TABLETS

entrophen*
(acetylsalicylic acid tablets, USP)
Enteric-coated with POLYMER 37*
Anti-inflammatory-Analgesic Agent
Platelet Aggregation Inhibitor
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain
ing acetylsalicylic acid coated with POLYMER 37*.
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA) has analgesic, anti
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and
antipyretic effects are useful, the major purpose
for which ASA is used is to reduce the intensity of
the inflammatory process. Inhibition of prosta
glandin synthesis may be involved in the anti
inflammatory action of ASA.
ASA also alters platelet aggregation and release
reaction by inhibiting prostaglandin synthesis
Thromboxane A2 is an essential step in platelet
aggregation. ASA prevents Thromboxane A2for
mation by acetylation of platelet cyclooxygenase.
This inhibition of prostaglandin synthesis is
irreversible and affects platelet function for the
life of the platelet.
The POLYMER 37* coating substantially resists
disintegration in aqueous fluids having a pH lower
than 3.5 for a period of at least 2 hours and is
capable of disintegrating in aqueous fluids having
a pH of at least 5.5 in from 10 to 30 minutes. Thus,
POLYMER 37* coating effectively inhibits the
release of ASA in the stomach, whilst allowing the
tablet to dissolve in the upper portion of the small
intestine for absorption from the duodenal area.
Clinical experience has shown that POLYMER 37*
coated acetylsalicylic acid diminishes or eliminates
gastric distress during long-term treatment with
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs
and symptoms of the following:
Osteoarthritis
Rheumatoid arthritis
Spondylitis
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the
risk of recurrent transient ischemic attacks or
stroke in men who have had transient ischemia of
the brain due to fibrin platelet emboli. At present
there is no evidence that ASA is effective in
reducing transient ischemic attacks in women, or
is of benefit in the treatment of completed strokes
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients
Active peptic ulcer
Patients who had a bronchospastic reaction to
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of
accidental poisoning in toddlers and infants.
ENTROPHEN* should, therefore, be kept well out
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution
to patients with asthma and other allergic condi
tions, with a history of gastrointestinal ulcerations,
with bleeding tendencies, with significant anemia
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid
function tests.
Acute hepatitis has been reported rarely in
patients with systemic lupus erythematosus and
juvenile rheumatoid arthritis with plasma sali
cylate concentrations above 25 mg/100 mL.

Patients have recovered upon cessation of
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic
effects. ASA has been found to delay parturition
in rats. This effect has also been described with
non-steroidal anti-inflammatory agents which
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy
may lengthen the gestation and parturition time.
Because of possible adverse effects on the
neonate and the potential for increased maternal
blood loss, ASA should be avoided during the last
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN*
and anticoagulants are prescribed concurrently, as
ASA may potentiate the action of anticoagulants.
Salicylates may potentiate sulfonylurea hypo
glycemic agents. Large doses of salicylates may
have a hypoglycemic action, and thus, affect the
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric
agents, smaller amounts may depress uric acid
clearance and thus decrease the uricosuric
effects of probenecid, sulfinpyrazone and
phenylbutazone.
Sodium excretion produced by spironolactone
may be decreased in the presence of salicylates.
Salicylates also retard the renal elimination of
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting,
diarrhea, gastrointestinal bleeding and/or ulcera
tion. Ear reactions: tinnitus, vertigo, hearing loss.
Hematologic reactions: leukopenia, throm bo
cytopenia, purpura. Dermatologic and Hypersen
sitivity reactions: urticaria, angioedema, pruritus,
various skin eruptions, asthma and anaphylaxis.
Miscellaneous reactions: acute reversible hepatotoxicity, mental confusion, drowsiness, sweating
and thirst.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE
Symptoms
In mild overdosage these may include rapid and
deep breathing, nausea, vomiting (leading to
alkalosis), hyperpnea, vertigo, tinnitus, flushing,
sweating, thirst and tachycardia. (High blood
levels of ASA lead to acidosis.) Severe cases may
show fever, hemorrhage, excitement, confusion,
convulsions or coma, and respiratory failure.
Treatment
Treatment is essentially symptomatic and sup
portive. Administer water, universal antidote and
remove by gastric lavage or emesis. Force fluids
(e.g., salty broth) to replace sodium loss. If the
patient is unable to retain fluids orally, the alkalosis
can be treated by hypertonic saline intravenously.
If salicylism acidosis is present, sodium bicar
bonate intravenously is preferred because it
increases the renal excretion of salicylates.
Vitamin K is indicated if there is evidence of
hemorrhage. Hemodialysis has been used with
success.
Respiratory depression may require artificial
ventilation with oxygen. Convulsions may best be
treated by the administration of succinylcholine
and artificial ventilation with oxygen. Central
nervous system depressant agents should not
be used.
Hyperthermia and dehydration are immediate
threats to life and initial therapy must be directed
to their correction and to the maintenance of
adequate renal function. External cooling with
cool water or alcohol should be provided quickly
to any child who has a rectal temperature over
104°F.
DOSAGE AND ADMINISTRATION
Analgesic; antipyretic
Up to 2.925 g daily as necessary.
Anti-inflammatory
Because the suppression of inflammation in
creases with the dose of salicylate even beyond
the point of toxicity, the therapeutic objective is
to employ as large a dose as possible short of
toxicity. Most patients will tolerate blood salicylate
levels in the range of 20 to 25 mg per cent. The
most common reason for failing to obtain a
therapeutic response to ASA is the administration
of inadequate doses.

The generally accepted way to achieve effective
anti-inflammatory' salicylate blood levels of 20 to
25 mg per cent is to titrate the dosage by starting
with 2.6 to 3.9 g daily, according to the size, age
and sex of the patient. If necessary, the dosage is
then gradually adjusted by daily increments of
0.65 g until symptoms of salicylism e.g., auditory
symptoms, occur. Then, the dosage is decreased
by 0.65 g daily until these symptoms disappear
and maintained at that level as long as necessary.
In adults the median dose at which tinnitus
develops is 4.5 g per day, but the range extends
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients
should be advised not to vary the dose from day
to day depending on the level of pain because
that often fluctuates independently of the intensity
of the inflammation. A continuous regimen of
0.65 g four times daily is considered to be
minimum therapy for adults. ENTROPHEN*
should be administered four times daily. For night
time and early morning benefits, the last dose
should be given at bedtime.
O nce m ainte n a n ce dose is e s ta b lis h e d ,
ENTROPHEN*-15 may be useful to encourage
patient compliance.
Optimally, salicylate therapy should be monitored
by periodic blood salicylate level determinations.
If this is not practical, the appearance of auditory
symptoms in the form of tinnitus or deafness are
acceptable as an indication of the maximum
tolerated salicylate dose.
There is an inverse relation between blood
salicylate levels at which auditory symptoms
appear and the age of the patient. In the young
adult, this is usually in the range of 20 to 30 mg
per cent. In children, however, the level may be
much higher, or the effect apparently absent.
Because salicylate toxicity may appear without
such warning in children, the usual practice is to
give ASA in a daily dose of 50 to 100 mg per
kilogram of body weight and to follow blood levels
aiming for a concentration of about 30 mg per cent.
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of
body weight administered in divided doses to
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472—ENTROPHEN*-15 tablets containing
975 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Oval, pale yellow, film-coated
tablets with the FROSST name engraved on one
face and 472 on the other and supplied in bottles
of 100 and 500.
No. 470—ENTROPHEN*-10 tablets containing
650 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Oval, orange, film-coated tablets,
with the FROSST name engraved on one face
and 470 on the other and supplied in bottles of
100, 500 and 1,000
No. 438—ENTROPHEN*-5 tablets containing
325 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Round, brown, film-coated tablets,
with the FROSST name engraved on one face
and 438 on the other and supplied in bottles of
100, 500 and 1,000.
FULL PRODUCT MONOGRAPH AVAILABLE
ON REQUEST.
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Surgical Treatment of the Dilated Aortic Root in a
Child with Marfan’s Syndrome
D ennis L. M odry, md, frcs[c ],* J ames L imacher , md, F R C P [ c ] f
A nthony R.C. Dobell , md, facs, frcs[c]*

Life-threatening cardiovascular
manifestations of M arfan’s syndrome
are rare in young children. The authors
report the case of a 41/2-year-old
girl with Marfan’s syndrome who had
a large aneurysm of the ascending
aorta necessitating operation. The
aneurysm was successfully resected,
the aortic valve replaced and both
coronary arteries implanted into a
prosthetic graft (Bentall's procedure).
Other published reports of children
with aortic aneurysms due to
Marfan's syndrome are reviewed.
Les manifestations cardiovasculaires
du syndrome de Marfan menapant
le pronostic vital sont rares chez le
jeune enfant. Les auteurs signalent le
cas d’une fillette de 4 V2 ans
souffrant du syndrome de Marfan
chez qui un large anevrisme
de I’aorte ascendante necessita
une operation. L’anevrisme fut
reseque avec succes, la valvule
aortique fut remplacee et les
arteres coronaires furent implantees
dans une greffe prosthetique
(technique de Bentall). On passe en
revue les autres rapports publies
sur des enfants souffrant d'anevrisme
aortique du au syndrome de Marfan.

Rupture or dissection of the ascending
aorta causes the death of 95% of
patients with Marfan’s syndrome.1
Since degeneration of the tunica
media characteristically involves the
aortic root, the aneurysms are often
associated with wide dilatation of the
aortic valve anulus and sinuses of
Valsalva, with upward displacement
of the coronary ostia away from the
heart. Current surgical therapy con
sists of prosthetic replacement of both
the aortic valve and ascending aorta

from the level of the aortic anulus,
with reimplantation of the coronary
arteries into the side of the conduit
(Bentall’s procedure).2 Most patients
with Marfan’s syndrome who have
had serious aortic insufficiency or
aneurysmal dilatation of the ascending
aorta have been at least 16 years of
age, so aortic valve replacement has
not been limited by a small anulus.210
Rarely have there been manifestations
of Marfan’s syndrome producing lifethreatening cardiovascular complica
tions in a very young child.1115 We
report the successful surgical pallia
tion of a child with aneurysmal dilata
tion of the aortic root in whom an
aortic valve conduit of adult size
could be used because of sufficient
aortic annular dilatation.

and

A 4'A-year-old girl was hospitalized
for investigation of a 3-month history
of diminishing exercise capacity. She
showed marked precordial pounding
after only mild activity and required
several minutes of supine rest during
play. A diagnosis of Marfan’s syndrome
had been made by her ophthalmologist
1 year earlier when he observed bilater
ally dislocated lenses. No other family
members were afflicted.
The patient exhibited the character
istic marfanoid habitus. She was at the
75th percentile for weight (20 kg) and
the 97th percentile for height (119 cm).
Palpation of the precordium demon
strated an apical beat displaced to the
sixth interspace in the anterior axillary

line and a marked right parasternal
pounding impulse which, by phono
cardiography, corresponded to aortic
valve closure. The ascending aorta was
greatly enlarged and was pressing
against the anterior chest wall. There
was also a grade 3/6 pansystolic mur
mur radiating to the axilla, shown by
echocardiography to be due to signi
ficant mitral leaflet prolapse.
Chest films demonstrated marked
enlargement of the ascending aorta.
Cardiac catheterization revealed normal
right atrial, right ventricular and pul
monary arterial pressures with a normal
peak left atrial pressure of 12 mm Hg
and a mean left atrial pressure of 5
to 7 mm Hg. The left ventricular pres
sure was 92/4 mm Hg with no gradient
across the aortic valve. The left ventri
cular end-diastolic volume measured
echocardiographicallv was 4.0 cm (nor
mal 3.6 cm) and the left atrium
measured 3.5 cm (normal 2.0 cm)
despite the normal left atrial pressures
recorded. Angiography confirmed mod
erate mitral insufficiency and beauti
fully demonstrated both the widely
dilated (diameter 7 mm) aortic root
(Fig. 1) and displacement to the left
and counter-clockwise rotation of the
heart by the aneurysm (Fig. 2). Although
no gradient was measured across the
aortic valve, its motion was abnormal
and a ”jet stream” was noted. The
aneurysm was approximately five times
greater in diameter than the descending
thoracic aorta.
At operation, the patient was surface
cooled to 32 °C, following which partial
cardiopulmonary bypass through the
external iliac vein and artery was used
to lower her body temperature to

FIG. 1— Aortogram shows marked
aneurysmal dilatation of ascending aorta
and sinuses of Valsalva.

FIG. 2— Left ventriculogram demon
strates displacement to left and counter
clockwise rotation of heart by aneurysm.
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190C. Through a median sternotomy
a second venous cannula was placed in
the right atrium. The massive ascending
aortic aneurysm was about the same
size as the heart and it extended to
within 2 cm of the innominate artery.
The aorta was cross-clamped proximal
to the aneurysm which was opened
longitudinally. Cold potassium cardioplegic solution (200 ml) was then in
fused directly into the coronary arteries.
The base of the aneurysm was found
to be formed by the extremely distended
cusps of a bicuspid aortic valve and
the coronary arteries arose about 2.5
cm above the anulus (Fig. 3). The aortic
valve was resected and the mitral valve
inspected. It appeared normal. A com
posite graft containing a no. 21 BjorkShiley tilting disc valve sutured into
one end of a no. 22 woven conduit
was then sutured to the aortic anulus.
Two buttons of aortic wall containing
the right and left coronary ostia were
then sutured with continuous 5-0 Prolene to two appropriately positioned
side holes in the conduit. The distal
end of the conduit was sutured with
continuous 4-0 Prolene to the distal
aorta. This region was externally butt
ressed with a circumferential Teflon
graft. Histologically, sections through
the wall of the aneurysm showed loss
of elastic and muscle fibres and ac
cumulation of mucoid material between
the widely separated tissue elements.
This is the classic picture of cystic
medial degeneration (Fig. 4).
No difficulties were encountered fol
lowing operation. The child was dis
charged 10 days later and acetylsalicylic
acid (300 mg hid) was prescribed.
Discussion

The classic Marfan gene is ex
pressed in a highly variable manner23
and the rare cases of fatal aortic rup
ture in children must relate to the
more severe forms of the disease in
which there is accelerated marked
degeneration of the aortic root
media.24 As the diseased and weakened
aortic root and ascending aorta are
subjected to the pulsatile forces of
aortic blood flow, an aneurysm of the
ascending aorta and sinuses of Val
salva is produced. It is the substantial
associated aortic annular dilatation
that allows replacement of the aortic
root in a child with a composite graft
containing an adult-sized aortic valve.
The first successful resection of an
aortic aneurysm in a child was re
ported by Durnin and colleagues11 in
1965. Their patient, an 8-year-old
boy, had a graft sutured to a supracoronary rim of diseased aorta. Long
term follow-up was not reported.
Nasrallah and associates14 reported a
series of 25 patients with Marfan’s
syndrome operated on between 1964
and 1968; it included one child 4
years of age. At that time, all grafts
were placed in a supracoronary posi
tion, leaving either a rim of diseased
aortic root between the anulus and
conduit, or tongues of aortic root
containing each coronary artery as
described by Wheat and coworkers.2j
Endaneurysmorrhaphy with aortic
anuloplasty has had limited short-term
success, as Jortner and colleagues26
showed in 1969 in a 6-year-old boy
with an acute dissecting aneurysm.
Because of fatal hemorrhage along

This report demonstrates that Bentall’s operation can be used success
fully in the rare case of a small child
with a large aneurysm of the ascend
ing aorta due to cystic degeneration
of the tunica media. Although most
reports of patients with fatal aortic
rupture have concerned adults, the
rare occurrence of this complication
in children is well documented. Before
1944, only four children under the
age of 10 years had reportedly died
from aortic dissection.16 Subsequently,
isolated reports of this complication
in a mother and child17’18 and in in
complete or forme fruste types of
Marfan’s syndrome19'20 have been
published. Aneurysmal rupture has
been reported in a 12-year-old girl
following limited exercise testing.21
The youngest patient reported with
fatal aortic dissection was 4 years
old.22 The most recent report was of
a 91/2 -year-old boy with a progres
sively dilating aortic root15 who had
3—Operative view shows marked
been followed up since he was IVi ly FIG.
dilated sinuses of Valsalva and bi
cuspid aortic valve. Viewed from above.
years old.

suture lines in diseased aortas, sub
sequent further aneurysmal dilatation,
fatal rupture or dissection, the above
techniques are less than optimal. The
approach described by Bentall and
De Bono2 in 1968 minimizes most
of these risks. The only portions of
diseased ascending aorta remaining
after this procedure are the aortic
buttons containing the coronary arte
ries. In 1972, Ross and associates12
reported on the success of Bentall’s
procedure in an 11-year-old child. In
the same year, Caves and Paneth13
reported an 11-year-old child with
Marfan’s syndrome who required not
only Bentall’s procedure but also mi
tral valve replacement. The child most
recently reported is included in the
1978 report by Mayer and colleagues10
of 16 patients. The child was 13 years
old, but no other details were given.
Unfortunately, aneurysms can de
velop further along the aorta in
patients who survive the repair of
their aortic dissection.27 This is not
surprising since after conduit replace
ment of the ascending aorta, the full
force of left ventricular ejection is
transmitted directly, to the more distal
aorta already weakened by degenera
tive change. Mayer and colleagues10
point out that in up to one third of
patients, formation of a pseudoaneu
rysm may occur at the coronary ostia
and distal suture line. In an effort to
prevent this the inferior coronary
ostial suture line has been buttressed
with Teflon felt or the aortic buttons
have been sutured on the inner side

FIG. 4— Tunica media from site of
aneurysm showing accumulation of mu
coid material separating and dismping elastic fibres (hematoxylin-phloxinesaffron stain, reduced by 46% from
X 160).
501
VOLUME 24. NO. 5. SEPTEMBER 1981 / THE CANADIAN JOURNAL OF SURGERY

of the graft. Zubiate and Kay8 used
aortocoronary bypass grafting with
saphenous vein to avoid this problem,
but then two more suture lines are
involved. On the other hand, com
plications at the distal suture line may
be prevented by buttressing the distal
anastomosis and remaining ascending
aorta externally with a circumferential
Teflon graft as described here.
The current recommendations for
children and adults with Marfan’s
syndrome include annual echographic
assessment of the ascending aorta
until it exceeds the upper limits of
normal by 50%, after which these
studies should be performed every
6 months.28,29 Since aortic disruption
has not been described in children
with an aortic root diameter of less
than 6 cm, the decision to operate
should be postponed until this condi
tion has been met and the aortic
anulus is sufficiently large that later
reoperation to insert a larger valve
prosthesis can be avoided. In children
with life-threatening dilatation of the
aortic root, we recommend prosthetic
replacement of both the aortic valve
and the ascending aorta from the level
of the aortic anulus, with reimplanta
tion of the coronary arteries into the
side of the conduit, as described in
this report. Recommendations follow
ing surgery, in view of the high in
cidence of complications at the suture
line, include annual echography and
angiography.10 The use of propra
nolol, both before and after opera
tion. to retard aortic dilatation is
theoretically appealing and is cur
rently recommended.29 A randomized
prospective trial of propranolol thera
py in patients with only minimal
aortic dilatation is now in progress.27

References
1. M urd och JL, W alker BA, H a lper n BL,
K u zm a JW , M c K u s ic k V A : Life expec

tancy and causes o f d eath in th e M arfan
syndrom e. N E ngl J M ed 1972; 286; 804-8
2. B entall H, D e B ono A : A technique for
com plete replacem ent of the ascending
aorta. Thorax 1968; 23: 338-9
3. E dw ards WS, K err A R : A safer technique
for replacem ent o f the entire ascending
a o rta and aortic valve. / Thorac Cardiovasc Surg 1970; 59: 837-9
4. S ingh M P, B entall H H : C om plete re 
placem ent of th e ascending ao rta and the
aortic valve fo r the treatm ent o f aortic
aneurysm . J T horac Cardiovasc Surg 1972;
63: 218-25
5. C rosby IK, A s h c r a f t W C, R eed W A :
Surgery o f proxim al a o rta in M arfa n ’s
syndrom e. J Thorac C ardiovasc Surg 1973;
66: 75-81
6. H e l s e t h H K , H a g lin J J , S t e n l u n d R R ,
P ete r so n C R , G auger D W : A scending

aortic aneurysm s with associated aortic
regurgitation. A n n Thorac Surg 1973; 16:
368-74
7. H e l s e t h HK, H a g lin J J, S t e n l u n d RR,
P e t e r s o n C R: E valuation o f com posite
graft replacem ent of the aortic ro o t and
ascending aorta. A n n Thorac Surg 1974;
18: 138-41

502

8. Z ubia te P, K ay J H : Surgical treatm ent of
aneurysm of the ascending aorta with
aortic insufficiency and m arked displace
ment o f the coronary ostia. / Thorac Car
diovasc Surg 1976; 71: 415-21
9. K o u c h o u k o s N T , K arp RB, L ell W A:
Replacem ent of the ascending aorta and
aortic valve with a com posite graft: results
in 25 patients. A n n Thorac Surg 1977; 24:
140-8
10. M ayer J E j r , L ind say W G, W ang Y,
J o rg en sen CR, N ic o l o f f D M : Composite
replacem ent of the aortic valve and as
cending aorta. J Thorac Cardiovasc Surg
1978; 76: 816-23
11. D u r n in RE, L in d e s m it h G, M eyer B,
F yler D C : A orta surgery in a child with
M arfan’s syndrom e. A m J D is Child 1965;
110: 547-50
12. Ross D N , F razier TG , G o n za les -L avin
L: Surgery of M arfan ’s syndrome and
related conditions of the aortic root (annulo-aortic ectasia). T horax 1972; 27: 52-7
13. C aves P K , P a n e t h M : R eplacem ent of the
mitral valve, aortic valve, and ascending
aorta w ith coronary transplantation in a
child w ith the M arfan syndrom e. Ibid:
58-65
14. N asrallah AT, C o o ley DA, G o u sso u s
Y, H a l l m a n
G L,
L u fsch a n o w sk i
R,
L ea c h m a n
R D : Surgical experience in
patients w ith M arfan’s syndrom e, ascending
aortic aneurysm and aortic regurgitation.
A m J C ardiol 1975; 36: 338-41
15. G oertz K, D ie h l A M , V a see n o n T, M attio li
L:
A catastrophic complication.
Acute dissection of an aortic aneurysm in
a child w ith M arfa n ’s syndrom e. J Kans
M ed S o c 1978; 79: 115-7
16. S c h n it k e r M A, B ayer C A : Dissecting
aneurysm in young individuals, particularly
in association w ith pregnancy, with report
of case. A n n Intern M ed 1944 ; 20: 486-511
17. G r o n d in C M , S tein b er g C l, E dwards J E :

Dissecting aneurysm com plicating M arfan’s
syndrom e (arachnodactyly) in a mother
and son. A m H eart J 1969; 77: 301-6
18. Y ou ng D : Fam ilial dissecting aneurysm
com plicating
M arfa n ’s
syndrom e.
Am
Heart J 1969; 78: 577-8
19. G r if f it h s C J, H a y h u r s t A P, W hitehead
R: D issecting aneurysm in m other and
child. B r H eart J 1951; 13: 364-8
20. C o l e m a n P N : A
rysm in a ch ild .
313-7

ca se o f d issectin g an e u 

J Clin Pathol 1955; 8:

21. Du R ie tz B, L u n d s t r o m N R : Ruptured
aneurysm s of the a o rta in a 12-year-old
girl. A c ta Paediatr Scand 1967; 56: 541-6
22. W ong

FL,

F ried m a n

S,

Y akovac

W:

Cardiac com plications of M arfan’s syn
drome in a child. A m J D is C hild 1964;
107: 404-9
23. P yeritz RE, M u r p h y EA, M c K u sic k VA:
Clinical variability in the M arfan syn
drome. B irth D efects 1979; 15: 155-78
24. S c h l a t m a n n T JM , B ecker A E : Patho
genesis o f dissecting aneurysm of aorta.
C om parative histopathologic study of sig
nificance of m edial changes. A m J Cardiol
1977; 39: 21-6
25. W heat M W , B o r u c h o w IB, R a m sey HW :
Surgical tre a tm e n t of aneurysm s of the
aortic ro o t. A nn Thorac Surg 1971; 12:
593-607

26. J ortn er R, S h a h in W , E sh k o l D, G ueron
M, L evy M J : C ardiovascular m anifestations
and surgery for M arfan ’s syndrom e. Dis
Chest 1969; 56: 24-30
27. W eld on C S: D iscussion of M ayer JE ,
L indsay W G , W ang Y, J o rg en sen CR,
N ic o lo ff D M : C om posite replacem ent of
the ao rtic valve and ascending aorta. J
Thorac Cardiovasc Surg 1978; 76: 822
28. P y eritz R E , M c K u s ic k V A : T h e M a rfan
s y n d ro m e : d ia g n o sis a n d m a n ag em e n t. N

Engl J M e d 1979; 300: 772-7
29. C o m e P C , B u lk ley B H , M c K u sic k V A ,
F o r tu in N J : Echocardiographic recogni

tion o f silent aortic root dilatation in
M arfan’s syndrom e. Chest 1977; 72: 789-91
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(Thrombin, USP) Bovine Origin—
formerly: Thrombin, Topical
INDICATIONS: Thrombostat is indicated as an
aid in hemostasis wherever oozing blood from
capillaries and small venules is
accessible.
In various types of surgery,
solutions of Thrombostat may <
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absorbable gelatin sponge
USP for hemostasis.
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Thrombostat is contra
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ADVERSE REACTIONS: An allergic type reaction
following the use of thrombin for treatment of
epistaxis has been reported. Febrile reactions
have also been observed following the use of
thrombin in certain surgical procedures but no
cause-effect relationship has
been established.

DOSAGE AND
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may be prepared in sterile
distilled water or isotonic
saline. The intended use determines the strength
of the solution to prepare. For general use in
plastic surgery, dental extractions, skin grafting,
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surfaces.
Caution: Solutions
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•\v L after 48 hours.
Complete dosage and administration for topical
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Pulmonary Core Biopsy by
Percutaneous Needle Aspiration
E mad A m e r ,
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Percutaneous aspiration needle biopsy
for pulmonary lesions has been
practised for many years but has not
until recently gained popularity.
Further proof of its simplicity, safety
and accuracy for both central and
peripheral lesions is given in this
retrospective study of 181 biopsies
performed in a community hospital.
The diagnostic yield was higher in
neoplastic (87.5%) than in nonneoplastic (68.4%) lesions and higher
in malignant (91%) than in benign
(58.3%) neoplasms. The larger
the lesion the higher was the
success rate — 95.6% if the lesion
was larger than 3 cm. The complication
rate was low (14.9%) and there
were no deaths. There was no
difference in the success rate or the
incidence of complications between
biopsy done for central or peripheral
lesions. The complication rate did
not differ between large and small
lesions, localized or diffuse. The
sample could be used for cell
block histologic sectioning, which
gave the same diagnostic accuracy as
cytologic examination. There were
no false-positive cytologic diagnoses.
During the procedure the operator
(a radiologist in all cases) was able
to predict the diagnosis in cases
of hamartoma and neurofibroma.
La ponction biopsie a I'aiguille
des lesions pulmonaires est pratiquee
depuis plusieurs annees mais jusqu'a
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tout recemment cette technique
n’avait pas gagne en popularity.
Cette etude retrospective de 181
biopsies effectuees dans un hopital
communautaire, fournit de nouvelles
preuves de sa simplicity, sa security
et sa precision pour les lesions
centrales aussi bien que peripheriques.
Le rendement diagnostique a ete
plus eleve dans les lesions neoplasiques
(87.5%) que dans les lesions non
neoplasiques (68.4%), plus eleve dans
les neoplasies malignes (91%) que dans
les neoplasies benignes (58.3%).
Plus grandes etaient les lesions,
meilleur fut le taux de reussite:
95.6% dans le cas des tumeurs de
plus de 3 cm. La frequence des
complications a ete faible (14.9%) et
il n'y eut aucun deces. On n’a
observe aucune difference entre les
taux de reussite ou les frequences
des complications des biopsies des
tumeurs centrales et des tumeurs
peripheriques. II n'y a pas eu de
difference dans la frequence des
complications, que les lesions aient
ete grosses ou petites, localisees
ou disseminees. Le prelevement a pu
etre utilise pour monter des coupes
histologiques qui ont donne la meme
precision diagnostique que I'examen
cytologique. II n'y eut aucun diagnostic
cytologique faussement positif.
Durant I'intervention, I'operateur
(un radiologists dans tous les cas)
a ete capable de predire le
diagnostic dans les cas d'hamartomes
et de neurofibromes.

Percutaneous needle aspiration of the
lung has been practised since 1883,1
but the procedure did not become
popular because of complications,
fear of tumour cell dissemination2,3
and inadequate specimens that re
sulted in a low diagnostic yield. Most
of these objections have been over
come by improved cytologic tech
niques, the development of image
amplified fluoroscopy permitting vi
sual guidance of the needle, the use
of thinner needles4 giving rise to fewer
complications, improved control of
complications and the increased
familiarity of radiologists with the
technique.

There have been an increasing
number of reports in the last 15
years attesting to the usefulness,
simplicity and safety of percutaneous
needle aspiration. Most studies showed
that the diagnostic yield is second
only to open thoracotomy for the
peripheral, localized pulmonary le
sion.5 While the procedure is rapidly
finding favour in many medical
centres, particularly in North Ame
rica, many are opposed to it, espe
cially in Europe.6 Little has been
published to evaluate the diagnostic
yield and complication rate according
to the size, location and nature of
the lesion.7
We report the experience with this
procedure in a community hospital,
emphasizing simplicity, safety, ra
pidity, lack of morbidity and high
diagnostic yield. The procedure often
obviates the need for thoracotomy.
In our hospital it was carried out
exclusively by the radiologists.
Patients and Method

Between 1974 and 1979 at St.
Clare’s Mercy Hospital in St. John’s,
181 biopsies were done on 172 pa
tients (128 men, 44 women). They
ranged in age from 24 to 80 years.
All the patients had undiagnosed
pulmonary lesions and were referred
for needle biopsy only after other
conventional diagnostic methods failed
to furnish a diagnosis. All patients
were hospitalized for the procedure.
At least one roentgenogram was
obtained for each patient; a lateral
view was obtained and tomography
done when indicated to locate the
lesion. Partial thromboplastin time,
prothrombin time and platelet count
were determined whenever a bleeding
diathesis was suspected.
Patients are usually required to
fast for 4 hours and are then given
50 mg of Atarax intramuscularly 30
minutes before the procedure.
Biopsy Technique

The patient is in the supine posi
tion for the anterior approach and
the prone position for the posterior
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approach. Occasionally oblique and
lateral positioning of the patient are
needed to bring the lesion closer to
the operator.
The procedure is performed with
strict aseptic technique. Xylocaine
hydrochloride is used for block anes
thesia, which includes the parietal
pleura. The biopsy needles used8 are
18-gauge and 15 and 20 cm long.
The needle with its stylet is inserted
directly to the edge of the lesion
under fluoroscopic guidance. (Single
plane fluoroscopy only is available
in our hospital.) When the tip of the
needle penetrates the lesion, increased
resistance is often felt. A well cir
cumscribed lesion may be displaced
to one side by the needle. If the
needle is driven into the lesion, it
can usually be readily transfixed. The
operator can confirm the position of
the needle by deflecting its hub; this
will cause visible movement of the
lesion. Sometimes it is advantageous
to rotate the patient into an oblique
position with the needle in place to
confirm this.
Once the needle tip has been placed
in the desired position, the stylet is
removed and a 30-ml glass syringe
is attached to the hub through a twoway valve. With the application of
continuous suction and with motion
and rotation of the needle, a core
is cut from the lesion (Fig. 1). Suction
is maintained as the needle is quickly
withdrawn. The skin and subcu
taneous tissues are gently massaged
over the needle opening to prevent
air entering the pleural space. Tinc
ture of collodion and a sterile adhesive

bandage are applied over the needle
puncture site.
One posteroanterior roentgenogram
is then obtained and another 24 hours
later.
Specimens
The success of the procedure de
pends on the adequacy of the biopsy
specimen. The operator may have to
repeat the puncture more than once
to get adequate material. The ideal
specimen measures 0.5 mm X 2 to
5 cm. Generally the tissue obtained
was adequate for paraffin embedding
and staining with hematoxylin and
eosin. Histologic sections were made
whenever feasible. Smears for cyto
logic examination were stained by the
Papanicolaou method for the last 40
specimens; the first 141 were not
examined cytologically.
Whenever indicated and when suf
ficient material remained, the speci
men was examined for bacteria and
fungi. In the case of diffuse inter
stitial disease, samples were sent for
immunofluorescent examination and
dust particle identification.

(87.5%). Of these neoplasms, 100
were malignant, the diagnosis being
made by needle biopsy in 91% and
of the remaining 12 neoplasms, which
were benign (adenoma or neurogenic
tumour), 7 (58.3%) were proved by
needle biopsy. In some cases it was
not possible to tell whether the malig
nant tumour was primary or meta
static, even after follow-up (Table I).
Nineteen patients with interstitial
lung disease had biopsies done; a
diagnosis was made in 13 (68.4%)
(Table II). The biopsy was considered
negative if the specimen showed
nonspecific inflammation or fibrosis.
One granuloma was a lymphogranu
loma while most of the others were
sarcoid or sarcoid-like granulomas.
One patient with Wegener’s granulo
matosis had a needle biopsy that gave
negative results. In one patient with
pleuropulmonary disease in whom all
other investigations were nondiagnos
tic the biopsy specimen showed the
presence of Actinomyces israelii.

Table 1 T u m o u r Types in 98 P a tie n ts in
Whom the D iagnosis Was M ad e by N e e d le
A s p ira tio n Biopsy

Results

One hundred and sixty-five patients
underwent a single biopsy; 5 had the
procedure repeated because the first
specimen was not diagnostic; 2 pa
tients had the procedure done three
times.
An intrathoracic neoplasm was
present in 112 patients; the diagnosis
was made by needle biopsy in 98

N o, of
p a tie n ts

Tum our type
Squamous
U n d iffe re n tia te d and sm all cell
A denocarcinom a
O th e r m a lig n a n t tu m o u rs
M eta static tum o urs
Adenom a and carcinoid
A lv eo lar cell carcinom a
N eurogenic tu m o u r
Sarcoma

31
20
13
12
11
4
3
3
1

To tal

98

Table II

N o n -n e o p la s tic D iagnoses M ad e
by N e e d le Biopsy
N o. of
biopsies

Diagnosis
S arco id -like granulom a
Tuberculous g ranulom a
A spergillom a
A c tin o m y c e s isra e lii

13
3
2
1

Total

19

Table III

C om p licatio n s of N e e d le B iopsy

C om plication

FIG. I—Core needle biopsy (hematoxylin and eosin, reduced by 27% from
X 380).

Hemoptysis
Pneum othorax
M ajor
M inor
C ard io re s p irato ry a rre s t
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N o. o f b iopsies
9
17
5
12
1
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The remaining 41 patients did not
show any evidence of intrathoracic
neoplasm or interstitial lung disease
either on biopsy or at follow-up.
Complications (Table III)

Most complications were minor
and there were no deaths. There
were 27 complications (14.9%) of the
181 biopsies. There was minimal
hemoptysis on the day of the pro
cedure, sometimes not recorded in
the chart, which occasionally conti
nued into the next day. No blood
transfusions were needed and there
was no appreciable drop in the hemo
globin level. During the procedure
the lesion occasionally became more
opaque on fluoroscopy presumably
due to tissue hemorrhage.
Associated with the 181 biopsies
were 17 (9.4%) cases of pneumo
thorax all on the same side as the
lesion. This rate is low compared
with that reported by others (between
20% and 40%). Five patients needed
intercostal tube drainage; one had
severe
subcutaneous
emphysema,
pneumomediastinum and pneumoperi
cardium, which cleared slowly. There
was one cardiorespiratory arrest
during the procedure but the patient,
who was elderly, was resuscitated
promptly.
In two patients who had small
lesions in the right lower lobe, the
biopsy specimens showed liver tissue.
We have no explanation for this
except for the proximity of the lesions
to the liver.
Discussion

In this series of patients with pul
monary lesions, all patients first had
sputum examination for malignant
cells; the specimens were stained and
cultured. For a localized pulmonary
lesion, bronchoscopy was performed
and whenever possible bronchoscopic
biopsy specimens and bronchial wash
ings were obtained. When there was
a small peripheral lesion broncho
scopy might not be done.
If the conventional methods of in
vestigation did not furnish a definite
diagnosis percutaneous needle biopsy
was carried out by a radiologist. A
biopsy result was considered to be
positive only if a definite diagnosis
of neoplasm, granuloma or bacterial
or fungal infection could be made.
When the biopsy specimen consisted
of normal lung tissue, blood clot,
infarcted lung, debris, fibrin or
fibrous tissue, or if it showed only
nonspecific inflammation or pneumo
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nitis, the result was considered neg
ative. In five patients this occurred,
so the procedure was repeated and
a positive diagnosis was then obtained
in three.
We compared the results of cyto
logic examination of the aspirate with
those of histologic examination of
the core specimen. There was no
difference in the findings relating to
malignant lesions. Cytologic examin
ation gave a positive diagnosis in two
cases in which the histologic exa
mination was negative and the re
verse was true in two others. All the
patients were found to have cancer
at either operation or autopsy. In
the remaining positively diagnosed
cases of malignant tumour the cyto
logic and histologic examinations
yielded the same result. Thus, the
cytologic examinations gave no false
positive results.
Little has been written comparing
the size of the lesion to the success
rate or to the incidence of complica
tions of needle biopsy.5,7 In our series
the larger the lesion the higher was
the success rate (Table IV). The
larger lesions were more easily loca
lized and penetrated. Also with re
spect to the small lesions, the four
that were considered to be negative
included two hamartomas and two
tuberculomas. Hamartoma is almost
impossible to penetrate because it is
displaced by the needle. The operator
was able to predict that the lesion
was a hamartoma from this observa
tion and from its subpleural location.
Even if tissue is obtained the diagnosis
of hamartoma cannot be made by
biopsy alone. There was no difference
in the incidence of complications in
small as opposed to large lesions.
There was one small pneumothorax
in the 11 patients with lesions smaller
than 1 cm and two pneumothoraces
in the 23 patients with lesions larger
than 3 cm.
The general trend is to reserve
needle biopsy for peripherally located
lesions. In central lesions it is usually
easy to make the diagnosis by sputum
and bronchoscopic examinations. We
used radiologic criteria for localiza-

tion; central lesions were those of the
inner third of the lung field and peri
pheral the outer third. We compared
the results in 19 central lesions and
24 peripheral lesions 2 to 3 cm in
size. In 19 central lesions the needle
biopsy gave a positive result in 15
(78.9%); there was one case of pneu
mothorax and one of hemoptysis. The
needle biopsy result was positive in
20 (83.3%) of the 24 peripheral
lesions and there were two patients
withpneumothorax and one with
hemoptysis. Thus, the location of the
lesion does not influence the success
or complication rates.
In interstitial lung disease, our suc
cess
rate was high compared with
that of other reports. This is because
we obtained core material and not
just aspirate. However, since the
bronchoscopic transbronchial biopsy
has become available we no longer
do percutaneous needle biopsy in
cases of interstitial lung disease. Of
the 19 patients 2 had a small pneumo
thorax.
Because needle biopsy may allow
relatively early diagnosis, the diag
nostic work-up can be considerably
shortened and sometimes open thora
cotomy can be avoided.
Conclusions

In experienced hands core biopsy
by percutaneous transthoracic needle
aspiration is simple and safe and
provides a high diagnostic yield, par
ticularly in localized lesions. The
procedure can be carried out in any
hospital; early diagnosis allows
prompt and definitive therapy.
We thank Mrs. V. Simms for preparing
the manuscript and Mrs. H. Bursey and
Mrs. P. Power for their helpful secretarial
assistance.
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W hat would constitute
a significant advance in
aminoglycoside antibiotic therapy?

Increased activity.
Decreased risk.

Increased activity'.
Decreased risk.

Rapidly bactericidal against sensitive organisms
□

Usually more active against Kle b sie lla sp. and
Enterobacter sp.

Particularly active against aminoglycosideresistant strains
□

Active against the majority of strains resistant to
tobramycin and gentamicin

□

Active against some amikacin resistant strains

m arni
Excellent clinical results in a therapeutically
challenging patient population

N E T -0 6 6 -E -C A /8 1

□

37 studies show 90% clinical cure/improvement,
including some compromised host conditions1

□

unusually high rate of pathogen elimination or marked
reduction

□

favorable response even in gentamicin failures

□

excellent results in children, including infants and
neonates

,

Increased activity.
Decreased risk.

Rigorous clinical trials bear out safety expectations
□

demonstrated in 890 courses of therapy1

□

ototoxic reactions rare, mild and transient

□

nephrotoxic reactions usually mild always reversible with sufficient
follow-up

□

adverse reactions in children notably absent

□

local reactions infrequent

MINIMAL ADVERSE REACTIONS IN CHILDREN Clinical studies with pediatric patients also underscore the
absence of drug related side effects. In a special analysis of 360 courses of therapy in children, infants
and neonates, only one patient experienced a reaction considered probably related to NETROMYCIN,
which was reversed when the dose was lowered to recommended levels,

Simplified dosage
Twice daily dosage for most infections,

4

SYSTEMIC OR URINARY TRACT INFECTIONS The recommended dosage
of NETROMYCIN injectable for patients with urinary tract or systemic
infections with normal renal function is 4,0 to 6.0 m g/kg/day given in
three equal doses every eight hours or two equal doses every twelve
hours, In general, within this dosage range, lower dosage will be used
f a urinary infections and higher dosage for systemic infections. F a
both uses, dosageshould be adjusted depending on severity of
infection and patient condition.
F a the average adult (50-80 kg), depending on the severity of
infection the usual dose is 100 mg to 150 mg administered every 8
hours or 150 mg to 200 mg every 12 hours for 7 to 14 days.

ADVERSE REACTIONS

NETROMYCIN* INJECTABLE
iNetiimicm Sulfate)

:!n adPinooio the u tjtoxioty and nephrotoxicity discussed under f8ECAOTf0NSand WARNINGS, other^Sverse re««jons, usua*1)
mild end infrequent which have been observed and may be associated wuh NETROMYCIN therapy ir liu d e ■•=*
M
Serum Enzymes: increases m serum transaminases ($001 and SGPTr and alkaline phosphatase

ANTIBIOTIC
D escription: Nenrmicm suffate is a semi synthetic. jrn s i^ fe T g i. 3rrnfiQglyce«de amifeooc prepared item a dehydrogenated analog 0!
gentamicin L , . ’ it -s 3 wane *0 buff powdei which 1$ r&adiiy sokitjte m wafer
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Hypersensitivity Reactions: eosmophilta, rasn and drug fever
Hematology decrease in hemoglobin, leukocytes and platelets

Composition. NETRfiMYUN ineWmcip suifara* s supplied as a dear, cofourtess to pale yellow solution of pH 4.5 to 5 h and is available
■n the (sHow-ng ijo te fifra ftyfis

;4 -fe-I .-T

Netiimc»n base*
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Sodium sulfite
Sodium sulfa re
Disadium edetafe
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DOSAGE AND ADMINISTRATION

>

NETROMYCIN may be given by deep intramuscular injection or intravenously, according to the dental situation. Dosage should be
calculated on the basis of body weight but in obese patients or emanated patients with low volumes oi distribution, dosage shoo'd be
'bas^,.onaoestim gte of
,
.
,
4
,
M '
DOSAGE
The recommended dose for mtram|$o$3f and intravenous administration is identic*^, -

NAME; OF DRUG

NETROMYCIN
iNenimicin Sfettr

^

V
In the event of overdose o r jdfec reaction, hemodialysis will aid in the ram oval of netilmicin from the biood. Appropriate support 4
therapy should be instituted to maintain respiratory and kidney function

'Charged as fietilmu.Bi suifai*1
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SYMPTOMS AND TREATMENT O f OVERDOSAGE

THERAPEUTIC CLASSIFICATION
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The usual duration of treatment is / to 14 days fn complicated infections, a longer course of therapy may be necessary P a t ie r \
treated beyund the usual permd should be carefully monitored lor changes in renal, auditory and vestibular h m m
PATIENTS WITH NORMAL RENAL FUNCTION

A.01QN NETROMYCIN is 0 bapienodai antibiotic which acts by inhibiting normal pratem syrithgss -n soscepf#?bacteria ir cu hi?«§fnnk
prevent amino & d
binding to the 30$ nbosomal sub turn
;
'
"
"
INDICATIONS AND CLINICAL USES: NETROMYCiN may be .mosaied for the treatment of infections caused by susceptible strains of
(schenc/ba coh. Proteus species ftndoie negative and some indole positive). A M , Entarotm ter, O uobm er and Staphylococcus
species,
Clintca! studies have shown NETROMYCIN to be effective in some senous infections, caused by Pseudomonas aeruginosa and
S enate species
!

ADULTS:
.
for patients with uncum jA^ted urinary pact infections, the recommended f e e is 4 0 mg/kg/day divided mto two equal dose: and
admires 1ered e*ver» ’ ? hours for 7 to 10 days for the average aiiui! !5fi 80 kgi 1:1: mg may be given every 52 hours.
fo rfe tie h ts w ith systemic rW e fe m i/ the 'usual dole i s - A j f p 6 0 m g ;kg/fe divided mta swo or Three equal dbse^'
tweNe hours. respectively:-:;

„

p d

For fhe average ad«H i50 80 kg), depending on ihe seventy of mfecnoh. the usual dose is 100 mg 10 150 mg administered every ;
8 hours or 15® m g ?o 200 mg every 12 hours for 7 to 14 days .
^

N HR 0M Y Q N may be indicated « the treatment of the following when caused by susceptible organisms as listed above, w *
....... septicemia
lower respiratory tract infections
unnarv tract tniecitsns
m rn rn
endometritis

fm patients with senous systemic infections title threatening: intravenous dosages up tu / 5 mg/kg/ctay divided into three egua;doses may b» administered, This tjbsage; should be reduced 10 6 0 mg/kg/day as soon asrismcaliy indicated, usually wiihm 48 fw u '
-

ConcifTiitari! administration of a pen-cilim type antibmoi: with NETROMYCIN should be considered as ffliual therapy m certain cases
i
these rasufts become avatNWe

K

lim ited Urnical studies have shown NETROMYCIN may also be effective tn me treatment 0?senous bone and son tissue infections
Appropriate semmvrty studies should be performed to determine the susceptibility of the causative organism to NETROMYCIN. On
the basis of clmtcai judgement and anticipated bacteriological findings, therapy may be instituted before results of these tests are obtained
If susceptibility tests show that the causative organism is resistant to NETROMYCIN, NETROMYCIN treatment should be replaced by other
appropriate therapy
Although NETROMYCIN may be indicated for the treatment of senous staphylococcal infections, ns use should be reserved for those
staphylococcal infections also involving susceptible strains of Gram negative bacteria and then only when pencMn or other potentially less
nephrotoxic drugs are inappropriate, ie g : {©hems aflergc to p ancA el. - • '

:

CHfLOREN: rhe recommended dose is 8 .0 to l b mg^g/day divided mto three equal doses and administered every eight hours T.Ws
should be reduced fa 6.S mgfkg/day as soon as clinically indicated
INFANTS AND NEONATES: (Greater than one week of age) The recommended dose is lb to 9 0 n<g/kg;day divided into three equal^
doses and administered every 8 horns
PREMATURE AND FULL TERM NEONATES: 'Less than one week of age! The recommended'dose is fe mg/kg/day divided -n;-: - w ,
"equal doses and administered.every iweNe hours iSee' PRECAUTIONS!
PATIENTS WITH IMPAIRED RENAL FUNCTION
ADULTS:

CONTRAINDICATIONS: NETROMYCIN is comramdicaied m patients with a history of hypersensitivity to aminoglycosides
WARNINGS
Ototoxicity: NETROMYCIN has the potential to cause disturbances m balance and a bearing loss. Particularly those patients w ith com
•promised rena! function, those who have been treated ptevrously w ith ototoxic drugs, or those who are receiving higher doses,of
NETROMYCIN than those recommended are at gteatei risk Reversal of developing ototoxicity is contingent on early recognition of the
signs and symptoms such' as tinnitus, fc/mess or hearing loss
in patients;w ith impaired renal function, the f e e and/or frequency of administration o f NETROMYCIN must be reduced f$ee AD
MINISTRATION AND DOSAGE! and renal, vestibular and auditory function, as well as serum levels of NETROMYCIN should be monitored
frequently
4
NETROMYCIN Should not be administered concomitantly w ith potent Mop diuretics Such as turosemide and ethacrymc acid as the
potential for ototoxicity is enhanced by the combination Oiuretics may enhance aminoglycoside toxicity either by altering the antibiotic
concentration m serom and tissues or by a direct action on the auditory apparatus
Nephrotoxicity: The administration of other potentially nephrotoxic drugs prior to or m conjunction with NETROMYCIN is likely to in
m a s s the risk of nephrotoxicity
Nephrotoxicity manifested by an increase in the level of blood urea nitrogen, or serum creatinine, 3 decrease m creatinine clearance,
or the presence of casts, cells, or protein m the unne, has been observed m patients administered NETROMYCIN These have been
observed more frequently m patients with a history of decreased renal function and m patients treated w ith larger doses o f NETROMYCIN
than those recommended In most cases, these changes have been mild and were reversible on discontinuing the administration, of
NETROMYCIN. Other risk factors include duration of therapy and concomitant administration of anticoagulants or turosemide, Patients
w ith diabetes meltitus appeared 10 have a slightly higher incidence of renal reactions.
Pregnancy: The safety of NETROMYCIN for use during piegnancy has not been established. Animal and human studies have
demonstrated that there is a maternal feta) transfer of some aminoglycoside antibiotics Although this has not yet been demonstrated with
NETROMYCIN, the -possthify. should be considered
PRECAUTIONS
Treatment w ith NETROMYCIN may result in the overgrowth of non-susceptible organisms If supennfecaoo occurs, appropriate
therapeutic measures should be instituted
NETROMYCIN, at doses considerably above those clinically recommended h e greater than HJ times', has been shown to cause
neuromuscular blockade and respiratory attest in rats and mice. The injection of calcium chloride elicited a complete and rapid antagonistic
f e l f e whereas neostigmine was m m p e
The possibility of neuromuscular blockade and respiratory arrest occurring m man should be considered, particularly if NETROMYCIN
is administered to patients receiving anesthetics, neuromuscular blocking agents le g. succmyichofme or tubacurannel or massive transfu
sions of citrate amicoagulated blood Thawte diuretics have been reported to aggravate tubocurarme induced neuromuscular bioek
Patients w ith neuromuscular disorders, such as myasthenia grains or Parkinson's disease, are at particular nsk. since NETROMYCIN
could aggravate muscular weakness
NETROMYCIN should be used with caution m premature and neonatal infants because of renaf immaturity and the resulting pro
longation of serum haff He of the-drug.
4

' The ir.'iiai dose is the same es that recommended for patients w ith n arW ra na llu n clio n Dosage must be adjusted in patient*. w *h
impaired renal function and when possible, serum concentrations of netilmicin should be monitored it serum concentrations cam el be
moortored, serum cr83friine and creatawie clearance vdues can be used as a guide for dosage adjustments Adjustments m dosage can be
'»ade by either fengthemng the mtervef between doses or by a reduction m dose administered a? eight hour intervals as follows
Normal dosage - Adjusted Intervals: 'f rhe patient's serum creatinine is known, the interval between the usual single dose giver, at
eight hourly intervals can be calcuteied by multiplying the patient s serum creatinine by a factor of eight. Thus, a panent w ith a sen,^
creatinme of 3 mg/100 mj. would be given 2 mg/kg every 24 h ou rs,«e. 3 x 8 - 24, rather than the: usual dose of 2 mg/kg every.
, 8 hours.
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The possibility o f development of resistance during prolonged therapy With NETROMYCIN should be kepi in mind
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Feeding Jejunostomy under Local Anesthesia
Jo e l B. F r e e m a n , MD, FRCS[C] AND ROBIN J. FAIRFULL S m i t h , m d , f r c s [ c ]

A feeding jejunostomy may be
performed with ease and safety under
local anesthesia. The authors describe
their technique. The tube is easy
to maintain and replace and avoids
some of the problems of feeding
gastrostomies. In patients with major
nutritional problems and a functioning
intestinal tract the need for parenteral
nutrition may be eliminated.
Line jejunostomie d'alimentation
peut etre pratiquee facilement et
surement sous anesthesie locale. Les
auteurs decrivent leur technique. Le
tube est facile a entretenir et a
remplacer et exempte done quelquesuns des problemes des gastrostomies
d'alimentation. Chez les patients
souffrant de problemes de nutrition
graves mais dont les voies intestinales
sont libres, la necessite de recourir
a I'alimentation parenterale peut etre
eliminee.

For a variety of reasons some cri
tically ill, malnourished patients, who
require nutritional support and who
have
functioning
gastrointestinal
tracts, cannot or will not tolerate
adequate oral protein and calorie
intake. Nasogastric feeding is some
times difficult or cumbersome when
used over long periods. An alternative
is a feeding gastrostomy or jejuno
stomy. The latter bypasses the pylorus,
reduces the risk of aspiration and is
much easier to perform if the patient
has previously had gastric surgery.
It is commonly believed that feeding
gastrostomy can easily be done under
local anesthesia. Our experience is
that a feeding jejunostomy can be
created under local anesthesia with
equal facility.
Technique

The procedure is done in the
operating room with an anesthetist

F rom the division o f general surgery,
Ottawa General Hospital, University
o f Ottawa, Ottawa, Ont.
Accepted fo r publication May 13, 1981
Reprint requests to: Dr. Joel B.
Freeman, Chief, Division o f general
surgery, Ottawa General Hospital,
501 Smyth Road, Ottawa, Ont.
K 1 H 8L6

standing by. The skin and subcutane
ous tissues are anesthetized with 1%
Xylocaine (with epinephrine, if there
are no contraindications) using a 23gauge spinal needle. A vertical para
median incision, 6 cm long, is made
to the left o f and extending for 3 cm
above and 3 cm below the umbilicus.
The anterior rectus sheath is anes
thetized, incised and elevated. The
rectus is either retracted laterally or
split ensuring that exposure extends
the entire length o f the skin incision.
The peritoneum is then anesthetized;
it is helpful if the anesthetist admin
isters small quantities of narcotics
intravenously at this point. The peri
toneum is opened and adhesions are
divided as encountered. The trans
verse colon and greater omentum are
retracted superiorly exposing the small
intestine. The ligament o f Treitz can
usually be identified by inserting the
hand immediately inferior to the root
o f the transverse mesocolon. A seg
ment of small intestine is brought into
the incision. Traction on the mesen
tery should be avoided. The proximal
jejunum is characterized by long,
single vessels from the vascular ar
cades. The mesentery is thin proximally but extends around the bowel
distally.
An incision 3 mm long is made
with electrocautery through the sero
muscular antimesenteric border o f the
jejunum. Spreading this incision with
a hemostat makes the mucosa pout.
The mucosa is grasped, then incised
and a no. 10 French catheter is
inserted. It is preferable to use a tube
with an end-hole. A stopcock is at
tached to the catheter, the distal
jejunum is occluded and sterile water
injected to make sure that the tip
is not kinked or located submucosally.
The catheter is then attached with a
3-0 absorbable purse-string suture.
The position o f the counterincision
through which the tube will be drawn
is identified and the area anesthetized.
A serosal tunnel 4 mm long is
fashioned with 3-0 silk. The catheter
is then brought out through the stab
wound. The jejunum is fixed to the
posterior rectus sheath, with 3-0 silk,
for a distance equal to the length o f
the tunnel. This prevents kinking or
herniation. The stopcock is attached
and the tube is irrigated once more

to confirm patency. The incision is
closed in the usual fashion. The tube
is sutured to the skin and secured
with adhesive. Feeding begins in 24
to 48 hours.
Results and Discussion

Over the past 18 months 20
patients have had feeding jejunostomy
tubes inserted under local anesthesia.
In three patients with upper esopha
geal obstructive lesions, simultaneous
suction gastrostomies were inserted
using the same incision. A ll patients
have been able to begin an enteral
feeding program either in hospital or
at home. This allows adequate pre
paration for major surgical procedures
or for nutritional support in cancer
patients who undergo chemotherapy
or irradiation. Enteral feeding by this
method eliminates the need for a
general anesthetic and for parenteral
feeding.
The most common complication
was blockage o f the tube. It is most
important to prevent this in the early
postoperative period when the tube
cannot be changed. W e routinely
irrigate the tubes with water three
times daily. A ll nursing and housestaff are alerted to notify us immemediately if blockage occurs. W e
have constructed a jejunostomy kit
that consists o f flexible guide wires,
small syringes and a variety o f feed
ing tubes. Forceful irrigation is usually
successful for early blockage. When
necessary we pass flexible guide wires
through the tube, paying particular
attention not to go past the end hole.
Medications should be given as liquids.
If tube dislodgement occurs more
than 7 days after operation, the tube
can be reinserted. Alternatively a
new tube can be stented with a lub
ricated flexible guide wire and rein
serted through the tract. The jejunum
is always sutured to the posterior
rectus sheath in the same direction
so that the operator knows the direc
tion of the tract when a new tube
must be inserted. When tubes are
replaced it is essential that their intra
luminal position be confirmed. This
can be done by a bedside roentgeno
gram made after injection o f 15 ml
of a water-soluble contrast material
into the tube.
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Celiac Artery Embolism: Case Report
S.J. F ratesi,
The authors describe an unusual
case of acute gastrointestinal ischemia
due to celiac artery embolism. The
patient, a 23-year-old man who had
recently suffered a myocardial
infarction, underwent selective
angiography under local anesthesia
with intravenous sedation because
angiography demonstrated good
collateral filling and because of
his poor cardiac status he was treated
nonoperatively with intravenously
administered heparin. Points to be
considered in the diagnosis of acute
intestinal ischemia include: (a) if the
initial investigations are suggestive
of the condition, angiography should be
performed; it can be done easily and
safely under local anesthesia with
intravenous sedation, (b) the symptoms
are often more severe than one would
expect from the physical findings
and (c) celiac artery occlusion may
be more common than previously
thought.
Les auteurs decrivent un cas
inhabituel d'ischemie gastro-intestinale
aigue due a une embolie du tronc
coeliaque. Le patient, un homme de
23 ans qui avait subi recemment un
infarctus du myocarde, a ete soumis
a une arteriographie selective sous
anesthesie locale et sedation
intra-veineuse. A cause de son
mauvais etat cardiaque il a ete traite
par la suite de facon non chirurgicale
par administration intraveineuse
d’heparine apres que I’arteriographie
eut demontre un bon remplissage
de la circulation collaterale. Les points
devant etre pris en consideration dans
le diagnostic de I'ischemie intestinale
aigue comprennant ce qui suit: a)
si les examens initiaux sont evocateurs de cette affection, une
arteriographie devrait etre pratiquee;
ceile-ci peut etre faite facilement
et surement sous anesthesie locale
et sedation intraveineuse, b) les
symptomes sont souvent beaucoup
plus importants que I'examen physique
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ne I’indique, et c) (obliteration du
tronc coeliaque est peut-etre plus
frequente qu'on ne I'a cru jusqu'a
maintenant.

The diagnosis of acute intestinal
ischemia is now made more frequently
and experience in the methods of
diagnosis, investigation and manage
ment is being gained. The cause of
the ischemia is either an occlusion or
a nonocclusive “low flow state”. The
process may be arterial or venous,
although the latter is relatively rare.
Arterial occlusion is usually due to
embolism or thrombosis. Occlusions
may involve the superior mesenteric
artery, celiac axis or the inferior
mesenteric artery, alone or in com
bination. There is some inherent pro
tection from collaterals between these
vessels.1
Embolic phenomena are usually
associated with an underlying myo
cardial abnormality and classically
involve the superior mesenteric arte
ry.2 The patients affected are usually
middle-aged or older with underlying
cardiac or atheromatous disease.
A young man who had suffered a
myocardial infarction and whose ce
liac artery was occluded by an em
bolus is presented. He was treated
nonoperatively with heparin.
Case Report

Five months before admission, this
23-year-old man had suffered myo
cardial contusion due to blunt trauma
to his anterior chest wall sustained
while playing hockey. Left ventricular
angiography at the time revealed an
intracavitary thrombus and the patient
was given anticoagulants for 3 months
(sodium warfarin. 10 mg/d). One month
after the anticoagulants were discon
tinued the patient suffered an acute
myocardial infarction (anterior wall)
and angiography revealed single coro
nary artery disease (proximal left ante
rior descending artery obstruction). The
left ventricular thrombus had almost
completely resolved.
Four weeks later the patient was
admitted with a 2-day history of
epigastric pain, abdominal cramps,
nausea and vomiting but no diarrhea.
He had been seen earlier in the day
and discharged; antiemetics had been
given. The pain had increased in severity
and radiated to the left anterior chest
and shoulder tip. The initial diagnosis
was renal colic.

The patient was apprehensive and
agitated. He complained of pain on
inspiration in the left upper quadrant
of the abdomen and left anterolateral
chest wall. His abdomen was soft but
there was marked voluntary guarding
and tenderness in the epigastrium and
left upper quadrant. Bowel sounds were
normal and rectal examination revealed
no abnormality. The patient was normotensive. His pulse rate was 90 beats/
min and he had an irregular heart beat
due to a sinus arrhythmia. The patient’s
complaints were out of proportion to
the physical findings.
Initial roentgenograms of the ab
domen (three views) and an intravenous
pyelogram showed no abnormality
except for mild ileus. The electrocardio
gram demonstrated the anteroseptal in
farct with changes suggestive of recent
activity.
Laboratory findings were as follows:
hemoglobin level 15.5 g/dl, serial leuko
cyte counts 10.8 X 109/ 1 and 17.6 X
109/1 (4 hours later) with 83% neutro
phils, serum amylase 51 mU/ml (normal
10 to 100 mU/ml), serum creatine
phosphokinase 123 mU/ml and 498
mU/ml (4 hours later) (normal 10 to
120 mU/ml), serum glutamic oxalo
acetic transaminase 120 mU/ml (normal
10 to 50 mU/ml) and serum alkaline
phosphatase 110 mU/ml (normal 40
to 110 mU/ml).
A tentative diagnosis of acute intes
tinal ischemia was made. The patient
subsequently underwent selective supe
rior mesenteric artery and celiac axis
arteriography under local anesthesia.3 A
normal abdominal aorta and bifurca
tion and normal renal arteries were
evident. There was no sign of segmental
spasm or a “low flow state”. The
superior mesenteric artery was normal
except for collateral filling of the right
and left hepatic arteries (Fig. 1). A

FIG. 1— Selective arteriogram showing
normal superior mesenteric artery except
for collateral filling of right and left
hepatic arteries.
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selective angiogram of the celiac axis
revealed a proxim al occlusion o f the
common hepatic artery with filling of
the right and left hepatic arteries
through the pancreaticoduodenal and
gastroduodenal vessels. There was also
a proximal filling defect of the splenic
artery with distal filling from collaterals
(Fig. 2).
A diagnosis of occlusion of the celiac
artery was made, probably due to an
embolus and it was elected to treat the
patient with anticoagulants rather than
by operation. The reason for this de
cision was twofold: adequate collateral
filling was dem onstrated angiographically and operative intervention would
be risky in a patient with a recent
myocardial infarction:1 The patient was
heparinized by an intravenous bolus
followed by a continuous drip to main
tain a therapeutic level. The abdominal
pain gradually resolved over the next
5 days although the nausea persisted
for 1 week. The heparin was given for
14 days and the patient was then given
sodium w arfarin (10 m g /d ).
The highest laboratory values re
corded during the 18-day hospital stay
were as follows: leukocyte count 23.1
X 109/1 (88% neutrophils) on day 3,
serum alkaline phosphatase 319 m U /m l
on day 10. serum lactic dehydrogenase
322 m U /m l (normal 60 to 227 m U /m l)
on day 10 and serum C PK 587 m U /m l
on day 8. The patient had a low grade
fever (tem perature up to 38°C) for the
first 5 days after which the tem perature
returned to norm al. Blood-gas and serum
phosphate levels were not serially re
corded.5

artery. In retrospect the patient’s ten
derness and guarding were more in
the epigastric and left upper quadrant
areas than centrally located (embryologic foregut versus midgut). At no
time was the patient hypertensive or
in heart failure, nor did he manifest
any form of vasculitis.
Acute intestinal ischemia due to
embolism usually is associated with
cardiac arrhythmias or myocardial
infarction. This patient had suffered
a recent myocardial infarction and
also was known to have a resolving
left ventricular thrombus.
In view of the patient's age and
his essentially normal peripheral ar
terial tree his condition was unlikely
due to acute thrombosis. Moreover,
there were no associated abnormalities
of serum cholesterol or triglycerides.
The celiac artery occlusion was proximally situated and allowed collateral
filling to maintain tissue viability.
Our patient was managed conserva
tively with intravenous fluids, heparin
given intravenously by continuous
drip, a nasogastric tube and broadspectrum antibiotics. His poor cardiac
status helped us to decide on this
approach since the operative risk
would have been high. However, had
he presented with a more certain
diagnosis of infarction or gangrene,
a laparotomy would have been
mandatory.7,8 The use of Dextran 40
has been reported in the nonopera
tive treatment of mesenteric embo
lism.9

Discussion

Little has appeared in the English
literature about acute gastrointestinal
ischemia due to celiac artery embol
ism. A patient with a celiac artery
embolus presenting with a gangren
ous gallbladder has been reported.'’
When our patient was first admitted
to the vascular service our diagnosis
was acute mesenteric ischemia due to
an embolus in the superior mesenteric

Conclusions

FIG. 2—Selective angiogram of celiac
axis demonstrating proximal occlusion of
common hepatic artery (left arrow) and
splenic artery (right arrow) and distal
filling from collaterals.
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NOTICES
Annual Meeting of the Society
for Biomaterials

The 8th annual meeting of the Society
for Biomaterials and the 14th Inter
national Biomaterials Symposium will
be held Apr. 24-27, 1982 at the
Contemporary Resort Hotel at Walt
Disney World near Orlando, Florida.
The meeting will provide a forum
for the presentation of recent findings
concerning the physicochemical and
biologic characterization of biomate
rials and efficacy testing of medical
and dental devices and materials.
Studies focusing on the structure and
properties of natural, biologic mate
rials will also be presented.
Topics to be addressed include:
characterization of biomaterials —
bulk and surface; biocompatibility;
biomaterial-tissue interface charac
teristics (biologic/biochemical and bio
mechanical); performance of devices
and materials (in orthopedics, dental
and maxillofacial procedures, cardio
vascular, ophthalmologic, otolaryngol
ogic and plastic/reconstructive surge
ry, sutures, dressings and drug release
systems).
The meeting will comprise contri
buted papers (oral and poster presen
tations), keynote speakers, tutorials,
open meetings (patents, clinical trial
protocols) and minisymposia.
Papers are being solicited from
biomaterials researchers in academe,
government and industry throughout
the world. All contributed abstracts
will be judged on scientific merit.
Those who wish further announce-
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intravenous fluids, vasopressors and other supportive measures as
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Congenital Posterolateral Diaphragmatic Hernia:
a Retrospective Study
J udith A. R ose-Spencer ,

md,

Congenital posterolateral diaphragmatic
hernia continues to be associated
with a high mortality from ventilatory
failure. To evaluate the malformation
and factors associated with survival,
43 children with congenital diaphrag
matic hernia seen in the neonatal
period were studied; 20 survived. The
male:female ratio was 2.1. No
consistent antenatal factors could be
implicated and, except for intestinal
malrotation and lung hypoplasia,
associated anomalies were uncommon.
The most common cause of death
was ventilatory failure and marked
bilateral lung hypoplasia was a common
autopsy finding. Most of those who
died were admitted within 8 hours
of birth. Tolazoline has been used
in 10 patients since 1975 and, of these,
4 survived. Postoperatively a transient
period of satisfactory lung function
correlated well with response to
vasodilators, which may be of value
in future therapy.
La hernie diaphragmatique posterolaterale congenitale continue d’etre
reliee a une forte mortalite due
a une insuffisance respiratoire. Afin
d'evaluer cette malformation et les
facteurs associes a la survie, on a
etudie 43 enfants atteint de hernie
diaphragmatique congenitale qui ont ete
vus durant la periode neonatale;
20 ont survecu. Le rapport maletfemelle
a ete de 2:1. Aucun facteur prenatal
constant n'a pu etre implique et,
sauf pour la deviation intestinale et
I'hypoplasie pulmonaire, les anomalies
associees ont ete rares. La cause
la plus frequente du deces a ete
I'insuffisance respiratoire, et une
hypoplasie pulmonaire bilaterale
marquee a ete souvent observee a
I'autopsie. La plupart de ceux qui sont
decedes avaient ete hospitalises
dans les 8 heures suivant la naissance.
Depuis 1975, de la tolazoline a ete
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utilisee chez 10 malades, et 4
d’entre-eux ont survecu. Une periode
postoperatoire transitoire de fonction
pulmonaire satisfaisante a montre
une bonne correlation avec la reponse
aux vasodilatateurs; ces derniers
peuvent devenir importants dans le
traitement de cette affection.

Congenital diaphragmatic hernia is
one of the most common surgical
emergencies in the newborn. It con
tinues to be associated with a high
mortality, primarily from respiratory
failure.1'3 Advances in resuscitation
and ventilatory support with improved
transportation have allowed delivery
of more seriously ill neonates to spe
cialty centres for treatment.4 Recent
interest in pulmonary vasospasm and
pulmonary vasodilator therapy has
suggested possible benefit from this
form of treatment.5,6 To evaluate the
characteristics of the malformation
and the factors associated with sur
vival, a retrospective study of con
genital diaphragmatic hernia was
made at our institution over a 12-year
period.
Patients

Between Jan. 1, 1968 and Dec. 31,
1979, 55 children (36 boys and 19
girls) were admitted to the Montreal
Children’s hospital with a diagnosis of
congenital diaphragmatic hernia. Nine
were between the ages of 3 months
and 5!/2 years; six of them had re
peated lower respiratory tract infec
tions. Three other infants who were
admitted with a diagnosis of conge
nital diaphragmatic hernia as new
borns, were found on investigation to
have eventration of the diaphragm
and were not operated upon.
There were 43 children with con
genital posterolateral diaphragmatic
hernia, presenting in the neonatal
period, and they form the basis of
this study.
Findings
H istory

Antenatal history of the 43 children
revealed that one mother had had
premature rupture of the membranes.

md, cm , frcs [c ]

another had undergone emergency
cesarean section for placenta previa
and a third had had induction of
labour for pre-eclampsia. The single
medical illness documented was thal
assemia minor in an Italian mother.
Four mothers had polyhydramnios.
Maternal age was unrelated to sur
vival. The average gestation period
of survivors was 38.67 weeks and
birth weight was 3.26 kg. Of those
who died the average gestation and
birth weight were 38.25 weeks and
2.93 kg respectively.
O perative Findings

The operative approach, whether
transthoracic or transabdominal, did
not influence survival. Those who
subsequently died all had a hypo
plastic or airless lung or lungs which
did not expand following repair. Five
patients had defects so large as to
require interposition of Marlex mesh;
all died. The actual measurements of
the defects and the presence or
absence of a sac were documented in
only a few cases, so no conclusions
with respect to survival can be drawn
from these findings.
Malrotation or incomplete rotation,
with or without Ladd’s bands was
noted in 11 patients at operation.
Other defects were a Meckel’s diver
ticulum in three, hiatus hernia in two,
congenital hypertrophic pyloric steno
sis in one, microphthalmia in one and
de Lange’s syndrome in one.
Com plications

The most common postoperative
complications were pneumothorax
and atelectasis with respiratory insuf
ficiency of varying degree. Six sur
vivors were ventilated for periods of
2, 4, 4, 6, 11 and 18 days respectively.
Twenty of the 25 eventual nonsur
vivors required mechanical ventilation
either continuously or intermittently
until their death.
One patient required reoperation
at 7 days for volvulus of the stomach,
another had partial gastric volvulus
causing gastroesophageal reflux which
was treated nonoperatively. Another
patient underwent a laparotomy at 1
year of age for lysis of adhesions. A
fourth child had an episode of intes-
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tinal obstruction at 8 and again at
9 years of age, both resolving without
operation. Another had a laparotomy
for lysis of Ladd’s bands at the age
of 7 years. This patient had had her
hernia repaired through a left thora
cotomy.
Vasodilator Therapy
Tolazoline hydrochloride, a pul
monary vasodilator, has been used in
10 patients since 1975. All were
neonates operated on within the first
24 hours of life who had severe
respiratory distress (arterial oxygen
tension 50 mm Hg or less on maxi
mum ventilatory support). There were
four survivors, three of whom had
a transient postoperative “honey
moon” period of adequate oxygena
tion and responded to the first test
dose of tolazoline (2 mg/kg given
intravenously) with an immediate
increase in descending aortic Pao2
of more than 200 mm Hg.
Survival
Of the 43 children 20 (46%) sur
vived (Fig. 1). Of the 23 patients
who died, 3 died before operation
could be undertaken. Postoperative
survival was therefore 50%. Two of
the 20 survivors died later, one at

age 1 V2 years of chronic respiratory
insufficiency. He required ventilatory
support intermittently for the entire
2Vi years. A second died of acute
lymphoblastic leukemia at 6 Vi years
of age. All other deaths occurred less
than 44 hours after operation. Twen
ty-four of the 25 who died were
admitted within 8 hours of birth,
while only 1 of those admitted after
N o n survi vors

■
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FIG. I— Number of patients and an
nual survival in neonatal congenital post
erolateral diaphragmatic hernia. Note
lack of consistent improvement over
study period.
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8 hours subsequently died (Fig. 2).
The most common cause of death
was pulmonary insufficiency. Pre
operative Pao2 in survivors was an
average of 40 mm Hg and carbondioxide tension was 58 mm Hg (frac
tional concentration of oxygen [Fio2]
= 0.6 to 1.0). Of those who died,
the oxygen tension was 37 mm Hg
and Pco2 79 mm Hg (Fio2 — 0.6
to 1.0). One child had small bowel
infarction leading to sepsis due to Sta
phylococcus pyogenes. Two patients
had septicemia due to beta hemolytic
streptococcus. Sepsis was suspected
in one of the infants in whom an
autopsy was not carried out. A fifth
child had pneumonia due to Klebsiella
sp. Intracerebral hemorrhage was an
associated factor in three cases.
One survivor had tetralogy of Fal
lot and another had congenital aortic
stenosis.
Autopsy Findings
Autopsy was performed on 23 chil
dren. Sixteen had a patent ductus
arteriosus and 4 had a patent foramen
ovale. Two patients had multiple,
severe congenital heart defects, which
contributed significantly to their
death. These included anomalous sys
temic and pulmonary venous drain-
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age, transposition of the great vessels,
endocardial cushion defects and ven
tricular septal defect. Three children
were found to have hypoplastic pul
monary arteries. Twelve had severe
pulmonary hypoplasia on the side of
the lesion, usually the left side. Fif
teen patients had severe bilateral
pulmonary hypoplasia. Both lungs
weighed a mean of 42% of expected
weights on the basis of body weight.7
Discussion

Survival of patients with congenital
diaphragmatic hernia repaired in the
neonatal period varies from 33% to
66%.I,M,S Most series reported steady
improvement in results until about
1970, followed by paradoxical dete
rioration. It was thought that the
increasing number of neonates reach
ing specialty centres, who previously
would have died before transfer, was
responsible for the poor results. Since
1973, the results obtained at the
Montreal Children’s Hospital seem to
reflect this trend with some improve
ment apparent after 1977 (Fig. 1). It
is interesting that four of the six sur
vivors since 1977 were treated with
tolazoline.9,10

There has been no change over
the years in the age of infants ad
mitted; the majority arrive within 8
hours of birth. It is very likely that
the large number of deaths is owing
to the fact that 15 of the 25 children
who died were intubated before or
immediately on arrival at the hospital.
At present, no other factors in mana
gement have been shown definitely to
influence survival.
Recent interest in abnormalities of
pulmonary vasculature with vasospasm
and increased reactivity to adverse
stimuli has led us to use vasodilator
therapy in all infants severely ill with
congenital diaphragmatic hernia.5,6
Although the numbers are small, it
appears that there may be benefit
from control of vasospasm in the
hypoplastic lungs. Absence of response
to a test dose of a vasodilator sug
gests a severe degree of lung hypo
plasia that is incompatible with sur
vival. Further studies using vasodila
tors are indicated.
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The American Association for Hand
Surgery will hold its annual meeting
in New York City from Oct. 15 to
18, 1981. The keynote address will
be given by Dr. J. William Littler of
New York.
For further information please
contact Ms. Jean Rickli, The Ameri
can Association for Hand Surgery,
2704 Marshall Court, Madison, WI
53705 or telephone (608) 238-9331.
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Hypertrophic Osteoarthropathy Complicating
Metastatic Ovarian Adenocarcinoma
W anda M. L e s t e r , md and D. I an R o b er tso n , m d , ph d , f r c p [c ]

This report documents for the first
tim e the association of hypertrophic
osteoarthropathy with ovarian
adenocarcinoma metastatic to the
lung, in a 47-year-old woman who
became totally incapacitated by her
joint pain. Surgical removal of the lung
metastases resulted in prompt
relief of her pain.
Theories of the pathogenesis of this
clinical syndrome are reviewed.
They include neurovascular, humoral
and estrogenic mechanisms. Pulmonary
arteriovenous shunting has also been
considered in the pathogenesis.
Operation should be considered in
all patients who are incapacitated by
joint pain associated with metastatic
disease in the lungs.
Ce rapport decrit pour la premiere fois
I'association d’une osteoarthropathie
hypertrophique et d’un adenocarcinome
ovarien avec metastase aux poumons,
observee chez une femme de 47 ans
qui fut rendue completement invalide
par les douleurs articulaires. La
resection chirurgicale des metastases
pulmonaires a entraine un soulagement
rapide de la douleur.
Les theories sur la pathogenese
de ca syndrome clinique sont passees
en revue. Elies incluent des
mecanismes neurovasculaire, humoral
et oestrogenique. La possibility
d’un poumon de choc doit aussi
etre consideree dans la pathogenese.
L'operation devrait etre envisagee
chez tous les malades rendus
invalides par des douleurs articulaires
reliees a des metastases pulmonaires.

Hypertrophic osteoarthropathy is a
clinical syndrome consisting of pain
and swelling of the joints, clubbing
of the digits and subperiosteal new
bone formation. The affected joints
are usually the wrists, ankles and
knees. Except in the rare hereditary
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of Manitoba, Winnipeg, Man.
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or idiopathic form it portends the
development of severe visceral disease.
In this paper we describe hypertrophic
osteoarthropathy associated with ova
rian carcinoma, an association that
has not previously been reported.

operation the joint pain and tenderness
had disappeared. She was discharged
on June 7 without pain, tenderness or
swelling in any joint. She has been
taking hexamethylmelamine (300 mg/d)
and has remained well and free of joint
pain; her last visit was on Jan. 28. 1980.

Case Report

Pathological Findings

A 47-year-old woman, gravida 4,
para 3, complained that for the pre
vious 6 months she had suffered menor
rhagia and pain in the right lower
abdominal quadrant. Three years ear
lier. in June 1976, a total hysterectomy
and bilateral salpingo-oophorectomy
had been performed in another hospital
for ovarian adenocarcinoma. Following
operation she was given melphalan for
11 months. In June 1977, at a “second
look” operation, tumour was found on
the right pelvic wall encasing the ureter.
The tumour was excised and biopsy of
omental nodules was carried out. The
patient was given two courses of doxo
rubicin (75 mg intravenously once a
month for 2 months). In March 1979,
she returned complaining of cough and
pleuritic chest pain. Concurrently she
had pain and swelling of the ankles,
toes and fingers. A chest roentgenogram
revealed a nodule (diameter 2 cm) in
the right lung which was suggestive of
pulmonary metastasis.
Over the next 2 months the joint
pain extended to involve her knees and
lateral aspect of the wrists. The prox
imal and distal interphalangeal joints
of the hands and the metatarsophal
angeal joints became increasingly tender,
swollen and red. Clubbing of the fingers
and toes was noted. The pain and
tenderness extended proximally to in
volve the heels, malleoli, left upper
tibia and fibula and the left lower
femur. Roentgenograms of her legs
revealed soft tissue swelling but no
subperiosteal new bone formation. By
early May she was totally incapacitated.
Tomography of the right lung on
May 8 revealed a soft tissue tumour
several centimetres in diameter in the
lower lobe as well as an enlarged
hilum. Roentgenograms of the legs
obtained on May 22 showed a very
fine linear periosteal reaction along the
right distal fibula consistent with hyper
tropic osteoarthropathy.
On May 24 the patient underwent a
right lower lobectomy and excision of
four tumour nodules in the upper and
middle lobes. A vagotomy was also
performed. Within 24 hours after the

Histologic sections of the right ova
rian tumour showed that it was an
adenocarcinoma of surface epithelial
origin containing various cell types
(Fig. 1). Many cells were mucus secret
ing but the tumour also contained
numerous endometrioid foci, some of
which showed squamous differentiation.
A minor serous component was also
present. The recurrence in the right
pelvic wall and omentum 1 year later
contained an approximately equal
admixture of mucous and endometrioid
components.
The pulmonary metastases each had
a morphology essentially similar to the
primary ovarian adenocarcinoma (Fig.
2). They also contained an admixture
of ovarian surface epithelial cell types
with a predominance of mucous and
endometrioid components.

Discussion
Hypertrophic osteoarthropathy is
now most commonly found in asso
ciation with bronchogenic carcinoma.1
Formerly, many intrathoracic chronic
inflammatory diseases were more
commonly associated with the con
dition including chronic lung sepsis
and bacterial endocarditis. Other con
ditions associated with hypertrophic
osteoarthropathy include chronic liver
and inflammatory bowel diseases.2
The use of the adjective pulmonary,
which is sometimes included, may be
misleading and should be omitted
from the name of the clinical syn
drome.
Only rarely are tumours me
tastatic to the lung associated with
hypertrophic osteoarthropathy. Firooznia and associates3 could find only
44 reported cases of this syndrome
to which they added 3 of their own.
They found that the commonest sites
of primary malignant tumours were
the musculoskeletal system and soft
tissues (23 cases) and the nasopharynx
(10 cases). The uterus and cervix
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were the third most frequent primary
sites (eight cases) with four carci
nomas, three leiomyosarcomas and
one chorionepithelioma. We have re
viewed the literature since the report
of Firooznia and have found no addi
tional cases of hypertrophic osteo
arthropathy complicating a gyne
cologic tumour metastatic to lung.
This is the first report of an ovarian
tumour associated with the condition.
The pathogenesis remains obscure.
A neurovascular mechanism was pro
posed following Flavell’s observation4
that vagotomy in patients with bron
chogenic carcinoma resulted in prompt
amelioration of the symptoms of
hypertrophic osteoarthropathy. The
afferent fibres of the reflex are
thought to travel by way of the vagus
nerve but the efferent course is
unknown. The mechanism of stimula
tion of the afferent fibres is also
poorly understood. The efferent
sympathetic fibres could be respon
sible for an expansion in the arteriolar
vascular bed which in turn could
cause a local increase in blood flow
leading to subperiosteal new bone
formation, subcutaneous edema and
joint effusions. Subsequent observa
tions, however, have shown that not
all cases of hypertrophic osteoarthro
pathy are associated with an increased
blood flow and that the increased
blood flow is not invariably dimi
nished by vagotomy.5
A humoral mechanism has been
postulated. Steiner and associates6
found elevated plasma levels of
growth hormone in a patient with
bronchogenic carcinoma and hyper
trophic osteoarthropathy that re
turned to normal levels following
resection of the pulmonary tumour.
They suggested that ectopic produc
tion of growth hormone by the
tumour might be the cause of the
complication. Cell culture of an
anaplastic lung carcinoma from an
other patient synthesized and released
material resembling human growth
hormone.7 Flowever, no positive cor
relation between elevated plasma levels
of human growth hormone and hyper
trophic osteoarthrophy in patients
with bronchogenic carcinoma has
been found by others.8
The frequent finding of gyneco
mastia in patients with secondary
hypertrophic osteoarthropathy sti
mulated interest in the possible role
of estrogens in this syndrome. Ginsburg and Brown9 found a high level
of total urinary estrogens in 7 of 11
men with bronchogenic carcinoma,
the increases being greatest in the
estriol fraction. They also found that

the conjugation and inactivation of
exogenous estrogens was unimpaired,
suggesting that the observed increased
levels of endogenous estrogens re
sulted from increased production.
Flypertrophic osteoarthropathy has
also been reported with Laennec's
cirrhosis which is known to be asso
ciated with deranged metabolism.10
Rarely, hypertrophic osteoarthropa
thy develops during pregnancy but
disappears rapidly after delivery.11

This finding has also been used to
support an estrogenic mechanism for
the cause of hypertrophic osteoarthro
pathy but it does not explain why
the condition is not more often
found in pregnant women, who have
high estrogen levels.
The only experimental model of
hypertrophic osteoarthropathy has
been produced in the dog by anasto
mosing the left pulmonary artery to
the left auricle.12 This has been con-

FIG . 1— Prim ary ovarian adenocarcinom a. In centre are several endom etrioid
glands (arrow) and to left, some show squam ous differentiation (arrow ). Secretory
product distends serom ucinous glands and compresses epithelium (hem atoxylin and
eosin, reduced by 28% from X l2 5 ).

F IG . 2— M etastasis in lung. This closely resembles ovarian prim ary and contains
endom etrioid and serom ucinous glands. In bottom left corner lipid-laden m acrophages
(arrow) are present within alveolar spaces (hem atoxylin and eosin reduced by 28%
from X 125).

VOLUME 24, NO. 5, SEPTEMBER 1981 / THE CANADIAN JOURNAL OF SURGERY

521

Double the calories without increasing fluid volume.

N EW

Liposyn

fat emulsion
for TPN

LIPOSYN supplies concentrated nutritional support in a
clinically proven isotonic formula.1 And since LIPOSYN is
based on safflower oil, it contains 77% linoleic acid — a
high percentage when compared to soybean oil lipids
(54% linoleic). LIPOSYN is convenient and cost-effective.
NEW LIPOSYN 10%
The most efficient lipid available today.

MEMBER

I p M A cJ

HOSPITAL PRODUCTS DIVISION
ABBOTT LABORATORIES, LIMITED
MONTREAL, CANADA H4P 1A5

PAAB

Reference: 1. Rapp RP et al: Safety of a New Safflower Oil Emulsion (Liposyn 10%) in Total
Parenteral Nutrition. Liposyn Research Conference Proceedings, New Orleans, La, April 1979.

L IP O S Y N * 10 % Injection
Intraveno us Fat Em ulsion 10 %
Intraveno us Nutrient S upplem ent
PRESCRIBING INFORMATION
DESCRIPTION
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Infusion of fat emulsion is contraindicated in patients demonstrating distur
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sidered evidence that pulmonary
arteriovenous shunting may be im
portant in the pathogenesis. Such
shunting may allow hormones or
hormone-like substances to bypass
metabolic degradation in the lung
and to stimulate subperiosteal new
bone formation. However, no evi
dence of arteriovenous shunting could
be found in some series including
both humans and dogs.13 Further,
patients with cyanotic heart disease
due to arteriovenous shunts might be
expected to show symptoms of hyper
trophic osteoarthropathy, yet they
rarely do.
Surgical treatment for patients
with hypertrophic osteoarthropathy
should not be denied merely because
they have evidence of widespread
metastatic disease. Some patients,
such as ours who was totally incapa
citated by her joint pain, respond
dramatically to thoracotomy with or
without vagotomy.14,15
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Ultrasonography in the Diagnosis
of Rectus Abdominis Hematoma
A . T r ia s ,

m d , f r c s [ c ],*

Because bleeding into the rectus
sheath may give a clinical picture
simulating an acute abdomen, it is
essential that an accurate diagnosis
be made so that an unnecessary
laparotomy is not performed. Plain
films do not give adequate information
and computerized axial tomography
is not always available, but
ultrasonography, which is noninvasive
and is readily available, provides
an accurate diagnosis as in the
case reported in this paper.
A 57-year-old woman had bilateral
hematomas of the rectus sheath that
did not occur simultaneously. She
had a chronic debilitating disease
as do the majority of such patients.
Long-term cortisone therapy with
secondary breakdown of connective
tissue was probably the predisposing
factor. During a blood transfusion
that was needed following operation
for osteomyelitis the patient
had a severe reaction acompanied
by sudden onset of severe
abdominal pain on the left side.
Ultrasonography confirmed
the tentative diagnosis of rectus
sheath hematoma. The patient was
treated conservatively. The pain
subsided within a few days leaving an
ecchymosis. Two weeks later she
experienced a similar pain on the
right side which was also diagnosed
by ultrasonography as a rectus
sheath hematoma. Again, with
conservative treatment the pain
subsided leaving discolouration of
the skin.
The authors stress the value of
ultrasonography in diagnosing rectus
sheath hematoma and the importance
of conservative management.
Parce qu’une hemorragie de la gaine
du muscle grand droit peut presenter
From the departments of *orthopedics,
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M. B o c t o r ,

m d , f r c p [ c ]+ and

V. E chave,

un tableau clinique simulant un
abdomen aigu, il est essentiel de poser
un diagnostic precis si on veut eviter
une laparotomie inutile. La radiographie
simple ne donne pas une information
adequate et la tomographie transverse
axiale avec ordinateur n’est pas
toujours disponible. Toutefois,
l'echographie ultrasonique, une
technique douce, facilement disponible,
assure un diagnostic precis tel que
le montre le cas decrit dans cette
publication.
Une femme de 57 ans presenta
des hematomes bilateraux sur la gaine
du grand droit; ceux-ci n'etaient pas
apparus simuitanement. Elle souffrait
d’une maladie debilitante chronique
comme c'est le cas chez la majorite
de ces patients. Une corticotherapie
prolongee avec bris secondaire des
tissus conjonctifs constituait
probablement un facteur predisposant.
Au cours d’une transfusion sanguine
requise a la suite d'une operation
pour osteomyelite, la patiente eut
une reaction severe accompagnee
par I'apparition brusque d'une douleur
abdominale intense du cote gauche.
L'echographie ultrasonique confirma
le diagnostic presomptif d'un hematome
de la gaine du muscle grand droit.
La maladie fut traitee de facon
conservatrice. Sur une periode de
quelques jours, la douleur disparut
laissant une ecchymose. Deux
semaines plus tard, une douleur
semblable apparut du cote droit que
l'echographie ultrasonique diagnostiqua
comme un hematome de la gaine
du muscle grand droit. Encore une
fois, avec un traitement conservateur
la douleur s'estompa laissant
un bleu.
Les auteurs soulignent I'interet
de l'echographie ultrasonique pour
diagnostiquer un hematome de la
gaine du grand droit, et I'importance
d'un traitement conservateur.

Bleeding into the rectus sheath is a
well known clinical entity. It results
in a clinical picture that may simulate
an acute abdominal condition. For
this reason it is essential to establish
an accurate diagnosis. Clinical signs
are not always clear and many of
these patients undergo an unnecessary

m d , f r c s [c ]$

laparotomy. Plain abdominal films
do not give adequate information and
computerized axial tomography, al
though useful, is not always available.
We found that ultrasonography, an
accurate, noninvasive examination,
provides the information needed to
establish a diagnosis. The occurrence
of bilateral rectus sheath hematomas
that do not occur simultaneously is
quite unusual.

Case Report
A 57-year-old woman had a 10-year
history of lupus erythematosus associated
with a nephrotic syndrome. From the
start she had been treated with corticoids and was receiving 30 mg of pred
nisone every other day. Bilateral aseptic
necrosis of the hips had been treated
with Moore arthroplasties a few years
earlier. In 1975 septic arthritis of her
left knee had necessitated an arthrodesis
but she was left with chronic osteomye
litis of the fused area.
Because of her osteomyelitis she was
hospitalized in February 1980. Radical
curettage was performed on the left knee;
the wound was packed open. On March
4 when the wound cavity proved to be
sterile, it was filled with free fat taken
from the subcutaneous tissue of the left
abdominal wall just caudad to the
umbilicus, and the skin was closed. Her
hemoglobin level dropped from 11 g/dl
to 5.1 g/dl on th day following operation
and two units of packed cells were trans
fused. Towards the end of the transfu
sion she had a severe shaking episode
during which she experienced sudden
onset of acute abdominal pain located
mainly in the left lower quadrant. The
abdomen became distended and tender,
particularly on the left side, but there
was no evidence of edema or collection
of blood in the subcutaneous tissues.
Peristalsis persisted and the patient was
able to drink and was not nauseated.
A tentative diagnosis of hematoma of
the left rectus sheath was made and
later confirmed by ultrasonography
(Fig. 1). During the following days the
syndrome subsided. In spite of the trans
fusion the hemoglobin level dropped to
4.1 g/dl and several transfusions were
needed to raise it to 10 g/dl at which
level it remained. A few days after
this bleeding episode ecchymosis ap
peared on the lower part of her left
abdominal wall and left side of the
pubis.
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ed. Our patient had taken large doses rectus abdominis muscle and there is
of cortisone for many years because no effective tamponade mechanism.
of a nephrotic syndrome secondary
Although there are few gastroin
to lupus erythematosus. This might testinal symptoms, signs of peritoneal
have predisposed to the occurrence irritation can occur; in these cases
of the hematomas.
differentiation from an intra-abdo
The condition is probably more minal condition is paramount so as
common than reported in the surgical to spare the patient an unnecessary
literature but minor bleeding can operation.4
occur with minimal symptoms and
Treatment of rectus sheath hema
diagnosis in these cases is difficult toma is conservative once the diag
to make. In a review of the literature nosis is established; analgesics and
Jones and Merendino3 found 250 blood volume replacement if neces
reported cases up to 1962.
sary are usually enough.
Discussion
Sometimes bleeding is severe with
The correct clinical diagnosis of
This case is both typical and subsequent vascular collapse and rectus sheath hematoma is not
unusual: typical because of the pa abdominal pain of sudden onset on always easy. In a review of 100
tient’s symptoms and unusual be the abdominal wall of the involved cases Teske5 found that the correct
cause the hematoma of the rectus side. A palpable tender mass is gene diagnosis was established preoperaabdominis sheath occurred bilaterally rally present, the hematoma being tively in only 17.
but not simultaneously. This was not confined by the rectus sheath.
For several years ultrasonography
Discolouration of the skin over- has been used in the differential diag
described in the literature we re
lying the hematoma may occur several nosis of abdominal wall lesions.6
viewed.
Hematoma of the rectus sheath days after the bleeding episode and These include abscesses of the
may follow trauma to the epigastric may extend, as in our case, to the abdominal wall, hernias, fluid col
vessels but it often occurs spontane skin overlying one side of the pubis. lections, solid tumours and rectus
ously in patients with infectious col Bleeding is more severe below the sheath hematomas.7 With ultrasono
lagen diseases and debilitating condi semicircularis line where the peri graphy the hematoma appears sonotions and those on anticoagulation toneum is loosely attached to the lucent with well defined margins.
therapy.1 It also has been described
Internal echoes depend on the stage
in pregnancy and following convulsive
of clot lysis.8
seizures.2 In the elderly, minor exer
We found ultrasonography readily
tion can be followed by rupture of
available, noninvasive, inexpensive
and bleeding from the atherosclerotic
and accurate in diagnosing bilateral
epigastric vessels which are unable
hematomas of the rectus abdominis
to adjust to the sudden change in
sheath in our patient.
length of the rectus muscle during
contraction and relaxation.
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presenting liquified hematoma (H), which
is bilateral on transverse scan (marker
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spigelian h e rn ia : u ltrasonic differen tial diag
nosis. A J R 1979; 133: 107-10
8. G rand M , V erbecq P , P agniez B, G est H :
L’hem atom e de la gaine des d ro its, un
diagnostic e ch o tom ographique. L ille M e d
1979; 24: 184-8
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In intra-abdominal and pelvic infections, MEFOXIN
— an effective single agent — provides bactericidal activity against
many mixed aerobic/anaerobic organisms including B. fragilis.
In many cases MEFOXIN* may eliminate the need for combination
antibiotic therapy which could include potentially more toxic agents.
MEFOXIN* is generally w ell tolerated... Data from
108 studies conducted world-wide on 2277 patients with infections at
various sites, 1924 of whom received MEFOXIN* revealed the drug to be
well tolerated by more than 90% of patients.1
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The First C ephamycin D erivative

(CEFOXITIN SO DIUM FOR INJECTION)

For S ingle A ntibiotic Therapy
O f M any M ixed Infections
MEFOXIN* is not active against Pseudomonas spp.,
most strains of enterococci, many strains of
Enterobacter cloacae, and methicillin-resistant
staphylococci.
1. van Wmzum, C.: Clinical safety and tolerance of cefoxitin sodium: an overview,
J Antimicrob Chemother 4 ( S u p p l B): 91-104. 1978.

(Tdlefoxin
(cefoxitin sodium for injection)

ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bactericidal action of cefoxitin, a
cephamycin derived from cephamycin C, results from the inhibition of
bacterial cell wall synthesis. Evidence suggests that the methoxy group
in the 7a position is responsible for’ the resistance of cefoxitin to
degradation by bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
TREATMENT

The treatment of the following infections when due to susceptible
organisms:
1— Intra-abdominal infections such as peritonitis and intra-abdominal
abscess
2— Gynecological infections such as endometritis and pelvic cellulitis
3 — Septicemia
4— Urinary tract infections (including those caused by Serratia marcescens
and Serratia spp.)
5 — Lower respiratory tract infections
6 — Bone and joint infections caused by Staphylococcus aureus
7— Soft tissue infections such as cellulitis, abscesses and wound
infections
Appropriate culture and susceptibility studies should be performed to
determine the susceptibility of the causative organism(s) to M EFOXIN*.
Therapy may be started while awaiting the results of these tests,
however, modification of the treatment may be required once these
results become available.
Organisms particularly appropriate for therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing and non-producing strains)

E. Coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species
Anaerobes

Bacteroides tragiiis
MEFOXIN* may also be appropriate for the treatment of infections
involving susceptible strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that MEFOXIN* can be adminis
tered to patients who are also receiving carbenicillin, gentamicin,
tobramycin, or amikacin (see PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for patients with bacteremia, bacterial
septicemia, or other severe or life-threatening infections, or for patients
who may be poor risks because of lowered resistance resulting from
such debilitating conditions as malnutrition, trauma, surgery, diabetes,
heart failure, or malignancy, particularly if shock is present or impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and postoperatively) to patients undergoing vaginal hys
terectomy and abdominal surgery when there is a significant risk of
postoperative infection or where the occurrence of postoperative
infection is considered to be especially serious.
In patients undergoing cesarean section, intraoperative (after clamping
the umbilical cord) and postoperative use of MEFOXIN* may reduce
the incidence of surgery related postoperative infections.
Effective prophylactic use depends on the time of administration.
MEFOXIN* usually should be given one-half to one hour before the
operation. Prophylactic administration should usually be stopped within
12 hours. It has been generally reported that continuing administration
of any antibiotic beyond 24 hours following surgery increases the
possibility of adverse reactions but, in the majority of surgical procedures,
does not reduce the incidence of subsequent infection.
If signs of postsurgical infection should appear, specimens for culture
should be obtained for identification of the causative organism(s) so that
appropriate therapy may be instituted.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who have shown hypersensi
tivity to cefoxitin or to the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted, careful inquiry should be
made to determine whether the patient has had previous hypersensitivity
reactions to MEFOXIN*, cephalosporins, penicillins or other drugs.
MEFOXIN* should be given with caution to penicillin-sensitive patients.

'Merck Sharp & Dohme Canada Limited, Trademark Owner
Charles E. Frosst & Co., Registered User

There is some clinical and laboratory evidence of partial cross
allergenicity between cephamycins and the other beta-lactam antibiotics,
penicillins and cephalosporins. Severe reactions (including anaphylaxis)
have been reported with most beta-lactam antibiotics.
Any patient who has demonstrated some form of allergy, particularly to
drugs, should receive antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs, administration of the drug
should be discontinued. Serious hypersensitivity reactions may require
treatment with epinephrine and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced when MEFOXIN* is adminis
tered to patients with transient or persistent reduction of urinary output
due to renal insufficiency (see DOSAGE and ADMINISTRATION)
because high and prolonged serum antibiotic concentrations can occur
from usual doses.
In patients treated with MEFOXIN* a false-positive reaction to glucose
in the urine may occur with Benedict's or Fehling’s solutions but not with
the use of specific glucose oxidase methods.
Using the Jaffe Method, falsely high creatinine values in serum may
occur if serum concentrations of cefoxitin exceed 100 mcg/mL. Serum
samples from patients treated with MEFOXIN* should not be analyzed
for creatinine if withdrawn within two hours of drug administration.
Increased nephrotoxicity has been reported following concomitant
administration of cephalosporins and aminoglycoside antibiotics.
The safety of M EFOXIN* in the treatment of infections during pregnancy
has not been established. If the administration of MEFOXIN* to pregnant
patients is considered necessary, its use requires that the anticipated
benefits be weighed against possible hazards to the fetus. Reproductive
and teratogenic studies have been performed in mice and rats and have
revealed no evidence of impaired fertility or harm to the fetus due to
MEFOXIN*
Cefoxitin has been observed in the milk of nursing mothers receiving
the drug.
Prolonged use of MEFOXIN* may result in the overgrowth of nonsusceptible organisms. Repeated evaluation of the patient's condition
is essential and if super-infection occurs during therapy, appropriate
measures should be taken. Should an organism become resistant during
an antibiotic therapy, another antibiotic should be substituted.
In children 3 months of age or older, higher doses of MEFOXIN*
(100 mg/kg/day and above) have been associated with an increased
incidence of eosinophilia and elevated SGOT.
The safety and efficacy of MEFOXIN* for the treatment of infections in
infants from birth to three months of age have not yet been established.

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse reactions rarely required
cessation of treatment and usually have been mild and transient.
Local Reactions

Thrombophlebitis has occurred with intravenous administration. Some
degree of pain and tenderness is usually experienced after intramuscular
injections using water. Induration has occasionally been reported.
Allergic

Maculopapular rash, urticaria, pruritus, eosinophilia, fever and other
allergic reactions have been noted.
Gastrointestinal

Diarrhea has been reported rarely.
Blood

Transient leukopenia and neutropenia have been reported. Some
individuals may develop positive direct Coombs tests during therapy
with MEFOXIN*.
Liver Function

Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline
phosphatase have been reported.
Kidney

Elevations in serum creatinine and/or blood urea nitrogen levels have
been observed. The role of M EFOXIN* in changes in renal function tests
is difficult to assess, since factors predisposing to prerenal azotemia or
to impaired renal function have often been present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no specific antidote is known.
MEFOXIN* can be eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
TREATMENT DOSAGE

MEFOXIN* may be administered intravenously or intramuscularly when
required. (See monograph for reconstitution directions for each route.)
Adult Dosage

The usual adult dosage is 1 g or 2 g of MEFOXIN* every 6 to 8 hours.
Dosage and route of administration should be determined by severity
of infection, susceptibility of the causative organisms, and condition of
the patient. The usual adult dosages are shown in the table below.

Usual Adult Dosage
Type of Infection

Daily Dosage

Uncomplicated forms*
3-4 grams
of infections such as
pneumonia, urinary tract
infection, soft tissue infection

Frequency and Route

1 gram every 6-8 hours
IV or IM

Moderately severe or
severe infections

6-8 grams

1 gram every 4 hours
or
2 grams every 6-8 hours IV

Infections commonly
needing antibiotics in
higher dosage (e.g.
gas gangrene)

12 grams

2 grams every 4 hours
or
3 grams every 6 hours IV

‘ Including patients in whom bacteremia is absent or unlikely.
Therapy may be started while awaiting the results of susceptibility
testing.
Antibiotic therapy for group A beta-hemolytic streptococcal infections
should be maintained for at least 10 days to guard against the risk of
rheumatic fever or glomerulonephritis. In staphylococcal and other
infections involving a collection of pus, surgical drainage should be
carried out where indicated.
Dosage in Adult Patients with Impaired Renal Function

MEFOXIN* may be used in patients with reduced renal function but
a reduced dosage should be employed and it is advisable to monitor
serum levels in patients with severe impairment.
In adults with renal insufficiency, an initial loading dose of 1 g to 2 g
should be given. After a loading dose, the following recommendations
for maintenance dosage may be used as a guide:
RENAL
FUNCTION

CREATININE
CLEARANCE
mL/min

DOSE

FREQUENCY

every 8-12 hrs
1-2 g
50-30
Mild impairment
every 12-24 hrs
1-2 g
29-10
Moderate impairment
every
12-24 hrs
0.5-1
g
9-5
Severe impairment
every 24-48 hrs
0.5-1 g
<5
Essentially no function
In the patient undergoing hemodialysis, the loading dose of 1-2 g should
be given after each hemodialysis, and the maintenance dose should be
given as indicated in the table above.
Infants and Children

The recommended dosage in children three months of age and older
is 80 to 160 mg/kg of body weight per day divided into four to six equal
doses. The higher dosages should be used for more severe or serious
infections. The total daily dosage should not exceed 12 g.
At this time no recommendation is made for children from birth to three
months of age (see PRECAUTIONS).
At present there is insufficient data to recommend a specific dosage for
children with impaired renal function. However, if the administration of
MEFOXIN* is deemed to be essential the dosage should be modified
consistent with the recommendations for adults (see Table above).
PROPHYLACTIC USE

For prophylactic use, a three-dose regimen of MEFOXIN* is recom
mended as follows:
Vaginal hysterectomy and abdominal surgery

2 g administered intramuscularly or intravenously just prior to surgery
(approximately one-half to one hour before initial incision).
The second and third 2 g doses should be administered at 2-6 hour
intervals after the initial dose.
Cesarean Section

The first dose of 2 g should be administered intravenously as soon as
the umbilical cord has been clamped. The second and third 2 g doses
should be given intravenously or intramuscularly four hours and eight
hours after the first dose.

DOSAGE FORMS
Sterile MEFOXIN* is a dry white to off-white powder supplied in vials
containing cefoxitin sodium as follows:
No. 3356—1 g cefoxitin equivalent in boxes of 10 vials
No. 3357—2 g cefoxitin equivalent in boxes of 10 vials
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BOOK REVIEWS
COMPLICATIONS IN VASCULAR
SURGERY. Edited by Victor M.
Bernhard and Jonathan B. Towne. 657
pp. Illust. Grune & Stratton, Inc.,
New York; Academic Press Canada
Limited, Don Mills, Ont., 1980. $79.35
(Can.). ISBN 0-8089-1283-6.

This book is designed to cover compre
hensively the perioperative complications
of vascular surgical procedures. The 43
chapters are divided into eight specific
sections. There are over 60 contributors
who are authorities in the field.
The book is concise, well illustrated
and covers the field in an orderly
fashion. Many of the chapters are out
standing. The references are helpful and
the index is good.
Because it is an outstanding contribu
tion to its field, the volume should be in
the library of all surgeons performing
vascular surgery. It is an excellent ref
erence text for residents in surgery ro
tating on a vascular service and would
be invaluable to those surgeons not spe
cializing in vascular surgery who might
be called upon, in urgent situations, to
perform emergency vascular surgery.
C .M . COUVHS, MD, FACS, FRCS[C]

3104 Cox Rd„
Kelowna, BC.
SURGICAL REVIEW I. Edited by
J.S.P. Lumley and J.L. Craven. 407
pp. Illust. Pitman Medical Publishing
Co. Ltd., Tunbridge Wells, Kent; Uni
versity Park Press, Baltimore, 1979.
$29.25. ISBN 0-272-7925-9.

The purpose of the book as outlined by
the editors is to provide a general re
view of broad areas of surgery. It was
designed for candidates preparing for
the final British fellowship examinations.
In North America the qualifying examin
ation in surgery does not include such a
wide range of topics. For this reason it
may have limited appeal for examination
candidates in North America.
Nine of the 22 chapters in this book
are contributed by experts in their fields
and are devoted to cancer, including
cancer of the urinary tract.
Although some of the chapters provide
specific data from the authors’ experi
ence, many are devoted to classifications
and general reviews. Most of this mate
rial could be obtained from the many
updated and excellent textbooks of sur
gery.
Because of its disparate nature, the
book does not flow and one has to con
stantly “change gears”. Most chapters
would benefit by having more illustra
tions. The bibliographies are inconsistent.
Many chapters have long detailed lists
of references whereas others are quite
short. A few (perhaps 8 to 10) standard
or key references for each chapter
would be preferable.
The chapters on surgery of Hodgkin’s
disease, current controversy of the man(continued on page 531 )
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Bronchogenic Cyst Presenting as a Supraciavicular Mass
P. D ubois, md, R. B elanger, md, frcs[c] and J.L. W ellington , md, frcs| c]

Bronchogenic cyst is one of the
more common congenital pulmonary
anomalies. It is related to abnormal
budding of the tracheobronchial tree
during embryologic development.
These lesions may present as a mass
in the lung parenchyma in the
mediastinum or within or below the
diaphragm. An unusual case of
bronchogenic cyst presenting as a
mass in the supraclavicular fossa
of a 24-year-old woman is reported.
Treatment of bronchogenic cyst
consists of excision of the mass.
Recurrence is rare if excision
is complete.
Le kyste bronchogene est I’une
des anomalies pulmonaires congenitales
les plus frequentes. II est relie
a un bourgeonnement anormal de
I arbre tracheo-bronchique au cours
du developpement embryonnaire. Ces
lesions peuvent etre presentes
sous la forme d'une masse dans le
parenchyme pulmonaire, dans le
mediastin, et dans ou sous
le diaphragme. On signale un cas
inhabituel ou un kyste bronchogene
est apparu sous forme d'une masse
dans la fosse supraclaviculaire,
chez une femme de 24 ans. Le
traitem ent du kyste bronchogene
consiste a exciser la masse.
La recidive est rare lorsque I'excision
est complete.

Case Report
A 24-year-old woman had had a
painless swelling in the right side of the
neck for 6 months. She said it varied
in size, becoming intermittently larger
with coughing or straining. According
to her mother she had had a swelling
in this area as an infant but the swelling
had disappeared by the time she was
5 years old.
The patient appeared healthy. There
was no palpable lymphadenopathy. The
findings on examination of the ear,
nose and throat were normal. The
chest was clear without tracheal devia
tion. There was a fluctuant, nontender
swelling in the right supraclavicular
fossa which was poorly circumscribed
and appeared to be deep to the sterno
cleidomastoid muscle (Fig. 1).
A tomogram of the upper mediasti
num revealed a soft tissue density in
denting the trachea. The results of arte
riography, venography and esophagoscopy were normal but ultrasonography
demonstrated a fluid-filled mass. Bron
choscopy showed that the right upper
lobe consisted of only two segments
but was otherwise normal.
Under general anesthesia and through
a right supraclavicular incision, a cystic
mass, which displaced the carotid
sheath anteromedially and extended into
the upper mediastinum, was encountered
deep to the sternocleidomastoid muscle.
There was no evidence of tracheal or
esophageal communication. The mass

Bronchogenic cysts are thought to
arise as a result of arrested develop
ment of a localized portion of the
bronchial system. This may be related
to local interference with blood supply
during fetal growth.1 The cysts may
appear as a mass lesion on chest
roentgenograms or may cause res
piratory obstruction or secondary in
fection. They may lose their connec
tion with the tracheobronchial tree
and migrate to a subcutaneous posi
tion in the neck.2 The patient reported
here presented with a swelling in the
supraclavicular fossa.
From the division of general surgery,
University of Ottawa and the Ottawa
General Hospital, Ottawa, Ont.
Accepted for publication Oct. 6, 1980
Reprint requests to: Dr. J.L. Wellington,
Division of general surgery, Ottawa
Genera! Hospital, 501 Smyth Road,
Ottawa, Ont. KIH 8L6
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FIG. I—Mass on right side is evident
as patient coughs.

was completely excised. The patient
made a good recovery and has been
well in the 18 months since operation.
The excised mass consisted of a cystic
structure lined with ciliated respiratory
epithelium and containing a yellowish
viscid fluid. The wall was composed of
smooth muscle with interspersed islands
of cartilage. Final diagnosis was bron
chogenic cyst.

Discussion
Embryologically the respiratory
tract and esophagus have a common
origin from the primitive foregut. The
respiratory anlage forms as a ventral
diverticulum produced by a lateral
septum which invades from each side.
By 12 to 16 weeks, 70% of the
bronchial system is complete.3 Bron
chogenic cysts arise secondary to
abnormal budding of the tracheal
primordium or because the lateral
septum is defective. Cysts arising early
in development tend to be located in
the mediastinum or pulmonary hilus
while those arising later are more
peripheral in location. The latter com
monly have a bronchial communica
tion which is unusual in more central
cysts.3 Communication with the eso
phagus is rare. When this occurs the
presence of cartilage in the cyst wall
establishes its respiratory origin.4
Bronchogenic cysts are distributed
equally between the sexes and are
found at all ages.5 They may be
asymptomatic or be associated with
signs of pulmonary infection if a
bronchial connection exists. Infants
commonly present with dyspnea se
condary to bronchial compression.
Cysts extending into the neck may
present as a cystic mass that varies
in size with changes in intrathoracic
pressure. Lesions such as cystic
hygroma, dermoid cyst, thyroglossal
duct cyst and thyroid goitre and lym
phadenopathy should be considered
in the differential diagnosis. Aneurysm
of the innominate artery may also
present as a right paratracheal mass.
In the mediastinum these cysts are
rarely situated anteriorly, being locat
ed more commonly in the superior,
middle or posterior mediastinum.3
Neurogenic tumours and esophageal
duplication may present a similar
appearance. Peripheral cysts must be
differentiated from granulomas, be
nign or malignant tumours and

VOLUME 24, NO. 5, SEPTEMBER 1981 / THE CANADIAN JOURNAL OF SURGERY

hamartomas. The presence of air may
suggest cavitation in a carcinoma,
tuberculosis or a pulmonary infarct.
A bronchogenic cyst containing an
air-fluid level may resemble a lung
abscess.
Tomography is useful in defining
more precisely the location of a cyst
in the mediastinum. Angiography may
be necessary to rule out a vascular
anomaly. In the neck, ultrasonography
helps in differentiating a solid from
a cystic mass. Endoscopy or contrast
examination may show indentation
of the esophagus.
Uninfected bronchogenic cysts con
tain yellow viscid fluid. Air or air
and fluid may be present if a bron
chial communication exists. The cyst
lining is composed of pseudostratified
ciliated columnar epithelium with
mucous glands. The wall consists of
smooth muscle and elastic fibres with
interspersed plates of cartilage.1 Cysts
may be tabulated or multilocated but
are usually single.6 Carcinomatous
change has been reported in a bron
chogenic cyst but is rare.7
Bronchogenic cysts should be ex
cised to establish a diagnosis and to
relieve symptoms. Segmental excision
is preferred for lesions in the lung
parenchyma. Recurrence is rare if
the excision is complete.
References
1. S pencer H: Pathology of the Lung, Exclud
ing Pulmonary Tuberculosis, 2nd ed, Pergamon, New York, 1968
2. C onstant E, D avis D, E dmister R: Bron
chogenic cyst of the suprasternal area. Case
report. Plast Reconstr Surg 1973 ; 52: 88-90
3. Schm idt FE, D rapanas T: Congenital cystic
lesions of the bronchi and lungs. Ann Thorac
Surg 1972; 14: 650-7
4. M indei .zun R. L ong P: Mediastinal bron
chogenic cyst with esophageal communica
tion. Radiology 1978; 126: 28
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A review of 46 cases. Am J Roentgenol
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6. M aier HC: Bronchiogenic cysts of the
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7. M oersh HJ, C lagett OT: Pulmonary cysts.
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agement of carcinoma of the breast, car
cinoma of the kidney and inguinal her
nia are excellent. The book is generally
well written and the index is adequate.
For economy of time and because of
the complexity of the undergraduate cur
riculum, this book is not recommended
for undergraduate teaching. However,
four or five of the chapters could be
assigned reading for students.

SESAP III Critique
ITEMS 309-312
In contrast to clostridial myositis, acute necrotizing fasciitis resulting
from hemolytic streptococci is usually of sudden onset and is associated
with overlying skin necrosis in the absence of crepitus. Systemic symp
toms may be minimal but may include apathy and disorientation with
a pattern of septic fever. Necrotizing fasciitis frequently occurs among
diabetics particularly in the buttocks, the perineum, and the lower ab
dominal wall. Wide debridement and bacterial smears with appropriate
antibiotic therapy are essential for the effective treatment of both
conditions.
309 |~A~| 310 [ b ]3 1 1 [ a ~]312 |~C~j
References

309-312/1. Meade JW, Mueller CB: Necrotizing infections of subcu
taneous tissue and fascia. Ann Surg 168:274-280, 1968
309-312/2. Rea WJ, Wyrick WJ Jr: Necrotizing fasciitis. Ann Surg
172:957-964, 1970
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Et apres . . . que deviennent les mastectomisees?
Louis D ionne ,

md , facs , frcs [ c ],*

Peu d’etudes analysent les
repercussions humaines de la
mastectomie. Les auteurs ont fait
deux enquetes chez des mastectomisees
pour analyser les consequences
de la perte du sein chez la patiente
elle-meme et chez sont conjoint.
En plus d’etre une atteinte a la
feminite, la perte d’un sein touche
profondement I’intimite d'un couple
et ebranle fortement la qualite
de vie amoureuse.
This study on the quality of life of
women who have had a mastectomy
has been carried out to illustrate
the side-effects of the loss of
a breast. The patient, herself, as well as
her husband, is often profoundly hurt
by this event; the quality of the
sexual relationship is also deeply
affected.

Le cancer du sein est une maladie
serieuse qui, non guerie, peut entrainer la mort. Les patientes connaissent
cette eventuality et ne l’oublient pas.
Telle une epee de Damocles, plane
le spectre d’une recidive ou d’une
metastase. Dans la therapeutique actuelle a visee curative, le traitement
implique la perte du sein.
L’importance du buste feminin,
comme symbole erotique, a atteint
dans notre societe un summum dont
seuls les publicitaires pouvaient rever.
Organes sexuels et erotiques privilegies, les glandes mammaires sont
devenues, dans la civilisation occidentale, le symbole de la feminite. Comme
le faisait remarquer Margaret Mead,1
“La poitrine feminine a ete tellement
idealisee en Amerique du Nord
qu’elle est devenu la principale source
d'identification de la femme.”
La mastectomie place done la
femme devant de nombreuses difficultes car, en plus de faire face a la
dure realite du cancer, la perte d’un
D u se rv ice de ch iru rg ie generate,
H d le l-D ie u de Q uebec et de I’U niversite
L av a l, Q uebec, PQ
* S ervice de chirurgie generate,
I’H o te l-D ie u de Q uebec
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2 e m e a n n ee
A c ce p te p o u r publication le 28
n o v e m b re , 1980
L es d e m a n d e s de tires a -p a rt doivent
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L ’H d te l-D ie u de Q uebec,
11 , C o te d u Palais, Q uebec, PQ G IR 2 J 6

532

R enee M orint

et

sein porte atteinte a son identity
feminine ainsi qu’a son attrait sexuel.
On soup§onne facilement les conse
quences de la mastectomie. Cependant, peu de travaux ont ete faits
pour montrer la profondeur et la
permanence de la balafre. L'intimite
d’un couple ne se penetre pas facile
ment, mais il parait qu’un couple sur
deux se desunit apres une mastec
tomie.
Cette cicatrice indelebile, physique
et morale, a retenu notre attention et
fait l’objet de la presente etude. Les
resultats sauront interesser principalement les chirurgiens qui pratiquent
la mastectomie. Comme nous, ils
pourront mieux realiser les conse
quences profondes que le geste chirurgical ablatif provoque chez leurs
patientes.
Methodes

V incent B erniert

Objectifs

Nous voulons sensibiliser les therapeutes, principalement les chirurgiens
qui excisent les glandes mammaires
comme traitement du cancer du sein,
aux consequences de la mastectomie.
II nous semble que peu de chirurgiens
s’occupent des problemes psychologiques, moraux, familiaux et sociaux
qui sont le lot des patientes ayant
subi cette operation. Les chirurgiens
sont habitues, par deformation professionnelle, a considerer le cancer
comme une maladie lethale et a evaluer les resultats du traitement chirurgical en fonction de la quantite de
vie plutot que d’apres la qualite de
celle-ci.
II nous parait important de faire
le point sur cette question compte
tenu des resultats obtenus par ces
etudes retrospectives. II nous parait
par ailleurs pertinent de le faire puisque, aujourd’hui, la mastectomie tend
a etre mise de cote en faveur de
techniques conservatrices preconisees
par des therapeutes qui semblent plus
conscients que les chirurgiens des con
sequences de la mastectomie. II ne
faudrait toutefois pas que par sen
timents d’humanisme on nie a la
patiente toute possibility de guerison
en conservant la glande mammaire
cancereuse la oil l’ablation totale est
necessaire. Cependant, une fois mieux
renseigne sur les consequences de la
mastectomie, le chirurgien pourra
mieux aider la patiente et son con
joint a s’adapter a cette nouvelle
situation.

Nous avons fait deux etudes retro
spectives chez des patientes mastec
tomisees. Dans un premier temps,
nous avons, de fajon globale, essaye
d’evaluer le tableau tant physique et
moral que social et familial. Chez
un second groupe de patientes mas
tectomisees, mariees au moment de
l’operation, nous avons explore les
repercussions d’ordre sexuel touchant
l’intimite amoureuse du couple.
Les outils, utilises pour ce travail,
ont ete le questionnaire et l’interview.
Nous avons profite des services d’etudiants dans le cadre du programme
de recherche clinique de la faculte
de medeeine de l’Universite Laval.
II n’est pas facile de juger de l’intensite des sentiments. Aussi avons- Analyse — sommaire
nous adopte la methode des echelles Reaction postoperatoire
analogues (analog scale) decrite par
Lorsqu’un chirurgien annonce a une
Aitken.2-3 Cette methode permet d’e
valuer l’intensite d’un sentiment et de patiente qu’elle doit subir l’ablation
traduire en chiffres sur une echelle la d’un sein, rares sont celles qui requalite de la reponse. Ces chiffres fusent categoriquement; les reactions
peuvent ensuite se traduire en courbe sont souvent minimes et la patiente,
ou en schema pour donner une meil- dans un acte de foi tres normal,
leure appreciation visuelle des repon accepte habituellement cette eventu
ses chiffrees qui nous permettent de alite sans laisser voir ses emotions.
mieux juger le degre d’adaptation de
Dans les suites postoperatoires, les
chacune des patientes.
reactions sont d’intensite variable et
Deux cent cinquante-deux patientes il est surprenant de realiser (tableau
mastectomisees ont repondu au pre I) qu’environ une patiente sur trois
mier questionnaire tandis que 84 pa ne montre ouvertement aucune reac
tientes mariees ont repondu au second tion emotive; une patiente pretendra
questionnaire visant a degager la re meme parfois que la perte du sein
percussion d’ordre sexuel de la mas n’est pas un probleme en soi. La matectomie.
jeure partie des patientes (70 % ) rea-
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gissent cependant avec emotion; habituellement ce sont les infirmieres
qui constatent les pleurs, les crises
de larmes et acceptent les confidences.
Le tableau II illustre comment le
medecin a pu ou su conseiller les
conjoints au sujet des problemes
sexuels engendres par la mastectomie.
II est etonnant de noter que les deux
tiers des patientes avouent ne pas
avoir obtenu satisfaction a leur besoin
d’etre informees; il en est ainsi du
mari. Soit par crainte, soit par gene,
la patiente n’a pas ose questionner
son medecin. D’ailleurs, ceci est fort
comprehensible puisque le milieu hospitalier et l’entourage des professionnels de la sante ne laissent pas souvent
l’occasion d’une bonne conversation.
C’est au retour a la maison que
s’etablit, souvent pour la premiere
fois, la prise de conscience de la
triste realite. Le tableau III montre
clairement Fimportance et l’acuite
des problemes lorsque la patiente se
retrouve seule avec les siens, loin du
contexte hospitalier. C’est d’ailleurs
souvent la premiere fois que la pa
tiente regarde sa plaie, n’ayant pas
eu l’occasion ou le courage de le

T a b le a u

1 - R e a c t io n s

R e a c t io n s
E m o t iv e s
A ucune
S a n s re p o n se

faire a l’hopital. Une fois seule a la
maison, la realite saute aux yeux et
la reaction est plus vive.
Un an plus tard, la readaptation
physique est habituellement completee; la plaie est bien guerie et souple,
le bras a retrouve sa mobilite et il
n'y a plus de sequelle douloureuse a
l’articulation scapulo-humerale. Par
contre, la readaptation psychologique
n’a souvent pas atteint la qualite souhaitable.
Comportement 1 an apres
la mastectomie
Lorsque l’on demande a la patiente
de decrire l’aspect physique de la
mastectomie, on constate qu’apres 1
annee, 50% des femmes inadaptees
decrivent encore la cicatrice comme
laide et repugnante (tableau IV).
Certaines avouent meme ne jamais
se montrer nues et ne jamais se deshabiller devant un miroir ou regarder
leur cicatrice. Dans le groupe de
femmes readaptees, la cicatrice semble
etre plus acceptable et ces patientes
avouent se deshabiller facilement de
vant leur mari et devant un miroir.
Elies n’ont pas d’hesitation a regarder
leur cicatrice.

p o s t o p e r a t o ir e s

P a t ie n t e s , n o . (% )
165 (6 5 .5 )
79 (31 .3 )
8 (3 .2 )

Dans les tableaux V et VI nous
analysons a l’aide d’un questionnaire
les effets de la mastectomie sur les
relations sexuelles. Comme mentionne
plus haut, les patientes ont ete classees en trois groupes selon le type des
reponses.
Globalement, un tiers des mastectomisees seront marquees de fa?on
definitive et leurs relations sexuelles
seront brisees de fapon permanente,
sinon annulees completement. A
l’oppose, un tiers des patientes auront
traverse cette periode avec succes et
en ressortiront grandies; la qualite
des relations sexuelles, quoique changee, connait une intensite plus grande
et plus amoureuse.
En general, les femmes dont la vie
de couple, avant la perte du sein,
etait bonne et significative, obtiennent
un degre d’adaptation meilleur apres
mastectomie (figs. 1 a 3). L’attitude
de la femme et celle du mari, face
a la feminite et a Facte sexuel, a
egalement une importance dans la
capacite de readaptation du couple.
L’analyse des reactions du mari
met en evidence le role que celui-ci
peut jouer pour aider l’adaptation de
son epouse. L’affront, fait a son
epouse, est parfois penible a accepter
et souvent difficile a oublier. L’appetit et le plaisir sexuels sont definitivement atteints chez une proportion
importante de maris (tableau VII).
Toutefois, il n’est pas surprenant de
constater l’entree d’une tierce personne et parfois, la separation defi
nitive du couple.
Conclusions

T a b le a u II— B e s o in d ’ o b t e n i r d e I’ a id e
(n = 84)

R a is o n

No.

%

21

25

42

50

8

9.5

20

23.8

P a t ie n t e a p u d is c u t e a v e c
m e d e c in d e s p r o b le m e s
s e x u e ls
P a t ie n t e a u r a it a im e p o u v o ir
d i s c u t e r d e s p r o b le m e s
s e x u e ls
M a r i a p u s ’ e n t r e t e n ir d e s
p r o b le m e s s e x u e ls a v e c
m e d e c in
M a r i a u r a it a im e p o u v o ir
d i s c u t e r d e s p r o b le m e s
s e x u e ls

FIG. 1—Reponse de la patiente a la
question: “Vous arrivait-il de repousscr
les avances de votre mari?” I = inadaptee, M = mesadaptee, A = adaptee.

Cette etude retrospective a permis
a l’auteur de remettre en question
plus d’une donnee concernant la mas
tectomie et de faire un exercice
d’auto-evaluation penible mais salutaire. A notre avis, tous les chirurgiens, qui pratiquent la mastectomie,
devraient en faire autant pour le be
nefice de leurs patientes.

T a b le a u III— P r o b le m e s a u r e t o u r a la
m a is o n (N = 252)

P r o b le m e s

No.

%

Aucun
P h y s iq u e s
S e x u e ls
E m o t if s e t s o c ia u x

44
194
34
106

17.5
76.9
13.5
42.1

FIG. 2—Reponse de la patiente a la
question: “Ressentiez-vous de la gene a
vous montrer nue devant votre con
joint?"

FIG. 3—Reponse de la patiente a la
question: “Etes-vous satisfaite de vos
relations sexuelles?”

VOLUME 24, NO. 5, SEPTEMBER 1981 / THE CANADIAN JOURNAL OF SURGERY

533

Le chirurgien est un acteur de pre
mier plan dans la maladie cancereuse
du sein. C’est lui qui pratique la
mastectomie et, dans la majorite des
cas, c’est lui qui rcvoit les patientes
aux examens de post-cure. II faut que
le chirurgien realise le traumatisme
psychologique et les repercussions
sexuelles de la perte d’un sein. Nous
avons ete, par formation, interesses
plus particulierement a la quantite de
vie et aux sequelles physiques de la

mastectomie. Cette attitude est correcte, mais doit s’ouvrir sur l’aspect
de la “qualite de vie”. Ce n’est pas
en 1 semaine ou 1 mois que la patiente pourra passer a travers cette
epreuve et en ressortir grandie. La
cicatrisation prend 12 mois a se com
pleter; quant aux sequelles d'ordre
psychologique, certaines patientes ont
hesoin de plusieurs mois, voire de
quelques annees, avant d’en assumer
pleinement les consequences.

T a b le a u I V — P e r c e p t io n d e la m a s t e c t o m ie p a r la fe m m e
s e lo n s o n d e g r e d e r e a d a p t a t io n

Q u a l i f i c a t i f u t il i s e
N a t u r e lle
A c c e p t a b le
R e p u g n a n te
A u tre

R e a d a p te e , %

M e s a d a p te e , %

1 0 .3
7 9 .5
7 .7
2 .6

0
50 .0
4 4 .5
5 .6

In a d a p t e e , %
0
3 7 .5
5 6 .1
6 .3

T a b le a u V — C o m p a r a is o n d u c o m p o r t e m e n t s e lo n le d e g re d e r e a d a p t a t io n ; p e r io d e c o m p r is e
e n t r e 0 e t 1 a n a p r e s la m a s t e c t o m ie

C o m p o r te m e n t

R e a d a p te e , %

C o n s id e r e q u e I ’o p e r a t io n a p o r t e a t t e i n t e a s a
fe m in ite
C r a i n t d e n e p lu s p l a i r e p h y s iq u e m e n t a s o n
c o n jo i n t
R e s s e n t d e la g § n e a s e m o n t r e r n u e
A c c e p t e q u e s o n c o n jo i n t c a r e s s e s o n s e in
D i m i n u t io n d e s m a r q u e s d ’ a f f e c t i o n d e la
p a r t d u c o n jo in t
C r a i n t q u e so n c o n jo i n t r e p o u s s e s e s a v a n c e s
C h a n g e m e n t s d a n s la p r a t iq u e d e s r e la t io n s
s e x u e lle s
P l a i s i r r e s s e n ti e t a i t d i f f e r e n t
I n t e r S t p o u r le s r e la t i o n s s e x u e lle s
D i m i n u t io n d e la f r e q u e n c e d e s r e la t io n s
s e x u e lle s
R e s s e n t d e I ’a n x ie t e f a c e a s e s f u t u r e s
r e la t i o n s s e x u e lle s

M e s a d a p te e , %

In a d a p t e e , %

74 .4

7 7 .8

8 7 .5

73 .6
60 .5
10 0 .0

8 2 .4
8 8 .2
7 5 .0

9 3 .8
9 3 .8
6 2 .5

3 4 .2
40 .5

6 4 .7
5 8 .8

8 7 .5
6 2 .5

4 8 .6
2.7
9 4 .6

7 0 .6
2 9 .4
8 2 .4

1 0 0 .0
5 0 .0
6 2 .5

56 .8

8 2 .4

1 0 0 .0

56 .8

8 2 .4

9 3 .8

T a b le a u V I — C o m p a r a is o n d u c o m p o r t e m e n t s e lo n le d e g r e d e r e a d a p t a t io n ; p e r io d e
s u p e r ie u r e a 1 a n a p r e s la m a s t e c t o m ie

Dans les moyens utilises pour
favoriser l’adaptation, il y a lieu
d'inclure le couple. 11 est essentiel
de rencontrer le conjoint avant l’intervention et au cours de l’hospitalisation. Aussi, au cours des examens
de surveillance post-therapeutiques, le
chirurgien doit faire le point avec la
patiente et lui donner des conseils
judicieux. Nous conseillons a tous
les chirurgiens de demander que le
mari accompagne son epouse. Le
dialogue doit s’installer entre la pa
tiente et son chirurgien et dans cette
dualite, doit entrer le mari.
II est essentiel, a notre avis, que
la mastectomisee recente puisse egalement rencontrer et connaitre une
autre mastectomisee qui a passe a
travers cette epreuve et qui s’y est
adaptee. Cette rencontre de personne
a personne entre deux mastectomisees,
ne peut etre remplacee par celle d’un
professionnel, quels que soient ses
titres et ses qualites humaines. Aussi,
est-il important que des associations
de mastectomisees prennent naissance
et s’organisent afin que des mastec
tomisees visiteuses puissent favoriser
de telles rencontres, aussitot que pos
sible apres l’operation.
Cet article qui resume tres succinctement quelques donnees d’une
double etude retrospective, nous a
permis d’alerter les chirurgiens aux
consequences profondes et intimes de
la mastectomie.
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Bilateral Persistent Sciatic Artery with Bilateral
Aneurysms: Case Report and Review of the Literature
N.S.

V lM L A , M S,*

Persistent sciatic artery is a rare
anomaly, only 33 cases having been
reported to date. A 34th case is
described in this report. The patient,
a 45-year-old man, had bilaterally
persistent sciatic arteries with bilateral
aneurysms and acute ischemia due to
distal embolization. The literature
regarding the embryology, incidence
and the problems of diagnosis and
management of this rare condition is
reviewed. The authors emphasize
that in cases of aneurysm formation
if the sciatic nerve adheres to the
aneurysm no attempt should be made
to excise the aneurysmal sac.
La persistance de I'artere sciatique
est une anomalie rare puisque
seulement 33 cas ont ete signales
jusqu’a maintenant. On decrit ici
un 34e cas. Le patient, un homme
de 45 ans, avait une persistance
bilaterale des arteres sciatiques avec
anevrismes bilateraux, de meme
qu'une ischemie aigue due a une
embolie distale. Les publications
concernant I'embryologie, la frequence
et les problemes de diagnostic
de meme que la conduite a tenir
devant cette affection rare sont
passees en revue. Les auteurs insistent
que, dans les cas d'anevrisme, on
ne devrait pas tenter d'exciser la
poche d'anevrisme lorsque le nerf
sciatique adhere a I'anevrisme.

Persistence of the sciatic artery,
which is the axis artery of the lower
limb, is rare. Up to August 1977, a
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total of 32 patients with this anomaly
had been reported; of 5 who had
aneurysms 4 were treated surgically.
Another case in which the persistent
sciatic artery was found incidentally,
was reported recently by Youngson
and associates.1 We report here the
34th case of persistent sciatic artery
and the fifth patient with aneurysm
treated by operation. To the best of
our knowledge this is the first patient
who had aneurysms bilaterally in
persistent sciatic arteries.

G.S.

L

amba, m dJ

terior tibial artery was next exposed at
the ankle; an embolectomy catheter
could be passed upwards for 80 cm but
the catheter was neither seen nor felt
in the other two incisions. An unusual
developmental anomaly was suspected
and all incisions were closed.
Arteriography performed 4 hours

Case Report
A 45-year-old man was admitted com
plaining of sudden onset of severe pain
and numbness in the right lower leg
and foot. The pain and numbness had
been present for 4 days. He had suf
fered continuous dull pain in the right
gluteal region for the past IVi years
for which he had not been treated. He
was a nonsmoker and denied any history
of trauma, hypertension, diabetes or
syphilis. He was obese, but was normotensive with normal heart beat. The
right lower leg and foot were cold and
of a dusky colour; the pedal pulses were
absent. Popliteal and femoral artery
pulses on the same side were normal
as were the arterial pulses in the rest
of the body. There was an ill-defined
pulsating mass (8 cm X 6 cm) with a
harsh systolic bruit in the right gluteal
region. Systemic examination revealed
no other abnormality.
A clinical diagnosis of acute ischemia
of the right leg possibly due to embolism
(source unknown) with an aneurysm of
the inferior gluteal artery was made.
The differential blood count and
blood levels of sugar and urea nitrogen
were normal as were the electrocardio
gram and roentgenogram of the chest;
the VDRL test was nonreactive.
In view of the severe ischemia, sur
gical exploration was carried out 6
hours after admission. An anteromedial
approach to the proximal portion of
the popliteal artery was made but no
large arterial trunk was seen in the
upper popliteal fossa and the lower part
of the adductor canal. The femoral
artery was then exposed at the groin.
This was of smaller size than normal
and the deep femoral artery arose im
mediately below the inguinal ligament.
Through the femoral arteriotomy an
embolectomy (Fogarty) catheter could
be passed down to the mid-thigh but
no clots could be extracted. The post-

Fig. lb
FIG. 1—(a) Arteriogram showing bi
lateral persistent sciatic arteries, with
saccular aneurysm at trochanteric level
on right side and small fusiform dilata
tion in intrapelvic course on left side,
(b) I.ine diagram of (a). External iliac
system is shown with white margins.
Arrows show persistent sciatic arteries
and aneurysms.
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later through the left femoral artery by
the Seldinger technique showed that
both internal iliac arteries were larger
than the external iliac arteries and
coursed outside the pelvis as persistent
sciatic arteries. On the right this vessel
had a saccular aneurysm (3.5 cm x
3.5 cm) at the level of the greater
trochanter and on the left side there
was a small dilatation in its intrapelvic
course (Fig. 1). Both sciatic arteries
coursed behind the femur and continued
as the popliteal arteries. There were
multiple filling defects in the calf vessels
on the right side due to emboli.
A second operation was carried out
soon after, through a posterior incision
in the popliteal fossa and the ankle
incision was reopened. Small organized
thrombi were removed by ante- and
retrograde flushing through the distal
popliteal and posterior tibial arteries.
The limb warmed up immediately and
the pedal pulses were present the follow
ing day.
Three weeks later through a postero
lateral incision in the right gluteal
region, the sciatic artery and the aneu
rysm were exposed by splitting the fibres
of the gluteus maximus muscle. The
aneurysm measuring 8 cm X 6 cm
extended from just distal to the lower
border of the piriform muscle and the
sac was densely adherent to the adja
cent sciatic nerve. The artery proximal
and distal to the aneurysm was dissected
free, ligated near the sac and divided.
The sac was opened, intramural throm
bus removed and ostia of three major
arterial branches were transfixed from
within. In view of the dense adhesion
to the fibres of the sciatic nerve no
attempt was made to excise the sac.
Arterial continuity was restored with an
8-mm Dacron interposition graft (Fig.
2). The intramural thrombus was sterile
on culture. Recovery was smooth. All
distal pulses were palpable. The patient
has been followed up for more than 2
years and remains asymptomatic.

Discussion
The sciatic artery, the axis artery
of the lower limb, normally disap
pears about the 33-mm stage of the
embryo.2 It normally becomes frag
mented into discontinuous contribu
tions to lesser vessels as the formation
of the femoral system progresses on
the flexor surface of the limb. Soon
after the development of the axis
artery from the umbilical artery, the
femoral artery develops as a lateral
branch of the external iliac and its ter
minal end divides into descending
genicular and ramus communicans
superior arteries. The latter com
municates with the lower part of the
axis artery. From this junction the
popliteal artery descends, being fed
by both these vessels. About this time
the proximal parts of the deep
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femoral and the lateral femoral cir
cumflex arteries start developing from
multiple channels called rete femoralis. T he sciatic artery now starts its
fragmentation and the only parts that
persist in later life are the proximal
portion of the inferior gluteal arteries
and the terminal portions of the third
and fourth perforating branches of
the deep femoral artery. The distal
portion of the axis artery continues
as the peroneal artery (Fig. 3).
The persistent sciatic artery may
be complete providing the major
blood supply to the limb or it may
be incomplete when its continuity is
broken or when it anastomoses with
the internal iliac or the popliteal
artery by small collateral channels.
The complete sciatic artery con
tinues from the internal iliac, gives
off superior gluteal and internal
pudendal branches and passes through
the lower part of the greater sciatic
foramen below the piriform muscle.
Its relation to the sciatic nerve is
variable. It may be in the sheath of
the nerve, the nerve being flattened
over the vessel; it may be adherent
to the tibial division of the nerve or
it may accompany the posterior
cutaneous nerve of the thigh. In the
thigh the artery lies under the glu
teus maximus and hamstring mus
cles, coursing over the posterior aspect
of adductor magnus whose insertion
it crosses to enter the popliteal fossa
to become continuous with the
popliteal artery.
Although persistent sciatic artery
was first described by Green3 in 1832,
the first angiographic documentation
was provided by Cowie and collea
gues1 in 1960. Of the 33 examples
reported 22 have been in cadavers.4
Three of the persistent sciatic arteries
have been incomplete and 30 com
plete. Of the complete group only
one patient did not have an external
iliac-femoral system.4 In the rest (29)
the degree of hypoplasia of the fe
moral system was variable, the artery
terminating as the profundo-circumflex complex in 2, at the adductor
hiatus level in 8 and in the popliteal
fossa in 11 with or without com
munication with the popliteal artery.
In eight patients no details of the
femoral system were given. Eight of
the 33 examples reported had bi
lateral persistence of the sciatic
artery.5
Of the 11 clinical cases reported
4 patients presented with aneurysms,
tender gluteal masses with calf claudi
cation,6 gluteal swelling with gan
grenous toes,7 painful gluteal masses
with claudication due to obstructed

aneurysm8 and a gluteal mass with
radiating pain in the limb.9
Other modes of clinical presenta
tion have been a shorter limb with
claudication and varicose veins,1 hemihypertrophy of pelvis and lower limb
with multiple capillary hemangiomas
and varicose veins,10 gangrene of the

F IG . 2— (a) D iagram m atic representa
tion of operative findings showing inti
mate relation o f sciatic nerve to aneurysm,
(b) Completed operative procedure, showopened aneurysm al sac and “inlay” D a
cron graft.

F IG . 3— D evelopment of lower limb
arteries; interrupted line represents sciatic
artery system which norm ally-disappears
in adult (after Senior2).
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foot due to occlusion of the sciatic
artery11 and pulmonary emboli with
right-sided weakness.12
Bower and associates5 reported two
patients; one had acute ischemia of
the distal leg and foot and in the
other the anomaly was an incidental
finding, femoral artery occlusion
being present on the contralateral
side.
Our patient therefore is the 34th
with persistent sciatic artery to be
reported in the literature, the 9th to
have this anomaly bilaterally and 5th
with an aneurysm of this vessel re
paired surgically. Because of the
presence of a small aneurysmal dilata
tion on the opposite side we con
sider our patient to be the first re
ported with bilateral aneurysms.
The cause of aneurysms in this
vessel is not clear from the reported
cases. In two patients the VDRL test
result was positive but in the others
a congenital weakness of the vessel
wall or recurrent trauma due to a
vulnerable position on the extensor
aspect of the limb have been blamed.
Since our patient had a negative
VDRL test result and because one of
the aneurysms was in the intrapelvic
portion some developmental weakness

in the arterial wall seems the likely
cause.
The common presence of a palpable
femoral artery pulse makes clinical
diagnosis difficult. If the popliteal
and pedal pulses are normal but the
femoral pulse is not palpable this
condition should be strongly sus
pected, even though this situation
has been reported in only one patient.
Angiography may also fail to diag
nose the condition unless the entire
iliac system is studied in all patients
with limb ischemia or pulsatile gluteal
masses. This is important because the
sciatic artery may be the dominant
source of blood supply to the lower
limb and sacrifice of it might be
disastrous.
Although Bower and associates5
recommended that reconstruction
should be carried out from the
femoral to the available distal artery
in order to avoid the extensor sur
face of the limb, in all the aneurysms
reported so far, including our patient,
repair has been carried out on the
sciatic artery itself. It must be em
phasized that if the sciatic nerve is
adherent to the aneurysm no attempt
should be made to excise the aneurys
mal sac.
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Double-Channel Pylorus: Congenital or Acquired?
E.Q. A rch a m po n g ,

m b , m s ( l o n d ) , fr c s , f r c s ( e d in ) , * R.J.
I. B o u l t , m d , f r c p [ c ]

It is d iffic u lt to decide on the best
m ethod of management fo r the
double-channel pylorus because there
is no agreement as to w hether th is
uncommon condition is congenital or
acquired. Of 60 cases reported in
the lite rature 55 were associated w ith
peptic ulcer disease strongly
suggesting an acquired origin. A
congenital origin should be accepted
only if specific crite ria obtain:
(a) presence in early childhood, (b)
presence of mucosa, lamina propria
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and m uscularis mucosae on m icroscopic
exam ination and (c) characteristic
find in gs at fluoroscopic exam ination.
The authors report three patients
w ith a double-channel pylorus. In one
a pre pyloric ulcer im m ediately preceded
the developm ent o f the false
antroduodenal channel. The other
patients had peptic ulcer disease.
A ll were treated conservatively.
O peration is unnecessary except fo r
com plications that may arise. The
authors' cases dem onstrate that
unless the diagnosis of double-channel
pylorus is considered the radiologic
and endoscopic findings may be
m isinterpreted.
II est d iffic ile de decider sur ce qui
co n stitu e la m eilleure methode
de tra ite m e n t pour un dedoublem ent
du pylore puisqu'on ne s ’entend
pas sur I'origine congenitale ou acquise
de cette affectio n rare. Sur les
60 cas qui ont ete signales dans
la litte ra tu re , 55 etaient relies a un
ulcere gastro-duodenal, ce qui

suggere fo rte m e n t une origin e acquise.
Une o rigin e congenitale ne p o u rra it
e tre acceptee que s ’il e x is ta it des
crite re s bien specifiques: a) la
presence de I'a ffe ction des le to u t
jeune age, b) la presence d'une
muqueuse, du chorion d ’une m em brane
muqueuse e t d'une m usculaire
m uqueuse a I'examen m icroscopique
e t c) des observations cara cte ristiq u e s
au fluoroscope.
Les auteurs signalent tro is pa tie n ts
ayant un dedoublem ent du pylore.
Dans un cas, un ulcere prepyloriq ue
preceda im m ediatem ent I’appa rition
de la fausse voie antro-duodenale.
Les autres malades so u ffra ie n t d'un
ulcere gastro-duodenal. Les pa tie n ts
fu re n t tous tra ite s de faqon
conservatrice. L'operation n 'e s t pas
necessaire sauf s’il su rvie n t des
com plications. Les cas d e c rits par les
auteurs dem ontrent qu'a m oins que
le diagnostic de dedoublem ent du
pylore s o it envisage, les ob serva tions
radiologiques et endoscopiques
peuvent e tre mal in te rpre te es.
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Congenital anomalies of the pyloroduodenal area, namely pyloric dia
phragm ,1"1 duodenal atresia, imper
forate pyloric web and annular pan
creas, are relatively uncommon com
pared with the acquired lesions of
this area associated with peptic ulcera
tion. Penetration of a peptic ulcer
into a hollow organ such as trans
verse colon or a solid organ such as
pancreas is a familiar occurrence and
there is little doubt about the etiology
of the resulting fistula. Rarer, but
more impressive fistulas between
stom ach and gallbladder5 and pleural
or pericardial cavity6'7 may occur, but
their origin in preexisting gastric
ulcers is seldom in doubt. Because a
gastroduodenal fistula is less symp
tom atic, the double-channel pylorus
is often considered to be of con
genital origin rather than a complica
tion of ulcer disease.
We report three patients with a
double-channel pylorus all showing
clinical features suggesting progres
sion from preexisting peptic ulcers.
In one patient, the course of the
change could be traced radiologically.
C ase R eports

Case 1
A 52-year-old woman presented at
the Health Sciences Centre primary care
unit on Jan. 1, 1980, with severe abdo
minal pain. She had experienced similar,
though less severe, episodes of epi
gastric pain intermittently for 3 to 4
months, each episode lasting about 2
hours. The attacks were precipitated or
aggravated by fatty foods and alleviated
by antacids. More recently, the pain
was awakening her from sleep. There
was no association with a change in
posture. She had been taking no medica
tions. Hypertension, diagnosed 6 years
earlier, was controlled by hydrochloro
thiazide which she had stopped taking
3 months before. The patient had been
a heavy weekend drinker until June
1979 w-hen she stopped drinking. She
was still drinking large amounts of tea
and coffee, and she smoked half a
package of cigarettes daily.
She was an obese, anicteric woman
but, except for a blood pressure of
170/110 mm Hg, cardiopulmonary
disease was not evident. The abdomen
was flat and soft, with minimal epi
gastric and right upper quadrant ten
derness. Murphy’s sign was negative.
An oral cholecystogram showed a
normal gallbladder. Roentgenography
after barium swallow, performed on
Jan. 17, revealed a 1.5-cm prepyloric
ulcer on the lesser curvature (Fig. 1).
Gastroscopy, performed on Feb. 6,
showed a normal esophagus, but the
gastroesophageal junction was high, sug
gesting that she had a hiatus hernia.
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The gastric mucosa appeared injected,
but there were no erosions. The prepy
loric ulcer was not seen. At the pylorus
two channels were seen; each admitted
the gastroscope into the duodenum
(Fig. 2). The mucosa at the orifice of
each channel was smooth and intact.
The lining of the uppermost channel
could not be seen properly. A biopsy
specimen of the septum between the
two channels showed normal gastric
mucosa. The duodenal mucosa appeared
injected. A review of the previous roent
genogram confirmed that there had
been no double channel at that time.
A subsequent roentgenogram done after
barium swallow on Feb. 22, 1980
showed a well established double chan
nel with no prepyloric ulcer (Fig. 3).
In the interval between the first roent
genogram and the gastroscopy, the
patient became asymptomatic and has
remained so, even after she stopped
taking cimetidine.
Case 2
A 61-year-old man had a history of
repeated vomiting, culminating in frank
hematemesis. Twelve years earlier he
had had a duodenal ulcer with hemate
mesis. He smoked 30 cigarettes a day,
he was taking no medications and had
no allergies.
On admission the patient appeared
pale. He had no icterus and no signs
of liver disease. Cardiorespiratory func
tion was satisfactory. The abdomen was
slightly tender in the epigastrium with

FIG. 1— Case 1. Prepyloric ulcer.

FIG. 2— Case 1. Endoscopic photo
graph shows openings to two pyloric
channels. Upper opening leads to false
channel.

no guarding or masses. His hemoglobin
value was 8.9 g/dl. He was given blood
transfusions and cimetidine intravenous
ly. Gastroscopy the following day re
vealed a mucosal tear at the esophageal
junction which was not actively bleed
ing. The gastric mucosa showed several
erosions with altered blood clots. The
duodenum was readily entered and
seemed normal, with no bleeding. Upon
withdrawing the gastrocope, however,
a second opening adjacent to the pylorus
was seen. This led to a channel that
contained fresh blood. Roentgenography
of the stomach and duodenum after
barium swallow confirmed the presence
of a double pyloric channel (Fig. 4).
By the fourth hospital day the patient’s
hemoglobin level was stable at 10.9
g/dl; he was asymptomatic and insisted
on leaving hospital.
Case 3
A 71-year-old housewife had suf
fered from rheumatoid arthritis for 16
years. Initially the condition was treated
with salicylates, but 1 year later pred
nisolone (5 mg once a day) was sub
stituted because of lack of response.
She had taken this dosage since; the
disease had slowly progressed. Suddenly
in May 1977 she had an episode of
hematemesis for which she was hospi
talized and treated conservatively;
endoscopic examination showed that the
bleeding was from a gastric ulcer which
healed with rest and antacids.
In October 1979. she complained of
epigastric pain and heartburn; roent-

FIG. 3— Case
1.
Roentgenogram
showing pyloric channel entrance and
false channel.

FIG. 4— Case 2. Normal pyloric chan
nel and pyloroduodenal fistula.
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genography after a barium meal showed
a prepyloric ulcer. She was put on a
course of cimetidine which relieved her
symptoms within a week. Her cimetidine
dosage was reduced and then discon
tinued in November. A roentgenogram
at that time showed that a pyloroduodenal fistula had formed (Fig. 5). The
patient refused to undergo gastroscopy.
She has remained asymptomatic and is
currently taking prednisolone (7.5 mg/d)
for her arthritis and Inderal (20 mg
qid) for hypertension.

Discussion
There is no agreement on the
mechanism by which this unusual
anatomic entity develops. This makes
for problems in management and in
assigning a name to the condition.
The etiology is either congenital or
acquired (related to gastroduodenal
fistulas arising from an ulcer). Gould3
in 1961 described three types of
abnormal connection between the
stomach and duodenum: type 1 joins
the middle or lower third of the lesser
gastric curvature to the first part of
the duodenum; type 2 connects the
posterior aspect of the stomach to the
third or fourth part of the duodenum
and type 3 connects the distal antrum
with the first part of the duodenum:
our cases were type 3. Of 60 cases
of double-channel pylorus (type 3)
that have been published to date,*'15
in only 5 did the patient appear to
be completely free of ulcer disease.11’5
Only one of these five15 showed
radiologic and endoscopic appear
ances strikingly different from the
ulcer-associated cases. The disting
uishing features were that the chan
nel was longer, it was on the great
er curvature of the stomach and
had normal gastric mucosal folds
passing through it. This case was also
remarkable in demonstrating histolo
gically not only full intestinal dif
ferentiation (mucosa, lamina propria
and muscularis mucosae), but also

radiologic evidence of active contrac
tion of the contained muscle. More
over, there was heterotopic pancreatic
tissue to support the claim of an
embryologic origin of the defect in
this patient. The frequent association
of double-channel pylorus with peptic
ulcer disease, clearly demonstrated in
55 of 60 cases, strongly suggests that
the condition is secondary to peptic
ulceration. It would need to be
established that the ulcer precedes
the appearance of the channel and
this is precisely the situation in 30 of
the 55 reported ulcer-associated cases.
Our three cases, like those reported
by Rohde and associates,16 Pandarinath and colleagues17 and Drapkin
and associates18 demonstrate this. It
is also notable that all these patients
had relief of their symptoms when
the fistula was established.
Rokitansky111 suggested that such a
fistula could arise from two ulcers
— a prepyloric and duodenal ulcer
approaching each other. Since he did
not report any cases, it is difficult
to know how often this may occur.
It is interesting that although duo
denal ulcers comprise 80% of peptic
ulcer disease,15 in all but four patients
with a double pyloric channel re
ported in the literature, the ulcer was
in the prepyloric area.
The literature does not present a
consensus on the most suitable method
of management of the double-channel
pylorus mainly because of the debate
over its etiology. Most authors ad
vocate a conservative approach since
the symptoms appear to remit once
the fistula forms, providing, as it
were, a spontaneous pyloroplasty.11
This approach cannot be entirely ac
cepted because there are no indica
tions of the outcome when patients
are seen at the time of their initial
ulcer attacks. The prospects of mal
ignant change even in the case of
prepyloric ulcers usually encountered
also require consideration. In general,
if multiple endoscopic biopsy speci
mens show no malignant changes
conservative treatment with cimeti
dine is effective. Regular follow-up is
essential, and this applies in parti
cular to patients treated initially for
bleeding. If operation should be re
quired because of recurrent bleeding
or delayed healing, Billroth I gastrec
tomy or septal division followed by
vagotomy and pyloroplasty for the
prepyloric ulcer are possible. We
favour the latter procedure.
Conclusions

FIG . 5— Case 3. Pyloroduodenal fistula.

The double-channel pylorus, which

is being reported with increasing fre
quency, is closely related to antroduodenal peptic ulcer disease. A
double-channel pylorus may arise
congenitally, but the evidence cur
rently is that this is much rarer — a
ratio of at least 1:11. Features sug
gesting a congenital origin are: (a) no
history of ulcer, (b) diagnosis early
in life, (c) appropriate histologic
characteristics including the presence
of mucosa, lamina propria and mus
cularis mucosae and (d) a radiologically demonstrable channel that not only
shows normal gastric or duodenal
mucosa but also normal contractility.
Whether congenital or acquired, the
long-term management of this con
dition is at the moment not clear.
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Sterile

Solu-Medrol
(methylprednisolone sodium succinate)
Action:

Solu-Medrol, like other corticosteroids, exerts its action
by its anti-inflammatory effect.
Indications and Clinical Uses:

Intravenous administration of Solu-Medrol is indicated
in situations in which a rapid and intense hormonal
effect is required.
Shock:

In severe shock adjunctive use of intravenous methyl
prednisolone sodium succinate (Solu-Medrol) may aid
in achieving hemodynamic restoration. Corticoid
therapy should not replace standard methods of
combating shock, but present evidence indicates that
concurrent use of large doses of corticoids with other
measures may improve survival rates. In particular,
large pharmacological doses of Solu-Medrol have been
proven useful in bacteremic or endotoxin shock,
hemorrhagic shock, traumatic shock, and cardiogenic
shock.
Contraindications:

Except when used for short-term or emergency therapy
as in acute sensitivity reactions, Solu-Medrol is
contraindicated in patients with arrested tuberculosis,
herpes simplex keratitis, acute psychoses, Cushing’s
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:

Existence of diabetes, osteoporosis, chronic psychoses,
active tuberculosis, renal insufficiency or predisposition
to thrombophlebitis requires that Solu-Medrol be
administered with extreme caution. In the presence of -f
infection, the causative organism must be brought
under control with appropriate anti-bacterials, or
therapy with Solu-Medrol should be discontinued.
While therapy with corticoids does not appear to be
contraindicated in pregnancy, caution is recommended,
particularly during the first trimester. Also, newborn
infants of mothers who received such therapy during
pregnancy should be observed for signs of hypoadrenalism and appropriate measures instituted if such
signs are present. Since Medrol, like prednisolone, sup
presses endogenous adrenocortical activity, it is highly
important that the patient receiving Solu-Medrol be
under careful observation, not only during the course
of treatment but for some time after treatment is
terminated. Adequate adrenocortical supportive
therapy including ACTH, must be employed promptly
if the patient is subjected to any unusual stress such as
surgery, trauma, or severe infection. Patients should be
advised to inform subsequent physicians of the prior
use of Solu-Medrol.
There have been a few reports of cardiovascular
collapse associated with the rapid intravenous admini
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause
and relation to other medications (i.e., diuretics) is not
known at this time, but physicians should be alert to
this possibility.
Adverse reactions are not likely to result from short
term intravenous administration of Solu-Medrol, but
may be anticipated if continued therapy with oral or
intra-muscular corticosteroid preparations is to follow.
Medrol has less tendency than prednisolone to induce
retention of sodium and water, and in some cases has
been observed to produce diuresis and an increased
excretion of sodium. Likewise, therapy with Medrol
appears to produce less nervousness and psychic
stimulation than that produced by prednisolone. While
epigastric distress has not been totally lacking in
patients receiving Medrol, the incidence and severity of
this side reaction to date suggest that although Medrol
has an enhanced anti-inflammatory potency when com
pared with prednisolone on a weight basis, the socalled ulcerogenic potential of this corticosteroid is no
greater, and may even be less, than that of
prednisolone.
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Symptoms and Treatment of Overdosage:

Single large doses of Solu-Medrol do not have any
apparent toxic effect and require no specific therapy.
Continuous overdosage would require careful gradual
reduction of dosage in order to prevent the occurrence
of acute adrenal insufficiency.
Dosage and Administration:

In treating severe shock there is a tendency in current
medical practice to use massive (pharmacological)
doses of corticosteroids. The following are Solu-Medrol
doses suggested by various authors:
Author

Dose

Repeat

Oaks
Weil
Melby
Cavanagh
Dietzman

100 mg
200 mg
250 mg
15 mg/kg
30 mg/kg

Every 2-6 hours
100 mg. every 4-6 hours
Every 4-6 hours
Every 24 hours
In 4 hours if needed

Therapy is initiated by administering Solu-Medrol
intravenously over a period of at least 10 minutes. In
general high dose corticosteroid therapy should be
continued only until the patient’s condition has
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose
short term corticoid therapy are uncommon, peptic
ulceration may occur.
In other indications initial dosage will vary from 10 to
500 mg depending on the clinical problem being
treated. The larger doses may be required for short
term management of severe, acute conditions. The
initial dose usually should be given intravenously over
a period of at least 10 minutes. Subsequent doses may
be given intravenously or intramuscularly at intervals
dictated by the patient’s response and clinical
condition.
Availability:

As Solu-Medrol (methylprednisolone sodium succinate)
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials
with water for injection.
Product monograph is available on request.

Adverse Reactions:

With the exception of the differences noted in the
preceding paragraph, Medrol is similar to hydro

cortisone and prednisolone in regard to the kinds of
adverse reactions and metabolic alterations to be
anticipated when treatment is intensive or prolonged.
Negative nitrogen balance is usually counteracted by a
high protein intake. In patients with diabetes mellitus,
Solu-Medrol may increase insulin requirements during
the period of administration. Ecchymotic manifesta
tions, while noted only rarely during the clinical
evaluation of Medrol, may occur. Excessive loss of
potassium is not likely to be induced by effective
maintenance doses of Medrol. If such reactions are
serious or distressing to the patient, reduction in
dosage or discontinuance of corticoid therapy may be
indicated. While a retardant effect on wound healing is
seldom encountered, except in high doses, it should be
a matter of consideration when Solu-Medrol is admin
istered in conjunction with surgery.
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Surgical Symposium
The division of general surgery, Uni
versity of Ottawa School of Medicine
is pleased to announce that the third
annual November surgical symposium
will be held November 13 and 14,
1981 at the Hotel Plaza (formerly the
L’Auberge de la Chaudiere) in Hull,
Quebec. The program will deal with
a variety of problems of interest to
general surgeons. In addition to local
faculty, guests include Drs. John
Sawyers, professor of surgery, Vander
bilt University, F.G. Pearson, professor
of surgery, University of Toronto and
Marvin J. Wexler, assistant professor
of surgery, McGill University.
For additional information please
contact Dr. J.L. Wellington, Chairman,
program committee, November sur
gical symposium, department of sur
gery, Ottawa General Hospital, 501
Smyth Rd., Ottawa, Ont. K1H 8L6.
BOOK REVIEWS
(continued from page 531)
DEVELOPMENTS IN DIGESTIVE
DISEASES. Edited by J. Edward Berk.
258 pp. Ulust. Lea & Febiger, Phila
delphia, 1980. $28.75 (Can.). ISBN
0-8121-0754-3.

The third edition of this series has been
written primarily with the medical gas
troenterologist in mind. The articles are
essentially comprehensive reviews of
current diagnostic and therapeutic me
thods, as well as newer concepts in the
area of digestive disorders.
Unfortunately, the book contains, little
of direct interest to the practising sur
geon. Of 13 topics covered, only the
section on proximal gastric vagotomy has
surgical content. Another chapter on
nonsurgical biliary decompression is of
extreme interest to the general surgeon,
but, as the title suggests, has no surgical
content.
The other subjects covered are endo
scopic control of gastrointestinal bleed
ing, enteral hyperalimentation, biofeed
back, breath tests, functional scintigra
phy; two chapters on inflammatory
bowel disease; immunologic develop
ments and genetics, viral hepatitis, in
fectious diarrhea, bowel hormones, hor
mone candidates and somatostatin.
Altogether, this is an attractive and
informative volume. It will be especially
useful to students preparing for their
fellowship examinations and to practi
tioners anxious to know the latest in
the field of digestive diseases.
ISADORE W . W EIN TRU B, MD, FRCP[C]

PAAB
CCPP
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Preoperative Liver Biopsy and Survival
after Portasystemic Shunting
A rnold P. L ang,

md , fr cp [c],*

Shirish P atel ,

M. J am es P h il l ip s ,

The value of preoperative liver biopsy
in predicting the outcome of
portasystemic shunting was
investigated. Using coded slides,
the authors examined liver biopsy
specimens from 41 patients with
alcoholic cirrhosis who underwent
portasystemic shunting. The degree
of fatty change, alcoholic hyalin,
alcoholic hepatitis, central hyalin
sclerosis and the activity and severity
of the cirrhosis were assessed and
possible correlations were noted
with the preoperative Child’s
classification, postoperative
encephalopathy and with early and
late mortality. A correlation was
found between the presence of
alcoholic hyalin in more than 10% of
hepatocytes and early mortality;
all of the six patients who died within
30 days of operation had this
finding in the liver biopsy specimen.
Early mortality correlated better with
alcoholic hyalin than with the Child's
classification. There was some
correlation between late mortality
and the degree of hyalin sclerosis
and with the activity and severity of
cirrhosis. The authors conclude that
the findings of a liver biopsy done
preoperatively are valuable in indicating
prognosis and operative mortality in
alcoholic cirrhosis.
On a etudie la valeur de la biopsie
hepatique preoperatoire pour predire
les resultats de I'anastomose
porto-systemique. A I’aide de
diapositives codees, les auteurs ont
examine les biopsies hepatiques
de 41 malades souffrant de cirrhose
alcoolique chez qui on pratiqua
une anastomose portosystemique.
Le degre de steatose, la presence
de corps de Mallory, I'hepatite
alcoolique, la sclerose hyaline centrale
et I'activite et la gravite de la
cirrhose ont ete evalues et les
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correlations possibles ont ete
recherchees avec la classification
preoperatoire de Child, I'encephalopathie postoperatoire et la mortalite
precoce et tardive. Une correlation
a ete retrouvee entre la presence des
corps de Mallory dans plus de 10%
des hepatocytes et une mortalite
precoce; les six malades qui sont
decedes dans les 30 jours qui
suivirent I'operation presentaient
tous cette observation dans la
biopsie hepatique. La mortalite precoce
a montre davantage de correlation
avec la presence de corps de Mallory
qu’avec la classification de Child.
On a constate une certaine correlation
entre une mortalite tardive et le
degre de sclerose hyaline ainsi
qu’avec I'activite et la gravite de la
sclerose. Les auteurs concluent
que la biopsie hepatique pratiquee
avant I'operation est un indicateur
utile du pronostic et de la mortalite
peroperatoire dans la cirrhose
alcoolique.

There have been promising reports
of prolonged survival after the newer
types of portasystemic anastomoses.1-3
The role of preoperative liver biopsy
in predicting survival of portasystemic
anastomoses and in deciding whether
to perform a shunt has been the sub
ject of a number of recent articles,
which reach opposing conclusions.4-9
This report is based on a semiquantitative assessment of morphologic
variables in liver biopsy specimens
from patients with alcoholic cir
rhosis who subsequently had porta
systemic shunting. The relation of
these variables to operative and late
survival is discussed.

necrosis of liver cells, leukocyte infil
tration, hyalin, swollen hepatocytes),
(c) central hyalin sclerosis and fibro
sis (fibrosis and obliteration of central
[terminal hepatic] veins) and (d) cir
rhosis. Alcoholic hepatitis was graded
as absent, mild, moderate or severe.
Alcoholic hyalin alone was also graded
separately according to the percentage
of hepatocytes that contained it:
absent, 1+ (less than 5% ) (Fig. 1), 2 +
(5% to 10%) (Fig. 2) and 3 + (great
er than 10%) (Fig. 3). Central hyalin
sclerosis and fibrosis were graded as
absent, mild, moderate or severe.
Cirrhosis was classified as incomplete
or complete and inactive or active.
Activity was considered present if
there was inflammation, necrosis or
active fibrosis at the margins of
nodules. The slides were coded and
before final histologic grading were
examined on two different occasions
without knowledge of the patient’s
clinical status. The slides were de
coded and these histologic variables
were then correlated with the clinical
risk category according to Child’s
classification10 — the postoperative
mortality (defined as death occurring
within 30 days of operation), the late
mortality and the development of
encephalopathy.
During the same period 34 patients
(controls) treated medically were as
sessed in a similar fashion.
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Patients and Methods

In this study were 41 patients
with portal hypertension resulting
from alcoholic cirrhosis of the liver
who had a shunt and who underwent
preoperative or operative liver biopsy,
or both. A semiquantitative assess
ment of four histologic variables in
the liver biopsy was made: (a) alco
holic hyalin (beadlike clumps of peri
nuclear eosinophilic material consist
ing of swollen fragmented cell orga
nelles), (b) alcoholic hepatitis (focal
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(hematoxylin and eosin, reduced by 63%
from X 250).
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Results
Six patients died early; of these,
two had moderate and four had severe
alcoholic hepatitis. One patient with
severe and five patients with moderate
alcoholic hepatitis survived the post
operative period (Table I). There was
a striking correlation between the
presence of alcoholic hyalin in the
preoperative liver biopsy and early
death. All six patients who died early
had hyalin in more than 10% (3+ ) of
hepatocytes (Fig. 3) whereas none of
the patients with less than 10% hyalin
died in the postoperative period (Table
II). In contrast, nine patients in the
control group were found to have
3 + hyalin; all survived hospitalization
and two patients survived 2 years
after biopsy.
Indications of more chronic liver
damage, central hyalin sclerosis and
fibrosis and the activity of cirrhosis
did not correlate with early mortality
but did correlate, though not signifi*
*»*'»* j
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cantly, with late mortality in the
follow-up period. Of those with severe
central hyalin sclerosis, 46% died
in the follow-up period compared
with 20% of those with mild or
absent sclerosis (Table III). Thirtyseven percent of those with active
advanced cirrhosis died compared
with 31% of those with inactive

advanced cirrhosis (Table IV).
Child’s classification showed some
correlation with early death in that
no one in the A group died postoperatively. However, some patients
survived operation despite being in
the high clinical risk categories,
Child's group B or C (20 of 23 in
group B and 4 of 7 in group C)

Table 1 -R ela tio n of Alcoholic Hepatitis, C hild’s Classification and Early Death
C hild’s group
Alcoholic
hepatitis

No. of
patients

Absent
Mild
Moderate
Severe

19
10
7
5

Table II

A

B

6
4

Early
deaths

C
11
4
7
1

1

2
2
3

Degree of Hyalin Necrosis and Operative Survival

Alcoholic hyalin

% hepatocytes
w ith hyalin

No. shunted

Survivors

Deaths

Mikkleson, 1974s

Absent
1+
2+
3+

0
<5
5 to 25
>25

19
6
3
1

18
6
1
0

1
0
2
1

This series

Absent
1+
2+
3+

0
<5
5 to 10
>10

19
11
5
6

19
11
5
0

0
0
0
6

72

62

10

Series

Total
# *

*•

‘

*

%

*

#

'

0
0
2
4

M'

•
Table III— Relation of Central Hyalin Sclerosis and Late Death
*
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Central hyalin
sclerosis
j

*’
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FIG. 2—Hyalin in 5% to 10% of
hepatocytes (2+ ) (arrows) (hematoxylin
and eosin, reduced by 53% from x 250).

Absent
Mild
Moderate
Severe

No. of
patients

Operative
survival, no.

5
6
12
17

4
6
11
13

Late deaths,
no. (% )
1
1
4
6

(25)
(16.7)
(36.4)
(46.2)

Table IV— Relation of Cirrhosis and Late Death

Cirrhosis
Incomplete
Inactive advanced
Active advanced

No. of
patients

Operative
survival, no.

1
16
24

—

Late deaths,
no. (% )
—

16
19

5 (31.3)
7 (36.8)

Table V - Relation of Alcoholic Hyalin, C hild’s Classification and Early Death
C hild’s group
Alcoholic
hyalin

FIG. 3—Severe alcoholic hepatitis with
ballooning and 3 + hyalin (hematoxylin
and eosin, reduced by 53% from x250).
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Absent
1+
2+
3+

No. of
patients
19
11
5
6

A

B

C

5
4
2

12
5
3
3

2
2
—

Early
deaths
—
—
—

3

6
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(Table V). Thus, the Child’s grouping
was not as useful as was the extent
of alcoholic hyalin in predicting the
outcome in any individual case.
No correlation was found between
the development of encephalopathy
and any of the liver biopsy findings.
Discussion

This study indicates that in a liver
biopsy specimen obtained before
portasystemic shunting, the percent
age of hepatocytes containing alco
holic hyalin is an important prognostic
indicator of postoperative survival.
In this series, those with hyalin in
more than 10% of hepatocytes did
not survive the immediate postopera
tive period.
The significance of alcoholic hyalin
and of alcoholic hepatitis in the prog
nosis of alcoholic liver disease is con
troversial. In general, it is agreed that
the presence of alcoholic hyalin usu
ally is associated with more severe
parenchymal injury and a greater
risk of disease progression.18,1115 Some
investigators have reported increased
morbidity and mortality when hyalin
is seen in the liver1’'14,16 whereas
others have found no significant dif
ferences in mortality. Thus, in 257
patients with alcoholic liver disease,
Harinasuta and Zimmerman6 found
no differences in mortality between
100 patients with alcoholic hyalin in
their biopsy specimens and 157 pa
tients without it. They did not specify
the amount of hyalin present.
There is greater controversy con
cerning the value of preoperative liver
biopsy in predicting the outcome of
portasystemic shunting.
Gall and Keirle5 in 1965 were the
first to report the relation of patholo
gic factors to shunt survival. They
examined biopsy specimens or livers
at autopsy from 63 patients who had
undergone portasystemic shunting.
They found that all five patients who
exhibited acute alcoholic hepatitis
died in the immediate postoperative
period. Four other patients with alco
holic cirrhosis but without hepatitis,
survived. They concluded that opera
tion should be particularly avoided
when parenchymal necrosis is accom
panied by alcoholic hepatitis.
In 1968 when Mikkleson and asso
ciates16 first reported on their shunted
patients they noted that 65% of those
with hyalin necrosis died compared
with none of those without it. Mik
kleson8 further carried out a prospec
tive controlled study of electively
shunted patients, all of whom were
Child’s group A (Table II). Shunting
was preceded by liver biopsy and,

although those with alcoholic hyalin
were to be excluded, unintentionally
six with hyalin in 5% or less of hepa
tocytes and three with 5% to 25%
hyalin had shunts. All those with less
than 5% hyalin survived, but two of
those with 5% to 25% hyalin died.
This compared with one death in 19
shunted patients who had no alcoholic
hyalin in the hepatocytes. Of 12
patients with more than 25% hepa
tocytes containing hyalin, none were
shunted and only 4 survived. Two of
the four survivors later showed
biopsy-proven resolution of hyalin
necrosis, were shunted and survived.
One inadvertently had a shunt despite
persisting alcoholic hyalin and he died
postoperatively. The authors con
cluded that moderate to severe degree
of acute hyalin necrosis adversely
influences survival after portacaval
shunting.
More recently Eckhauser and asso
ciates4 confirmed the importance of
the quantity of hyalin in determining
shunt prognosis. In their study, pa
tients with many Mallory bodies had
a "survival half life” of 0.2 years
and 1-year survival rate of 10%,
whereas those with little or absent
hyalin had a “patient survival half
life” of 5 years and a 1-year survival
rate of 72%.4
The opposite viewpoint, that the
finding of alcoholic hepatitis in pre
operative liver biopsy specimens does
not affect survival, is taken by Rouselot and coworkers,9 including Hans
Popper. This group studied 201
biopsy specimens from shunted pa
tients and found a low operative
mortality and no difference in sur
vival between those patients whose
specimens had hyalin or necrosis and
those that did not (85% and 88%,
respectively). They concluded that ne
crosis with or without hyalin is not
associated with an unacceptable mor
tality and that liver biopsy should not
be the determining factor in the de
cision to do elective shunts.
Kanel and associates7 have sup
ported this view. In their study of
45 patients with Laennac’s cirrhosis
they found no difference in survival
between those with active and those
with inactive cirrhosis and they com
mented that even patients with florid
alcoholic hepatitis at the time of
shunting lived for many years after
the shunt.
It should be noted that neither of
these two later studies quantitated
the amount of the hyalin present or
the degree of alcoholic hepatitis. Our
study and Mikkleson’s8,16 indicate that
quantitation, especially when applied

to alcoholic hyalin, is valuable in
predicting those at risk for shunting
(Table II).
We believe that the findings of
preoperative liver biopsy are im
portant in deciding whether to per
form a shunt in the individual patient.
While many patients with milder
degrees of activity may survive the
operation, those with severe alcoholic
hepatitis and particularly those with
hyalin in more than 10% of hepato
cytes should not be shunted until there
is biopsy-proven resolution of the
histologic changes. We found that the
Child’s groupings were not as reliable
as amount of alcoholic hyalin in the
specimen.
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maximum S35.000 per annum.
Fellowship is for one year
but second year application antici
pated.

For application forms contact:
KIDNEY FOUNDATION OF CANADA
Alberta Branch
103, 5920- 1 A St SW
Calgary, Alberta, Canada
T2H 0G3
APPLICATIONS NOT ACCEPTED
AFTER OCTOBER 31, 1981
S81-017
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Victor W. Fazio, MB, BS, FRACS
Chairman,
Dept, of Colon and Rectal Surgery
Cleveland Clinic Foundation,
Cleveland, Ohio
FRIDAY, NOVEMBER 6, 1981
at the Main Lecture Auditorium
Toronto General Hospital

For further information contact your local
Auto Suture® representative, or telephone:
(519) 685-9594
S81-016

445
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ETH ICON*
Innovators in wound closure

* E thicon S utures Ltd.

PROXIMATE staplers have been
proven 99% reliable in actual use

superior cos

lion
: results

Excellent control, improved accuracy
The PROXIMATE disposable skin stapler is a fast, simple
closing device that can reduce operating time and provide
excellent cosmetic results. This instrument is designed to
fit your hand for comfortable, easy use. Smooth trigger
action with less firing force and flexible work angle
provide excellent control and accuracy.
Minimal trauma, staples removed easily
The PROXIMATE stapler forms virtually inert rectangular

shaped stainless steel staples. Wound edges are held
together by the staple’s legs. Tissue reaction and trauma
are minimal. Wider crowns keep the staples upright,
minimizing rotation, easing removal.
Staple counts and sizes for all closing needs
PROXIMATE products are available with regular and wide
staples in counts of 15, 35, and 55 to meet closing needs
for short, medium, and long incisions.

Faster, easier approximation.
Consistent, reliable skin coaptation.

Staples placed accurately.
Designed for precise placement.

Staples removed quickly.
Extraction easy for surgeon and
patien

Touch skin lightly using
centerline indicator and guide
notch to ensure equidistant staple
placement across the incision.
Fire, release com pletely, and
withdraw Instrum ent with
backward m otion.

Ample space between staple
crown and skin surface minimizes
crosshatching and eases staple
extraction. Properly placed staples
provide accurate apposition with
minimal tension.

Extractor designed for easy
removal of staples. S im ply
position ja w s beneath staple
span, squeeze handles until
fu lly closed, and lift staple.

Superior cosmetic results.

TI-CRON

... and where it counts at
the heart of the matter.
Ti-cron, a braided polyester suture
with a unique silicone treatment.
The silicone coating is exclusive to
Davis & Geek and results in a smooth
ness and suppleness unexcelled by
other polyester sutures.

DAVIS+GECK

/

where progress is born

Cyanamid Canada Inc.
2255 Sheppard Ave. East,
Willowdale, Ont. M2J 4Y5

